Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (24613)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 14, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol 2016; 22(34): 7824-7840 [PMID: 27678366 DOI: 10.3748/wjg.v22.i34.7824] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v22/i34/7824.htm |
| Number | Citing Articles |
| 1 |
Chikako Yamamoto, Shintaro Nagashima, Channarena Chuon, Ko Ko, Son Huy Do, Oline Lim, Sirany Hok, Somana Svay, Junko Matsuo, Keiko Katayama, Kazuaki Takahashi, Junko Tanaka. Substitution of the CD81 Binding Site and β-Sandwich Area in E2 of HCV in Cambodia. Viruses 2020; 12(5): 551 doi: 10.3390/v12050551
|
| 2 |
Saleh A. Alqahtani, Mark S. Sulkowski. Chronic Hepatitis C. Medical Clinics of North America 2023; 107(3): 423 doi: 10.1016/j.mcna.2023.01.001
|
| 3 |
Hailong Wang, Xiu Xin, Mingzhen Wang, Lingling Han, Jiadai Li, Yao Hao, Congyi Zheng, Chao Shen. Myxovirus resistance protein A inhibits hepatitis C virus replication through JAK-STAT pathway activation. Archives of Virology 2018; 163(6): 1429 doi: 10.1007/s00705-018-3748-3
|
| 4 |
Vera Holzmayer, Russell Taylor, Mary C. Kuhns, Susan H. Gawel, Nicaise Ndembi, Dora Mbanya, Lazare Kaptue, Mary A. Rodgers, Gavin Cloherty. Evaluation of hepatitis C virus antibody assay using dried blood spot samples. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-07821-0
|
| 5 |
Ming‐Lung Yu, Wei‐Lun Tsai, Chi‐Jen Chu, Jia‐Horng Kao. Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study. The Kaohsiung Journal of Medical Sciences 2021; 37(3): 245 doi: 10.1002/kjm2.12317
|
| 6 |
Michael Bowsher, Sheldon Hiebert, Rongti Li, Alan X. Wang, Jacques Friborg, Fei Yu, Dennis Hernandez, Ying-Kai Wang, Herbert Klei, Ramkumar Rajamani, Kathy Mosure, Jay O. Knipe, Nicholas A. Meanwell, Fiona McPhee, Paul M. Scola. The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease. Bioorganic & Medicinal Chemistry Letters 2018; 28(1): 43 doi: 10.1016/j.bmcl.2017.11.005
|
| 7 |
María Q. Marín, Patricia Pérez, Karl Ljungberg, Carlos Óscar S. Sorzano, Carmen E. Gómez, Peter Liljeström, Mariano Esteban, Juan García-Arriaza, J.-H. James Ou. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV. Journal of Virology 2019; 93(7) doi: 10.1128/JVI.00055-19
|
| 8 |
Fahimeh Ranjbar Kermani, Sedigheh Amini-Kafiabad, Kamran Mousavi Hosseini, Mahtab Maghsudlu, Zohreh Sharifi, Mohammad Ali Mansournia. Distribution of Hepatitis C Virus Genotypes and Related Risk Factors Among Iranian Blood Donors: A Penalized Logistic Regression. Jundishapur Journal of Microbiology 2018; 11(12) doi: 10.5812/jjm.69136
|
| 9 |
Luis Antonio Uribe‐Noguez, Alicia Ocaña‐Mondragón, José Antonio Mata‐Marín, María Elena Gómez‐Torres, Rosa María Ribas‐Aparicio, María de la Luz Martínez‐Rodríguez. Presence of rare hepatitis C virus subtypes, 2j, 2k, and 2r in Mexico City as identified by sequencing. Journal of Medical Virology 2018; 90(7): 1277 doi: 10.1002/jmv.25070
|
| 10 |
Suhail H Al-Amad. Willingness of dentists in the United Arab Emirates to perform restorative and surgical treatments for patients infected with hepatitis C. Archives of Public Health 2021; 79(1) doi: 10.1186/s13690-021-00756-4
|
| 11 |
Irina Volinsky, Salvo Danilo Lombardo, Paz Cheredman. Stability Analysis and Cauchy Matrix of a Mathematical Model of Hepatitis B Virus with Control on Immune System near Neighborhood of Equilibrium Free Point. Symmetry 2021; 13(2): 166 doi: 10.3390/sym13020166
|
| 12 |
I. A. Goncharova, A. A. Zarubin, N. P. Babushkina, I. A. Koroleva, M. S. Nazarenko. Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma. Vavilov Journal of Genetics and Breeding 2023; 27(1): 72 doi: 10.18699/VJGB-23-10
|
| 13 |
Benli Jia, Yong Wang, Gang Yu, Yunsheng Cheng, Chuang Yang, Feng Cao, Yan He, Pengwei Cao, Xiangling Meng, Dongsheng Yu. Naringenin ameliorates insulin resistance by modulating endoplasmic reticulum stress in hepatitis C virus-infected liver. Biomedicine & Pharmacotherapy 2019; 115: 108848 doi: 10.1016/j.biopha.2019.108848
|
| 14 |
Paul Alain Tagnouokam-Ngoupo, Marie Nicole Ngoufack, Sebastien Kenmoe, Simon Frédéric Lissock, Marie Amougou-Atsama, Robert Banai, Laure Ngono, Richard Njouom. Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patients. Virology Journal 2019; 16(1) doi: 10.1186/s12985-019-1214-9
|
| 15 |
Nadine Ahmed, Noreen Ahmed, Roxana Filip, John Paul Pezacki. Nuclear Receptors. 2021; : 315 doi: 10.1007/978-3-030-78315-0_13
|
| 16 |
Arnolfo Petruzziello, Rocco Sabatino, Giovanna Loquercio, Annunziata Guzzo, Lucia Di Capua, Francesco Labonia, Anna Cozzolino, Rosa Azzaro, Gerardo Botti, Yury E. Khudyakov. Nine-year distribution pattern of hepatitis C virus (HCV) genotypes in Southern Italy. PLOS ONE 2019; 14(2): e0212033 doi: 10.1371/journal.pone.0212033
|
| 17 |
Nelson Veiga Gonçalves, Claudia do Socorro Carvalho Miranda, Juan Andrade Guedes, Larissa de Cássia Tork da Silva, Elizabeth Maciel Barros, Cileide Gomes da Mota Tavares, Vera Regina da Cunha Menezes Palácios, Simone Beverly Nascimento da Costa, Helena Cunha Oliveira, Marília Brasil Xavier. Hepatites B e C nas áreas de três Centros Regionais de Saúde do Estado do Pará, Brasil: uma análise espacial, epidemiológica e socioeconômica. Cadernos Saúde Coletiva 2019; 27(1): 1 doi: 10.1590/1414-462x201900010394
|
| 18 |
А. A. Latanova, K. K. Tuchinskaya, E. S. Starodubova, V. L. Karpov. Hepatitis C Virus Nonstructural Protein 3 Increases Secretion of Interleukin-1beta in HEK293T Cells with Reconstructed NLRP3 Inflammasome. Молекулярная биология 2023; 57(5): 863 doi: 10.31857/S0026898423050099
|
| 19 |
Stephen Ejeh, Adamu Uzairu, Gideon A. Shallangwa, Stephen E. Abechi. In Silico Design, Drug-Likeness and ADMET Properties Estimation of Some Substituted Thienopyrimidines as HCV NS3/4A Protease Inhibitors. Chemistry Africa 2021; 4(3): 563 doi: 10.1007/s42250-021-00250-y
|
| 20 |
Luis Antonio Uribe-Noguez, Alicia Ocaña-Mondragón, José Antonio Mata-Marín, Allison Cázares-Cortázar, Rosa María Ribas-Aparicio, María Elena Gómez-Torres, Jesus Gaytán-Martínez, María de la Luz Martínez-Rodríguez. Case report: Identification of recombinant HCV genotype 1b–2b by viral sequencing in two patients with treatment failure, who responded to re-treatment with sofosbuvir and daclatasvir. Journal of Infection and Chemotherapy 2018; 24(11): 928 doi: 10.1016/j.jiac.2018.04.001
|
| 21 |
Mingjie Xu, Fang Liu, Qianqian Zhao, Yunying Zhou, Yuanmei Zhuang, Mingyu Ji. Seroprevalence of hepatitis C virus in Jinan, China, 2008–2020. European Journal of Medical Research 2023; 28(1) doi: 10.1186/s40001-023-01063-0
|
| 22 |
Resat Ozaras, Hakan Leblebicioglu. Viral Hepatitis: Chronic Hepatitis C. 2019; : 1 doi: 10.1007/978-3-030-03757-4_1
|
| 23 |
Pamela S. Belperio, Troy A. Shahoumian, Timothy P. Loomis, Larry A. Mole, Lisa I. Backus. Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3. Journal of Hepatology 2019; 70(1): 15 doi: 10.1016/j.jhep.2018.09.018
|
| 24 |
T. Joseph Mattingly, Bryan L. Love, Bilal Khokhar. Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review. PharmacoEconomics 2020; 38(9): 927 doi: 10.1007/s40273-020-00933-3
|
| 25 |
Md Arifur Rahman, Md Monirul Islam, Md Eunus Ali, Mohammad Ariful Islam, Farhana Afroze, Mohammad Shamim Hossain, Ahmed Abu Rus'd. Molecular Epidemiology of HCV RNA Genotype-3 in Dhaka City, Bangladesh. Global Medical Genetics 2023; 10(03): 199 doi: 10.1055/s-0043-1771182
|
| 26 |
Mohammad Sultan Khuroo. Viral Hepatitis: Acute Hepatitis. 2019; : 77 doi: 10.1007/978-3-030-03535-8_6
|
| 27 |
Nelba T. G. P. Miranda, Ronaldo L. de Souza, Jacqueline C. Monteiro, Iran B. Costa, Leonardo Q. Siravenha, Anderson L. B. da Luz, Núbia C. C. de Almeida, Aldemir B. Oliveira‐Filho, Rogério V. Laurentino, Luiz F. A. Machado. Seroprevalence of HBV and HCV in female sex workers from four cities in the state of Pará, northern Brazil. Journal of Medical Virology 2021; 93(6): 3730 doi: 10.1002/jmv.26759
|
| 28 |
Sanja Matic, Suzana Popovic, Dejan Baskic, Danijela Todorovic, Nenad Vukovic, Milan Stankovic, Predrag Djurdjevic, Nemanja Zdravkovic, Zeljko Mijailovic. Methanolic Extract of Teucrium Polium Exerts Immunomodulatory Properties in Human Peripheral Blood Mononuclear Cells. Serbian Journal of Experimental and Clinical Research 2022; 23(4): 345 doi: 10.2478/sjecr-2020-0018
|
| 29 |
Ali Ghasemi, Maryam Zadsar, Mojgan Shaiegan, Shahram Samiei, Ali Namvar, Mahboobeh Rasouli, Molood Moosanejad. Human platelet antigens polymorphisms; association to the development of liver fibrosis in patients with chronic hepatitis C. Journal of Medical Virology 2020; 92(1): 45 doi: 10.1002/jmv.25423
|
| 30 |
Jin Won Kwon, Ha Jin Tchoe, Jayoun Lee, Jae Kyung Suh, Jeong-Hoon Lee, Sangjin Shin. The Impact of National Surveillance for Liver Cancer: Results from Real-World Setting in Korea. Gut and Liver 2020; 14(1): 108 doi: 10.5009/gnl18522
|
| 31 |
Berhanu Elfu Feleke, Teferi Elfu Feleke, Wondimu Gebrekiros Adane, Abel Girma. Impacts of hepatitis B and hepatitis C co-infection with tuberculosis, a prospective cohort study. Virology Journal 2020; 17(1) doi: 10.1186/s12985-020-01385-z
|
| 32 |
Natasha K. Martin, Lara K. Marquez. Disease Modelling and Public Health, Part B. Handbook of Statistics 2017; 37: 93 doi: 10.1016/bs.host.2017.08.007
|
| 33 |
Dowluru S.V.G.K. Kaladhar, Tantravahi Srinivasan. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 257 doi: 10.1016/B978-0-323-98806-3.00005-2
|
| 34 |
Na He, Gong Feng, Shuai Hao, Meiqi Xu, Jing Liu, Fanjiao Kong, Zhuoxu Ren, Wenli Dou, Chengzi Yao, Tian Liang, Juan Wang. The impact of direct-acting antivirals on quality of life in patients with hepatitis C virus infection: a meta-analysis. Annals of Hepatology 2022; 27(4): 100705 doi: 10.1016/j.aohep.2022.100705
|
| 35 |
Ahmed Arafa, Ehab S. Eshak, Tarek A. Abdel Rahman, Manal M. Anwar. Hepatitis C virus infection and risk of pancreatic cancer: A meta-analysis. Cancer Epidemiology 2020; 65: 101691 doi: 10.1016/j.canep.2020.101691
|
| 36 |
Tarek Mohamed Kamal Motawi, Dina Sabry, Nagwa Ibrahim Shehata, Mira Magdy William, Atef Tadros Fahim. Impact of FOXP1 rs2687201 genetic variant on the susceptibility to HCV‐related hepatocellular carcinoma in Egyptians. Journal of Biochemical and Molecular Toxicology 2022; 36(3) doi: 10.1002/jbt.22965
|
| 37 |
Imam Waked, Sherif Alsammany, Sayed Hammad Tirmazy, Kakil Rasul, Jafar Bani‐Issa, Wael Abdel‐Razek, Ashraf Omar, Amr Shafik, Salem Eid, Amr Abdelaal, Ahmed Hosni, Gamal Esmat. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region. Liver International 2023; 43(10): 2062 doi: 10.1111/liv.15685
|
| 38 |
Uyen Mui, Christopher Haley, Stephen Tyring. Viral Oncology: Molecular Biology and Pathogenesis. Journal of Clinical Medicine 2017; 6(12): 111 doi: 10.3390/jcm6120111
|
| 39 |
M. Conti, T. Matulli Cavedagna, E. Ramazzotti, R. Mancini, L. Calza, M. Rinaldi, L. Badia, V. Guardigni, P. Viale, G. Verucchi. Multiplexed therapeutic drug monitoring (TDM) of antiviral drugs by LC–MS/MS. Clinical Mass Spectrometry 2018; 7: 6 doi: 10.1016/j.clinms.2017.12.002
|
| 40 |
Ahmed Atef Mesalam, Isabelle Desombere, Ali Farhoudi, Freya Van Houtte, Lieven Verhoye, Jonathan Ball, Jean Dubuisson, Steven K.H. Foung, Arvind H. Patel, Mats A.A. Persson, Geert Leroux-Roels, Philip Meuleman. Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1. Virology 2018; 514: 30 doi: 10.1016/j.virol.2017.10.019
|
| 41 |
Abdel-Rahman N. Zekri, Abeer A. Bahnassy, Mona S. Abdellateif. Hepatitis C - From Infection to Cure. 2018; doi: 10.5772/intechopen.76763
|
| 42 |
Jae-Cheol Kwon, Hye Young Chang, Oh Young Kwon, Ji Hoon Park, In Soo Oh, Hyung Joon Kim, Jun Hyung Lee, Ha-Jung Roh, Hyun Woong Lee. Seroepidemiology of Hepatitis Viruses and Hepatitis B Genotypes of Female Marriage Immigrants in Korea. Yonsei Medical Journal 2018; 59(9): 1072 doi: 10.3349/ymj.2018.59.9.1072
|
| 43 |
Cesar Henriquez-Camacho, Núria Serre, Francesca Norman, Adrián Sánchez-Montalvá, Diego Torrús, Ane Josune Goikoetxea, Juan María Herrero-Martínez, José Manuel Ruiz-Giardín, Begoña Treviño, Begoña Monge-Maillo, Israel Molina, Azucena Rodríguez, Magdalena García, Rogelio López-Vélez, José A. Pérez-Molina, Paloma Aguilera, María Martínez Serrano, Magdalena García Rodriguez, Marta Díaz Menendez, Yolanda Meije, Joaquim Martínez-Montauti, Xavier Sanz, Isabel Pacheco Tenza, Inmaculada Gonzalez Cuello, Belén Martínez López, Jara LLenas, Mar Masiá, Sergio Padilla, Mónica Romero, Philip Wilkman-Jorgensen, Diego Torrús, José Manuel Ramos Rincón, Eduardo Malmierca, Ana Perez-Ayala, Juan María Herrero, Manuel Lizasoain, Pablo Rojo, Mariano Matarranz, Carlos Zarco, Azucena Rodriguez-Guardado, Jonathan Fernández Suárez, Jose Antonio Boga Ribeiro, Josune Goikoetxea Aguirre, Miren Zuriñe Zubero Sulibarría, José Manuel Ruiz Giardin, Juan Victor Sanmartín López, María Velasco Arribas, Eva Calabuig Muñoz, Ana Mena Ribas, María Peñaranda Vera, Israel Molina, Adrián Sánchez Montalvá, Fernando Salvador, Ángel Dominguez, Francesca Norman, Begoña Treviño-Maruri, Nuria Serre Delcor, Antonio Soriano-Arandes, Diana Pou Ciruelo, Cristina Bocanegra. Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the +Redivi network. Travel Medicine and Infectious Disease 2019; 29: 51 doi: 10.1016/j.tmaid.2019.02.001
|
| 44 |
Jia-Horng Kao, Chun-Yen Lin, Wan-Long Chuang, Yao-Yun Cheng, Jui-Yu Hu, Wen-Kai Liang, Peter Friebe, Stuart Palmer, Chin-Shiou Huang. Clinical evaluation of IntelliPlexTM HCV genotyping kit for hepatitis C virus genotyping. Diagnostic Microbiology and Infectious Disease 2019; 94(4): 344 doi: 10.1016/j.diagmicrobio.2019.02.020
|
| 45 |
Eyasu Alem Lake, Robera Olana Fite, Lielt Gebreselassie Gebrekirstos, Meron Hadis Gebremedhin, Mohammed Suleiman Obsa, Kelemu Abebe Gelaw. Seroprevalence of hepatitis c virus infection among blood donors in Ethiopia: a systematic review and meta-analysis. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-05827-z
|
| 46 |
Hasan M Isa, Fatema A Alkharsi, Jawad K Khamis, Sawsan A Hasan, Zainab A Naser, Zainab N Mohamed, Afaf M Mohamed, Shaikha A Altamimi. Pediatric and adult liver transplantation in Bahrain: The experiences in a country with no available liver transplant facilities. World Journal of Transplantation 2024; 14(1): 87752 doi: 10.5500/wjt.v14.i1.87752
Abstract(101) |
Core Tip(99) |
Full Article(HTML)(664)
|
Full Article with Cover (PDF)-1100K(8)
|
Audio-704K(0)
|
Peer-Review Report-221K(8)
|
Answering Reviewers-580K(6)
|
Supplementary Material-265K(10)
|
Full Article (PDF)-755K(34)
|
Full Article (XML)-171K(10)
|
Times Cited (0)
|
Total Visits (1333)
|
Open
|
| 47 |
Jian Zhang, Wen Sun, Jun Lin, Ye Tian, Linlin Ma, Lei Zhang, Yichen Zhu, Wei Qiu. Long-term follow-up of HCV infected kidney transplant recipients receiving direct-acting antiviral agents: a single-center experience in China. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4217-7
|
| 48 |
Geison Luiz Costa de Castro, Ednelza da Graça Silva Amoras, Mauro Sérgio Moura de Araújo, Simone Regina Souza da Silva Conde, Antonio Carlos R. Vallinoto. Hepatitis C virus genotypes and associated risk factors in the state of Pará, Northern Brazil. The Brazilian Journal of Infectious Diseases 2020; 24(4): 304 doi: 10.1016/j.bjid.2020.06.010
|
| 49 |
Huiying Rao, Huixin Liu, Elizabeth Wu, Ming Yang, Bo Feng, Andy Lin, Ran Fei, Robert J. Fontana, Lai Wei, Anna S. Lok. Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis C. JHEP Reports 2020; 2(4): 100136 doi: 10.1016/j.jhepr.2020.100136
|
| 50 |
Aiymkul Ashimkhanova, Dmitriy Syssoyev, Arnur Gusmanov, Kakharman Yesmembetov, Arina Yespotayeva, Anara Abbay, Aiymzhan Nurpeissova, Antonio Sarria-Santamera, Abduzhappar Gaipov. Epidemiological Characteristics of Chronic Viral Hepatitis in Kazakhstan: Data from Unified Nationwide Electronic Healthcare System 2014–2019. Infection and Drug Resistance 2022; : 3333 doi: 10.2147/IDR.S363609
|
| 51 |
P Guntipalli, R Pakala, S Kumari Gara, F Ahmed, A Bhatnagar, M.-K. Endaya Coronel, A.A. Razzack, A.G. Solimando, A Thompson, K Andrews, G Enebong Nya, S Ahmed, R Ranaldo, R Cozzolongo, E Shahini. Worldwide prevalence, genotype distribution and management of hepatitis C. Acta Gastro Enterologica Belgica 2021; 84(4): 633 doi: 10.51821/84.4.015
|
| 52 |
Zobair M. Younossi, Linda Henry, Janus P. Ong, Atsushi Tanaka, Yuichiro Eguchi, Masashi Mizokami, Young‐Suk Lim, Yock Young Dan, Ming‐Lung Yu, Maria Stepanova. Systematic review with meta‐analysis: extrahepatic manifestations in chronic hepatitis C virus‐infected patients in East Asia. Alimentary Pharmacology & Therapeutics 2019; 49(6): 644 doi: 10.1111/apt.15131
|
| 53 |
Rania A. Zayed, Dalia Omran, Abeer A. Zayed, Lobna O. Elmessery. Determinants of Infection Outcome in HCV-Genotype 4. Viral Immunology 2017; 30(8): 560 doi: 10.1089/vim.2017.0071
|
| 54 |
Dhruv Verma, Carina Ashkar, Sammy Saab. Cost effectiveness of direct acting antivirals in the treatment of hepatitis C in vulnerable populations. Expert Review of Pharmacoeconomics & Outcomes Research 2021; 21(1): 9 doi: 10.1080/14737167.2021.1838898
|
| 55 |
Elisabeth Kallert, Laura Almena Rodriguez, Jan-Åke Husmann, Kathrin Blatt, Christian Kersten. Structure-based virtual screening of unbiased and RNA-focused libraries to identify new ligands for the HCV IRES model system. RSC Medicinal Chemistry 2024; doi: 10.1039/D3MD00696D
|
| 56 |
Ahmed Salman, Mohamed A. Salman, Amr M. Ismaeel Saadawy, Mohamed Tourky, Mohamed Shawkat. Portal venous hemodynamics as predictors for the development and grades of esophageal varices in Post‐HCV cirrhotic patients: An Egyptian center study. Advances in Digestive Medicine 2021; 8(3): 146 doi: 10.1002/aid2.13209
|
| 57 |
Ali Nada, Aliaa Sabry, Naglaa S. Elabd, Azza M. Abdu Allah, Nada Elnaidany, Mohamed Abbasy. B-type natriuretic peptide (BNP) in HCV-positive Egyptian patients: the impact of HCV eradication on plasma BNP levels. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00133-4
|
| 58 |
Ying Yang, Feng-Ping Wu, Wen-Jun Wang, Juan-Juan Shi, Ya-Ping Li, Xin Zhang, Shuang-Suo Dang. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China. World Journal of Gastroenterology 2019; 25(44): 6551-6560 doi: 10.3748/wjg.v25.i44.6551
|
| 59 |
Muhammad Sarfaraz Iqbal, Usman Ali Ashfaq, Sadia Aslam, Saba Khaliq, Muhammad Usman Ghani, Farzana Batool. Analysis of polymorphism rs1990760 of IFIH1 gene and treatment outcomes in HCV infection. Future Virology 2018; 13(3): 181 doi: 10.2217/fvl-2017-0116
|
| 60 |
Beatriz Torres-Vázquez, Ana María de Lucas, Carlos García-Crespo, Juan Antonio García-Martín, Adrián Fragoso, María Fernández-Algar, Celia Perales, Esteban Domingo, Miguel Moreno, Carlos Briones. In vitro Selection of High Affinity DNA and RNA Aptamers that Detect Hepatitis C Virus Core Protein of Genotypes 1 to 4 and Inhibit Virus Production in Cell Culture. Journal of Molecular Biology 2022; 434(7): 167501 doi: 10.1016/j.jmb.2022.167501
|
| 61 |
Roberto da Justa Pires Neto, Elodie Bomfim Hyppolito, Geraldo Bezerra da Silva Junior. Tropical Nephrology. 2020; : 193 doi: 10.1007/978-3-030-44500-3_15
|
| 62 |
Sonia Vázquez-Morón, Beatriz Ardizone Jiménez, María A. Jiménez-Sousa, José M. Bellón, Pablo Ryan, Salvador Resino. Evaluation of the diagnostic accuracy of laboratory-based screening for hepatitis C in dried blood spot samples: A systematic review and meta-analysis. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41139-8
|
| 63 |
|
| 64 |
Xiumei Chi, Moli Wang, Yu Pan, Jing Jiang, Tao Jiang, Hongqing Yan, Ruihong Wu, Xiaomei Wang, Xiuzhu Gao, Junqi Niu. Inosine triphosphate pyrophosphatase polymorphisms are predictors of anemia in Chinese patients with chronic hepatitis C during therapy with ribavirin and interferon. Journal of Gastroenterology and Hepatology 2020; 35(1): 97 doi: 10.1111/jgh.14812
|
| 65 |
Baomin Liu, Kuo Gai, Hui Qin, Xushi Liu, Yuan Cao, Qin Lu, Dandan Lu, Deyang Chen, Hengqiao Shen, Wei Song, Yang Zhang, Xiaojin Wang, Hongjiang Xu, Yinsheng Zhang. Design, synthesis and identification of silicon-containing HCV NS5A inhibitors with pan-genotype activity. European Journal of Medicinal Chemistry 2018; 148: 95 doi: 10.1016/j.ejmech.2018.02.025
|
| 66 |
Neemat M. Kassem, Hebatallah A. Kassem, Magdy Ibrahim, Hussam Zawam, Emad Hamada. The clinical impact of hepatitis C virus infection in Egyptian multiple myeloma patients. Journal of the Egyptian National Cancer Institute 2020; 32(1) doi: 10.1186/s43046-020-00054-0
|
| 67 |
Uday Kant Sah, Anil Kumar Sah, Mehraj Ansari, Priyanka Chaudhary, Saurav Gupta, Pawan Kumar, Jay Prakash Sah. HCV Co-Infection and Its Genotypic Distribution in HIV-Infected Patients in Nepalese Population. Tropical Medicine and Infectious Disease 2023; 8(7): 361 doi: 10.3390/tropicalmed8070361
|
| 68 |
Nancy Reau, Paul Y. Kwo, Susan Rhee, Robert S. Brown, Kosh Agarwal, Peter Angus, Edward Gane, Jia‐Horng Kao, Parvez S. Mantry, David Mutimer, K. Rajender Reddy, Tram T. Tran, Yiran B. Hu, Abhishek Gulati, Preethi Krishnan, Emily O. Dumas, Ariel Porcalla, Nancy S. Shulman, Wei Liu, Suvajit Samanta, Roger Trinh, Xavier Forns. Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection. Hepatology 2018; 68(4): 1298 doi: 10.1002/hep.30046
|
| 69 |
Maria John, Seema Oommen, Ozhiparambhil Anilkumar Jagan, Sincy George, Sivan Pillai. A Study on the Circulating Genotypes of Hepatitis C Virus in a Tertiary Care Hospital in Central Kerala. Indian Journal of Medical Microbiology 2018; 36(4): 532 doi: 10.4103/ijmm.IJMM_18_239
|
| 70 |
Yucel Aydin, Milad Chedid, Srinivas Chava, Donkita Danielle Williams, Shuanghu Liu, Curt H. Hagedorn, Suchitra Sumitran-Holgersson, Krzysztof Reiss, Krzysztof Moroz, Hua Lu, Luis A. Balart, Srikanta Dash. RETRACTED ARTICLE: Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-10087-6
|
| 71 |
Ying-Wen Wang, Wei-Ping Lee, Yi-Hsiang Huang, Ming-Chih Hou, Keng-Hsin Lan. Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06657-9
|
| 72 |
Brandon Wiggins, Smit Deliwala, Fady Banno, Kyle Knight, Mark Minaudo. Acute Renal Failure and Nephrotic Syndrome Secondary to Collapsing Glomerulopathy Associated With Hepatitis C. Cureus 2022; doi: 10.7759/cureus.23175
|
| 73 |
Sanhua Wei, Yingfeng Lei, Jie Yang, Xiaoyan Wang, Fang Shu, Xin Wei, Fang Lin, Bin Li, Ying Cui, Hai Zhang, Sanhua Wei. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes. Vaccine 2018; 36(17): 2273 doi: 10.1016/j.vaccine.2018.03.036
|
| 74 |
Mona Abdel-Hady, Deirdre A. Kelly. Encyclopedia of Gastroenterology. 2020; : 113 doi: 10.1016/B978-0-12-801238-3.65710-0
|
| 75 |
Vito Emanuele Catania, Giulia Malaguarnera, Giorgia Fiorenza, Eleonora Margherita Chisari, Anna Rita Lipari, Valentino Gallina, Manuela Pennisi, Giuseppe Lanza, Michele Malaguarnera. Hepatitis C Virus Infection Increases Fatigue in Health Care Workers. Diseases 2020; 8(4): 37 doi: 10.3390/diseases8040037
|
| 76 |
Idris Abdullahi Nasir, Sa’adatu Yakubu, Jelili Olaide Mustapha. Epidemiology and Synergistic Hepatopathology of Malaria and Hepatitis C Virus Coinfection. Virology: Research and Treatment 2017; 8: 1178122X1772441 doi: 10.1177/1178122X17724411
|
| 77 |
Asma Akhter, Mahwish Javed, Muhammad Imran. Comparative Analysis of PCR and LIPA Method for HCV Genotypes Screening. BioScientific Review 2019; 1(04): 29 doi: 10.32350/BSR.0104.04
|
| 78 |
Mohamed F. Montasser, Samy Zaky, Mohamed Salaheldin, Dina Johar, Abdelrahman Ibrahim Abushouk, Fathiya El-Raey, Muneer Al-Husseini, Elsayed G. Mohammed. Fib-4 Predicts Early Hematological Adverse Events Induced by Interferon-Based Triple Therapy in Chronic Hepatitis C Virus Patients. Journal of Interferon & Cytokine Research 2019; 39(2): 85 doi: 10.1089/jir.2018.0131
|
| 79 |
Edwin N. Okafor, Innocent N. Okonkwo, Martin C. Ugonabo, Ekene E. Chukwukelu, Obiageli U. Odurukwe, Sussan N. Osiri. Emerging risk factors associated with prevalence of hepatitis c virus infection among Nigerians: Findings from blood donors in an academic hospital, Enugu South‐Eastern Nigeria. International Journal of Clinical Practice 2020; 74(3) doi: 10.1111/ijcp.13460
|
| 80 |
Guy Rostoker. When should iron supplementation in dialysis patients be avoided, minimized or withdrawn?. Seminars in Dialysis 2019; 32(1): 22 doi: 10.1111/sdi.12732
|
| 81 |
Netanel Tzarum, Ian A. Wilson, Mansun Law. The Neutralizing Face of Hepatitis C Virus E2 Envelope Glycoprotein. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01315
|
| 82 |
Murat OCAL, Mehmet Emin BULUT. Determination of anti-HCV signal to cut-off value in patients with hepatitis C virus infection and the variety of antibody responses. The European Research Journal 2023; 9(3): 484 doi: 10.18621/eurj.945588
|
| 83 |
Abdullah A. Mobarki, Maymoon M. Madkhali, Gasim Dobie, Muhammad Saboor, Aymen M. Madkhali, Basem Madkhli, Yahia Hummadi, Abdullah Meshi, Hesham M. Al-Mekhlafi, Mohammad S. Akhter, Hassan A. Hamali. Patterns of Hepatitis B, Hepatitis C and HIV Among Blood Donors in Samtah-Jazan Region. Journal of Epidemiology and Global Health 2022; 12(3): 304 doi: 10.1007/s44197-022-00051-7
|
| 84 |
Ming-Han Hsieh, Tzu-Yu Kao, Ting-Hui Hsieh, Chun-Chi Kao, Cheng-Yuan Peng, Hsueh-Chou Lai, Po-Heng Chuang, Jung-Ta Kao. Long-term surveillance of liver histological changes in chronic hepatitis C patients completing pegylated interferon-α plus ribavirin therapy: an observational cohort study. Therapeutic Advances in Chronic Disease 2022; 13: 204062232110676 doi: 10.1177/20406223211067631
|
| 85 |
Mohamed Abd Ellatif Afifi, Ahmed Mohamed Hussein, Mahmoud Rizk, Dirk Uhlmann. Low Serum 25-Hydroxy Vitamin D (25-OHD) and Hepatic Encephalopathy in HCV-Related Liver Cirrhosis. International Journal of Hepatology 2021; 2021: 1 doi: 10.1155/2021/6669527
|
| 86 |
|
| 87 |
A.I.K. Mahanama, B. Samaraweera, T.T. Niroshanie, S.S.S.A.K. Seethagala, J.I. Abeynayake. Seroprevalence of hepatitis B and C virus infection among clinically suspected patients at state sector hospitals in Sri Lanka; a laboratory-based retrospective study. Infectious Diseases 2019; 51(9): 706 doi: 10.1080/23744235.2019.1640387
|
| 88 |
Nahla Fadl, Tamer Z. Salem. Hepatitis C genotype 4: A report on resistance‐associated substitutions in NS3, NS5A, and NS5B genes. Reviews in Medical Virology 2020; 30(4) doi: 10.1002/rmv.2120
|
| 89 |
Andreza Soriano Figueiredo, Elisabeth Lampe, Pedro Pereira Lira Furtado de Albuquerque, Flávia Löwen Levy Chalhoub, Ana Maria Bispo de Filippis, Livia Melo Villar, Oswaldo Gonçalves Cruz, Marcelo Alves Pinto, Jaqueline Mendes de Oliveira. Epidemiological investigation and analysis of the NS5B gene and protein variability of non-primate hepacivirus in several horse cohorts in Rio de Janeiro state, Brazil. Infection, Genetics and Evolution 2018; 59: 38 doi: 10.1016/j.meegid.2018.01.017
|
| 90 |
Mary Malebranche, Dawn King, Jennifer Leonard. Descriptive epidemiology of hepatitis C in individuals referred for specialized HCV care in Newfoundland and Labrador, 1996–2014. Canadian Liver Journal 2018; 1(3): 107 doi: 10.3138/canlivj.2018-0013
|
| 91 |
Guillermo Garcia-Lainez, Meryem El Ouardi, Alejandro Moreno, Emilio Lence, Concepción González-Bello, Miguel A. Miranda, Inmaculada Andreu. Singlet oxygen and radical-mediated mechanisms in the oxidative cellular damage photosensitized by the protease inhibitor simeprevir. Free Radical Biology and Medicine 2023; 194: 42 doi: 10.1016/j.freeradbiomed.2022.11.006
|
| 92 |
Mohammed A. Afifi, Mohammed W. Al-Rabia, Deema I. Fallatah. Animal Models In Experimental Medicine. 2024; : 20 doi: 10.2174/9789815196382124010005
|
| 93 |
Sarwat Mahmud, Silva P. Kouyoumjian, Zaina Al Kanaani, Hiam Chemaitelly, Laith J. Abu-Raddad. Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis. Annals of Epidemiology 2018; 28(7): 452 doi: 10.1016/j.annepidem.2018.03.007
|
| 94 |
Arwa Mohammed Othman, Asma’a Ahmed Al-hnhna, Belques Sharaf Al-Huraibi, Rowa Mohammed Assayaghi, Talal Yahya Al-Qahtani, Kamal Hamoud Jahzar, Marwan Mohammed Al-Huthaifi. Prevalence of hepatitis C virus among patients with arthralgia: is it logic for screening?. Virology Journal 2023; 20(1) doi: 10.1186/s12985-023-02124-w
|
| 95 |
Virginia Sedeño-Monge, Saul Laguna-Meraz, Gerardo Santos-López, Arturo Panduro, Francisca Sosa-Jurado, Alexis Jose-Abrego, Daniel Meléndez-Mena, Marco A. Muñoz-Ramírez, Monserrat Cosme-Chávez, Sonia Roman. A comprehensive update of the status of hepatitis C virus (HCV) infection in Mexico—A systematic review and meta-analysis (2008–2019). Annals of Hepatology 2021; 20: 100292 doi: 10.1016/j.aohep.2020.100292
|
| 96 |
Luis Antonio Uribe-Noguez, José Antonio Mata-Marín, Alicia Ocaña-Mondragón, Ericka Nelly Pompa-Mera, Rosa María Ribas-Aparicio, Carla Ileana Arroyo-Anduiza, María Elena Gomez-Torres, Alberto Chaparro-Sánchez, Jesus Gaytán-Martínez, Stefan Mauss. Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico. Journal of Infection and Chemotherapy 2020; 26(2): 205 doi: 10.1016/j.jiac.2019.08.009
|
| 97 |
Vincent Roumy, Lastenia Ruiz, Juan Celidonio Ruiz Macedo, Andrea-Luz Gutierrez-Choquevilca, Jennifer Samaillie, Leonor Arévalo Encinas, Wilfredo Ruiz Mesia, Hivelli Ericka Ricopa Cotrina, Céline Rivière, Sevser Sahpaz, Simon Bordage, Guillaume Garçon, Jean Dubuisson, Sebastien Anthérieu, Karin Seron, Thierry Hennebelle. Viral hepatitis in the Peruvian Amazon: Ethnomedical context and phytomedical resource. Journal of Ethnopharmacology 2020; 255: 112735 doi: 10.1016/j.jep.2020.112735
|
| 98 |
Muhammad Usman Ashraf, Kanzal Iman, Muhammad Farhan Khalid, Hafiz Muhammad Salman, Talha Shafi, Momal Rafi, Nida Javaid, Rashid Hussain, Fayyaz Ahmad, Syed Shahzad‐Ul‐Hussan, Shaper Mirza, Muhammad Shafiq, Samia Afzal, Sadia Hamera, Saima Anwar, Romena Qazi, Muhammad Idrees, Sohail A. Qureshi, Safee Ullah Chaudhary. Evolution of efficacious pangenotypic hepatitis C virus therapies. Medicinal Research Reviews 2019; 39(3): 1091 doi: 10.1002/med.21554
|
| 99 |
Gökhan ÖZGÜR, Esmeray MUTLU YILMAZ. Comparison of anti-HCV seroprevalence of patients who underwent cataract surgery and other ophthalmic procedures. Anatolian Current Medical Journal 2023; 5(4): 395 doi: 10.38053/acmj.1346900
|
| 100 |
Olena Ye. Fartushna, Maria M. Prokopiv, Victoria Y. Krylova, Svitlana V. Rohoza, Hanna V. Palahuta, Yana Y. Hnepa, Yevhen M. Fartushnyi. ASEPTIC MENINGITIS AS AN EXTRAHEPATIC MANIFESTATION OF HEPATITIS C: A CLINICAL CASE PRESENTATIONIN A WHITE YOUNG FEMALE EUROPEAN ADULT. Wiadomości Lekarskie 2022; 75(4): 1043 doi: 10.36740/WLek20220420123
|
| 101 |
Kholoud A. Elkashef, Wafaa A. Emam, Noha M. Mesbah, Dina M. Abo-Elmatty, Asmaa R. Abdel-Hamed. Prevalence of Occult Hepatitis C Virus Infection in Egyptian Patients with Lymphoma: A New Vision. Diagnostics 2022; 12(4): 1015 doi: 10.3390/diagnostics12041015
|
| 102 |
Page Axley, Zunirah Ahmed, Sujan Ravi, Ashwani K. Singal. Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review. Journal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00067
|
| 103 |
Yange Lang, Fangfang Li, Qiang Liu, Zhiqiang Xia, Zhenglin Ji, Juan Hu, Yuting Cheng, Minjun Gao, Fang Sun, Bingzheng Shen, Chang Xie, Wei Yi, Yingliang Wu, Jing Yao, Zhijian Cao. The Kv1.3 ion channel acts as a host factor restricting viral entry. The FASEB Journal 2021; 35(2) doi: 10.1096/fj.202000879RR
|
| 104 |
Maria R. Emma, Giuseppa Augello, Antonella Cusimano, Antonina Azzolina, Giuseppe Montalto, James A. McCubrey, Melchiorre Cervello. GSK-3 in liver diseases: Friend or foe?. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2020; 1867(9): 118743 doi: 10.1016/j.bbamcr.2020.118743
|
| 105 |
Hamid Heidarian Miri, Pooria Fazeli, Mohammad Ali-Hassanzadeh, Peyman Bemani, Dieter Kabelitz, Kurosh Kalantar. Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis. Archives of Virology 2021; 166(9): 2469 doi: 10.1007/s00705-021-05141-8
|
| 106 |
Priya Madan Yabaji, Aruna Shankarkumar, Akash Shukla, Shobna Bhatia. Hepatitis C Virus Infection in a Tertiary Care Hospital in Mumbai, India: Identification of a Mixed and Novel Genotype. Indian Journal of Medical Microbiology 2018; 36(3): 352 doi: 10.4103/ijmm.IJMM_18_221
|
| 107 |
Hsu-Heng Yen, Yang-Yuan Chen, Jun-Hung Lai, Hung-Ming Chen, Chih-Ta Yao, Siou-Ping Huang, I-Ling Liu, Ya-Huei Zeng, Fang-Chi Yang, Fu-Yuan Siao, Mei-Wen Chen, Pei-Yuan Su. Pan-Genotypic Direct-Acting Antiviral Agents for Undetermined or Mixed-Genotype Hepatitis C Infection: A Real-World Multi-Center Effectiveness Analysis. Journal of Clinical Medicine 2022; 11(7): 1853 doi: 10.3390/jcm11071853
|
| 108 |
ROBERT S. EGERMAN. New Antiviral Agents for Treatment of Hepatitis C. Clinical Obstetrics & Gynecology 2019; 62(4): 823 doi: 10.1097/GRF.0000000000000457
|
| 109 |
Rosangela Gaze, Luiz Carlos Fadel de Vasconcellos. Exposicao ocupacional à hepatite C: saber operário e rotas inexploradas de propagação do vírus. Revista Brasileira de Saúde Ocupacional 2020; 45 doi: 10.1590/2317-6369000015319
|
| 110 |
P Huang, CH Wang, LY Zhuo, XS Xia, S Yang, JW Zhang, HZ Fan, JJ Wu, R Yu, M Yue, Y Zhang. Polymorphisms rs763110 in FASL is linked to hepatitis C virus infection among high-risk populations. British Journal of Biomedical Science 2020; 77(3): 112 doi: 10.1080/09674845.2020.1747182
|
| 111 |
O. C. Smibert, M. A. Paraskeva, G. Westall, Greg Snell. An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients. Pediatric Drugs 2018; 20(6): 539 doi: 10.1007/s40272-018-0313-1
|
| 112 |
Geison Luiz Costa de Castro, Ednelza da Silva Graça Amoras, Mauro Sérgio Araújo, Simone Regina Souza da Silva Conde, Carlos David Araújo Bichara, Maria Alice Freitas Queiroz, Antonio Carlos Rosário Vallinoto. High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection. European Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00809-6
|
| 113 |
Ahmad Adebayo Irekeola, Nurul Adila Malek, Yusuf Wada, Nazri Mustaffa, Nur Izat Muhamad, Rafidah Hanim Shueb, Isabelle Chemin. Prevalence of HCV genotypes and subtypes in Southeast Asia: A systematic review and meta-analysis. PLOS ONE 2021; 16(5): e0251673 doi: 10.1371/journal.pone.0251673
|
| 114 |
C. An, W. Ma, R. F. He, T. Wu, J. N. Shi, T. T. Sun, W. H. Piao. Hepatitis C virus genotype diversity in Ningxia Hui autonomous region, Northwestern China. Brazilian Journal of Biology 2023; 83 doi: 10.1590/1519-6984.267641
|
| 115 |
Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park, Yoon Tae Jeen. Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases. Intestinal Research 2020; 18(1): 18 doi: 10.5217/ir.2019.09155
|
| 116 |
Reem M. Aljowaie, Fahad N. Almajhdi, Hebatallh H. Ali, Mohammad S. El-Wetidy, Medhat K. Shier. Inhibition of hepatitis C virus genotype 4 replication using siRNA targeted to the viral core region and the CD81 cellular receptor. Cell Stress and Chaperones 2020; 25(2): 345 doi: 10.1007/s12192-020-01077-1
|
| 117 |
Serge Ouoba, Jean Claude Romaric Pingdwinde Ouedraogo, Moussa Lingani, Bunthen E, Md Razeen Ashraf Hussain, Ko Ko, Shintaro Nagashima, Aya Sugiyama, Tomoyuki Akita, Halidou Tinto, Junko Tanaka. Epidemiologic profile of hepatitis C virus infection and genotype distribution in Burkina Faso: a systematic review with meta-analysis. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06817-x
|
| 118 |
James S. Ford, Erika Hollywood, Bradley Steuble, Zichun Meng, Stephanie Voong, Tasleem Chechi, Nam Tran, Larissa May. Risk factors for hepatitis C virus infection at a large urban emergency department. Journal of Viral Hepatitis 2022; 29(10): 930 doi: 10.1111/jvh.13730
|
| 119 |
Henrique Pott, Guilherme Bricks, Jorge Figueiredo Senise, Adauto Castelo. Chronic alcohol abuse and spontaneous clearance of hepatitis C virus. IDCases 2019; 17: e00534 doi: 10.1016/j.idcr.2019.e00534
|
| 120 |
E. R. Chernykh, E. A. Oleynik, O. Yu. Leplina, M. A. Tikhonova, T. V. Tyrinova, N. M. Starostina, A. A. Ostanin. Induction of HCV-specific cell response in vitro by dendritic cells generated with interferon-α. Russian Journal of Infection and Immunity 2019; 9(1): 76 doi: 10.15789/2220-7619-2019-1-76-86
|
| 121 |
Letitia Shunmugam, Pritika Ramharack, Mahmoud E. S. Soliman. Road Map for the Structure-Based Design of Selective Covalent HCV NS3/4A Protease Inhibitors. The Protein Journal 2017; 36(5): 397 doi: 10.1007/s10930-017-9736-8
|
| 122 |
Francesca Ceccherini-Silberstein, Valeria Cento, Velia Chiara Di Maio, Carlo Federico Perno, Antonio Craxì. Viral resistance in HCV infection. Current Opinion in Virology 2018; 32: 115 doi: 10.1016/j.coviro.2018.10.005
|
| 123 |
Nikola Kokanov, Snezana Jovanovic-Cupic, Marina Siljic, Valentina Cirkovic, Nina Petrovic, Bojana Kozik, Milena Krajnovic. Variability of the HCV core region and host genetic and epigenetic factors can predict the response to pegylated interferon/ribavirin therapy in genotype 1b hepatitis C patients from Serbia. Archives of Biological Sciences 2023; 75(3): 251 doi: 10.2298/ABS230316020K
|
| 124 |
Nahed Mohammed Hawsawi, Tamer Saber, Hussein M. Salama, Walaa S. Fouad, Howaida M. Hagag, Hayaa M. Alhuthali, Emad M. Eed, Taisir Saber, Khadiga A. Ismail, Hesham H. Al Qurashi, Samir Altowairqi, Mohmmad Samaha, Dalia El-Hossary. Genotypes of Hepatitis C Virus and Efficacy of Direct-Acting Antiviral Drugs among Chronic Hepatitis C Patients in a Tertiary Care Hospital. Tropical Medicine and Infectious Disease 2023; 8(2): 92 doi: 10.3390/tropicalmed8020092
|
| 125 |
William B. Coleman, Gregory J. Tsongalis. Molecular Pathology. 2018; : 231 doi: 10.1016/B978-0-12-802761-5.00012-2
|
| 126 |
Tarek Hassanein, Dean Tai, Chenghai Liu, Terry D. Box, Myron J. Tong, Lorenzo Rossaro, Renee Pozza, Jeffrey S. Glenn, Ramsey Cheung, Ammar Hemaidan, Yingchun He, Cynthia Behling, Xiqi Hu, Hala Makhlouf, Haina Fan, Yayun Ren, Elaine Lay Khim Chng, Ping Liu, John M. Vierling, Jian-You Guo. Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/4494099
|
| 127 |
Vasil B. Krapchev, Malgorzata Rychłowska, Alicja Chmielewska, Karolina Zimmer, Arvind H. Patel, Krystyna Bieńkowska-Szewczyk. Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice. Virology 2018; 519: 33 doi: 10.1016/j.virol.2018.03.026
|
| 128 |
Radwa Samir Hagag, Morkoss Medhat Fakhry, Ossama Ashraf Ahmed, Shaimaa Abdalaleem Abdalgeleel, Mahasen Aly Radwan, Gina Gamal Naguib. Assessment of efficacy and safety of two Egyptian protocols for treatment-experienced HCV patients: an observational study. The Egyptian Journal of Internal Medicine 2022; 34(1) doi: 10.1186/s43162-022-00126-8
|
| 129 |
Zabihollah Shoja, Maryam Chenari, Ali Jafarpour, Somayeh Jalilvand. Role of iron in cancer development by viruses. Reviews in Medical Virology 2019; 29(4) doi: 10.1002/rmv.2045
|
| 130 |
Yeimer Ortiz-Martínez, Santiago Castellanos-Mateus, Heiner Rojas-Moreno, Justin Suárez-Molina. YouTube videos as a source of Hepatitis C-related information: A cross-sectional study. Travel Medicine and Infectious Disease 2020; 37: 101708 doi: 10.1016/j.tmaid.2020.101708
|
| 131 |
Rui Huang, Huiying Rao, Qing Xie, Zhiliang Gao, Wu Li, Deyuan Jiang, Hongmei Mo, Benedetta Massetto, Luisa M. Stamm, Diana M. Brainard, Lai Wei. Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infection. Journal of Medical Virology 2019; 91(7): 1313 doi: 10.1002/jmv.25454
|
| 132 |
Taciana Pereira Sant'Ana Santos, Mariana de Menezes Pereira, Maria Isabel Schinoni, Geraldo Pedral Sampaio, Roque Aras, Maria Luiza Sousa Atta, Ajax M. Atta. Atherogenic cytokines and chemokines in chronic hepatitis C are not associated with the presence of cardiovascular diseases. Cytokine 2019; 115: 24 doi: 10.1016/j.cyto.2018.12.005
|
| 133 |
Jiuhong Zha, Bifeng Ding, Haoyu Wang, Weihan Zhao, Chen Yu, Katia Alves, Niloufar Mobashery, Yan Luo, Rajeev M. Menon. Pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir in Healthy Chinese Subjects and HCV GT1b-Infected Chinese, South Korean and Taiwanese Patients. European Journal of Drug Metabolism and Pharmacokinetics 2019; 44(1): 43 doi: 10.1007/s13318-018-0492-8
|
| 134 |
Ivan Alekseevich Akimov, D. I. Timofeev, A. R. Mavzyutov, M. K. Ivanov. Detection of circulating HCV recombinant form RF1_2k/1b in blood serum of patients by real-time RT-PCR. Russian Clinical Laboratory Diagnostics 2021; 66(2): 122 doi: 10.51620/0869-2084-2021-66-2-122-128
|
| 135 |
Yoshimi Shimizu, Yoshitaka Shirasago, Masuo Kondoh, Tetsuro Suzuki, Takaji Wakita, Kentaro Hanada, Kiyohito Yagi, Masayoshi Fukasawa, Michael S. Diamond. Monoclonal Antibodies against Occludin Completely Prevented Hepatitis C Virus Infection in a Mouse Model. Journal of Virology 2018; 92(8) doi: 10.1128/JVI.02258-17
|
| 136 |
Keyla Santos Guedes de Sá, Ednelza da Silva Graça Amoras, Simone Regina Souza da Silva Conde, Maria Alice Freitas Queiroz, Izaura Maria Vieira Cayres-Vallinoto, Ricardo Ishak, Antonio Carlos Rosário Vallinoto. Intrahepatic TLR3 and IFNL3 Expressions Are Associated with Stages of Fibrosis in Chronic Hepatitis C. Viruses 2021; 13(6): 1103 doi: 10.3390/v13061103
|
| 137 |
Netanel Tzarum, Erick Giang, Rameshwar U. Kadam, Fang Chen, Kenna Nagy, Elias H. Augestad, Rodrigo Velázquez-Moctezuma, Zhen-Yong Keck, Yuanzi Hua, Robyn L. Stanfield, Marlene Dreux, Jannick Prentoe, Steven K. H. Foung, Jens Bukh, Ian A. Wilson, Mansun Law. An alternate conformation of HCV E2 neutralizing face as an additional vaccine target. Science Advances 2020; 6(30) doi: 10.1126/sciadv.abb5642
|
| 138 |
Faisal Ismail, Soghra Haq, Islam El-Garawani, Eman Abdelsameea. Hepatitis C Virus Infection in Eastern Libya: Efforts Needed to Improve HCV Testing and Linkage to Care in the Resource-Limited Setting. Tropical Medicine and Infectious Disease 2022; 7(2): 14 doi: 10.3390/tropicalmed7020014
|
| 139 |
Miguel Moncayo, Enrique Teran, Jorge Reyes, Gabriela Yerovi, Marcia Robalino, Ana Cristina Aguilar, Daniel Garzon-Chavez. Identification of the Genotypes Circulating in the Ecuadorian Population Infected with the Hepatitis C Virus (HCV). Risk Management and Healthcare Policy 2023; : 1403 doi: 10.2147/RMHP.S412599
|
| 140 |
Esmaeil Mehraeen, Nazanin Janfaza, Ramin Shahidi, Arian Afzalian, Sanaz Varshochi, Reyhaneh Jashaninejad, Ava Pashaei, Marcarious M. Tantuoyir, Muhammed Camara, Parinaz Paranjkhoo, Zohal Parmoon, Shahmohamadi Elnaz, Roghayeh Salmani, Parisa Matini, Pegah Mirzapour, Hooman Ebrahimi, Ali Moradi, SeyedAhmad SeyedAlinaghi, Shayesteh Jahanfar. Important Risk Factors of Liver Cirrhosis in HIV and Hepatitis C Coinfected Patients: A Systematic Review. The Open AIDS Journal 2024; 18(1) doi: 10.2174/0118746136280350240214064332
|
| 141 |
Monjur Ahmed. Era of direct acting anti-viral agents for the treatment of hepatitis C. World Journal of Hepatology 2018; 10(10): 670-684 doi: 10.4254/wjh.v10.i10.670
|
| 142 |
Nang Kham-Kjing, Nicole Ngo-Giang-Huong, Khajornsak Tragoolpua, Woottichai Khamduang, Sayamon Hongjaisee. Highly Specific and Rapid Detection of Hepatitis C Virus Using RT-LAMP-Coupled CRISPR–Cas12 Assay. Diagnostics 2022; 12(7): 1524 doi: 10.3390/diagnostics12071524
|
| 143 |
Lorico DS. Lapitan, Mariusz Pietrzak, Marek Krawczyk, Elżbieta Malinowska. Serum biomarkers and ultrasensitive biosensors for diagnosis of early-stage hepatocellular carcinoma. Sensors and Actuators B: Chemical 2023; 393: 134209 doi: 10.1016/j.snb.2023.134209
|
| 144 |
Yu-Lung Chiu, Herng-Ching Lin, Nai-Wen Kuo, Senyong Kao, Hsin-Chien Lee. Increased risk of concurrent hepatitis C among Male patients with schizophrenia. Psychiatry Research 2017; 258: 217 doi: 10.1016/j.psychres.2017.08.036
|
| 145 |
Momoko Iwamoto, Aurelie Calzia, Amelie Dublineau, François Rouet, Janin Nouhin, Sokchea Yann, Sophorn Pin, Chhorvy Sun, Kimchamroeun Sann, Chhit Dimanche, Celine Lastrucci, Rebecca M. Coulborn, David Maman, Jean‐Philippe Dousset, Anne Loarec. Field evaluation of GeneXpert® (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in Cambodia. Journal of Viral Hepatitis 2019; 26(1): 38 doi: 10.1111/jvh.13002
|
| 146 |
Kiyotaka Yamazaki, Dendy Macaulay, Yan Song, Yuri Sanchez Gonzalez. Clinical and Economic Burden of Patients with Chronic Hepatitis C with Versus Without Antiviral Treatment in Japan: An Observational Cohort Study Using Hospital Claims Data. Infectious Diseases and Therapy 2019; 8(2): 285 doi: 10.1007/s40121-019-0234-5
|
| 147 |
Nirmal Kumar, Suchitra S. Prabhu, Isha Monga, Indranil Banerjee. Influence of IL28B gene polymorphisms on PegINF-RBV-mediated HCV clearance in HIV-HCV co-infected patients: A meta-analysis. Meta Gene 2021; 29: 100909 doi: 10.1016/j.mgene.2021.100909
|
| 148 |
Yucel Aydin, Christopher M. Stephens, Srinivas Chava, Zahra Heidari, Rajesh Panigrahi, Donkita D. Williams, Kylar Wiltz, Antoinette Bell, Wallace Wilson, Krzysztof Reiss, Srikanta Dash. Chaperone-Mediated Autophagy Promotes Beclin1 Degradation in Persistently Infected Hepatitis C Virus Cell Culture. The American Journal of Pathology 2018; 188(10): 2339 doi: 10.1016/j.ajpath.2018.06.022
|
| 149 |
Mohsen Nakhaie, Ehsan Taheri, Javad Charostad, Nasir Arefinia, Davood Kalantar-Neyestanaki, Mohammad Rezaei Zadeh Rukerd, Fatemeh Ahmadpour, Mohamad Hossein Pourebrahimi, Sara Ahmadinejad Farsangi, Sara Shafieipour. Prevalence of Hepatitis C Virus and Its Occult Infection in Hemodialysis Patients. Jundishapur Journal of Microbiology 2023; 16(5) doi: 10.5812/jjm-136504
|
| 150 |
M. I. Valetskyi, M. U. Zak, O. V. Chernyshov, M. V. Sverdlova, V. S. Potochniak. Chronic Viral Hepatitis C: The Evolution of Scientific Views. Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 2020; 5(5): 9 doi: 10.26693/jmbs05.05.009
|
| 151 |
Zuzana Macek Jilkova, Komal Saleem, Samia Afzal, Thomas Decaens. Predictive Factors for Hepatocellular Carcinoma Development after Direct-Acting Antiviral Treatment of HCV. Livers 2021; 1(4): 313 doi: 10.3390/livers1040024
|
| 152 |
Laura Pimpin, Helena Cortez-Pinto, Francesco Negro, Emily Corbould, Jeffrey V. Lazarus, Laura Webber, Nick Sheron. Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies. Journal of Hepatology 2018; 69(3): 718 doi: 10.1016/j.jhep.2018.05.011
|
| 153 |
Ryuichi Kumata, Jumpei Ito, Kenta Takahashi, Tadaki Suzuki, Kei Sato. A tissue level atlas of the healthy human virome. BMC Biology 2020; 18(1) doi: 10.1186/s12915-020-00785-5
|
| 154 |
Sana Riaz, Hira Tiwana, Muhammad Adil, Khaver Ali, Tariq Javed. Anti-hepatitis C virus and synergistic potential of Syzgium cumine a bioassay guided screening in liver-infected hepatocytes. Archives of Microbiology 2022; 204(1) doi: 10.1007/s00203-021-02646-3
|
| 155 |
Malgorzata Pawlowska, Malgorzata Sobolewska-Pilarczyk, Krzysztof Domagalski. Hepatitis C virus infection in children in the era of direct-acting antiviral. World Journal of Gastroenterology 2018; 24(24): 2555-2566 doi: 10.3748/wjg.v24.i24.2555
|
| 156 |
Dong Wook Jekarl, Hyunyu Choi, Seungok Lee, Jung Hyun Kwon, Sung Won Lee, Hein Yu, Myungshin Kim, Yonggoo Kim, Pil Soo Sung, Seung Kew Yoon. Diagnosis of Liver Fibrosis With Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein (WFA-M2BP) Among Chronic Hepatitis B Patients. Annals of Laboratory Medicine 2018; 38(4): 348 doi: 10.3343/alm.2018.38.4.348
|
| 157 |
Marianna Zając, Izabela Muszalska, Agnieszka Sobczak, Adrianna Dadej, Szymon Tomczak, Anna Jelińska. Hepatitis C – New drugs and treatment prospects. European Journal of Medicinal Chemistry 2019; 165: 225 doi: 10.1016/j.ejmech.2019.01.025
|
| 158 |
Christian Medina, Alexis Hipólito García, Francis Isamarg Crespo, Félix Isidro Toro, Soriuska José Mayora, Juan Bautista De Sanctis. A Synopsis of Hepatitis C Virus Treatments and Future Perspectives. Current Issues in Molecular Biology 2023; 45(10): 8255 doi: 10.3390/cimb45100521
|
| 159 |
Mohamed A. Daw. Hepatitis C in Developing Countries. 2018; : 57 doi: 10.1016/B978-0-12-803233-6.00006-0
|
| 160 |
Sepideh Nasimzadeh, Azarakhsh Azaran, Shahram Jalilian, Manoochehr Makvandi, Seyed Saeid Seyedian, Bijan keikhaei, Fateme Jahangiri Mehr. Prevalence of occult hepatitis C virus infection in beta-thalassemia major patients in Ahvaz, Iran. Archives of Virology 2021; 166(10): 2703 doi: 10.1007/s00705-021-05126-7
|
| 161 |
Babiker Saad Almugadam, Omer Mohammed Ali Ibrahim, Yousif Mousa Alobaid Ahmed. Seroprevalence of the Serological Markers of Transfusion-Transmissible Infections among Volunteer Blood Donors of Kosti Obstetrics and Gynecology Hospital. Medicines 2021; 8(11): 64 doi: 10.3390/medicines8110064
|
| 162 |
Víctor Granados-García, Yvonne N. Flores, Lizbeth I. Díaz-Trejo, Lucia Méndez-Sánchez, Stephanie Liu, Guillermo Salinas-Escudero, Filiberto Toledano-Toledano, Jorge Salmerón, Vincenzo De Luca. Estimating the prevalence of hepatitis C among intravenous drug users in upper middle income countries: A systematic review and meta-analysis. PLOS ONE 2019; 14(2): e0212558 doi: 10.1371/journal.pone.0212558
|
| 163 |
Jin Zhang, Xing Gao, Yuan Yuan, Chao Sun, Yuanlin Zhao, Liming Xiao, Ying Yang, Yu Gu, Risheng Yang, Peizhen Hu, Lijun Zhang, Chao Wang, Jing Ye. Perilipin 5 alleviates HCV NS5A-induced lipotoxic injuries in liver. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1022-7
|
| 164 |
Ekta Gupta, Jasmine Samal, Amit Pandey, Gaurav Singh, Hajra A. S. Gupta, Reshu Agarwal, Manoj Kumar Sharma. Treatment Response and Drug Resistance Profiling of Genotype 6 of Hepatitis C Virus in HCV/HIV Co-Infected Patients: A Pilot Study from INDIA. Viruses 2022; 14(5): 944 doi: 10.3390/v14050944
|
| 165 |
Arnolfo Petruzziello. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma. The Open Virology Journal 2018; 12(1): 26 doi: 10.2174/1874357901812010026
|
| 166 |
Marisa Silbernagl, Rudolf Slamanig, Gabriele Fischer, Laura Brandt. Hepatitis C infection and psychiatric burden in two imprisoned cohorts: Young offenders and opioid-maintained prisoners. Health Policy 2018; 122(12): 1392 doi: 10.1016/j.healthpol.2018.10.005
|
| 167 |
Andrew H Talal, Phyllis Andrews, Anthony Mcleod, Yang Chen, Clewert Sylvester, Marianthi Markatou, Lawrence S Brown. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone. Clinical Infectious Diseases 2019; 69(2): 323 doi: 10.1093/cid/ciy899
|
| 168 |
Yasmin A Saeed, Kate Mason, Nicholas Mitsakakis, Jordan J Feld, Karen E Bremner, Arcturus Phoon, Alice Fried, Josephine F Wong, Jeff Powis, Murray D Krahn, William WL Wong. Disparities in health utilities among hepatitis C patients receiving care in different settings. Canadian Liver Journal 2023; 6(1): 24 doi: 10.3138/canlivj-2022-0009
|
| 169 |
Anissa Chouikha, Marwa Khedhiri, Hatem Triki, Walid Hammemi, Amel Sadraoui, Henda Touzi, Ahlem Ben Yahia, Amel Chtourou, Saba Gargouri, Lamia Feki Ben Rajah, Hela Hakim Karray, Henda Triki. Focus on hepatitis C virus genotype distribution in Tunisia prior to elimination: a 16-year retrospective study. Archives of Virology 2021; 166(2): 501 doi: 10.1007/s00705-020-04918-7
|
| 170 |
Arnolfo Petruzziello, Samantha Marigliano, Giovanna Loquercio, Carmela Cacciapuoti. Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe. Infectious Agents and Cancer 2016; 11(1) doi: 10.1186/s13027-016-0099-0
|
| 171 |
Giuseppe Losurdo, Andrea Iannone, Antonella Contaldo, Michele Barone, Enzo Ierardi, Alfredo Di Leo, Mariabeatrice Principi. Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C. Diagnostics 2020; 10(12): 1037 doi: 10.3390/diagnostics10121037
|
| 172 |
Supradip Dutta, Aritra Biswas, Sagnik Bakshi, Promisree Choudhury, Raina Das, Shreyasi Nath, Prosanto Chowdhury, Maitreyee Bhattacharyya, Sharmistha Chakraborty, Shanta Dutta, Provash Chandra Sadhukhan. Molecular Epidemiology of HCV Infection among Multi-Transfused β-Thalassemia Patients in Eastern India: A Six-Year Observation. Thalassemia Reports 2023; 13(3): 165 doi: 10.3390/thalassrep13030016
|
| 173 |
Kyung-Ah Kim, June Sung Lee. Prevalence, Awareness, and Treatment of Hepatitis C Virus Infection in South Korea: Evidence from the Korea National Health and Nutrition Examination Survey. Gut and Liver 2020; 14(5): 644 doi: 10.5009/gnl19272
|
| 174 |
Mohamed Mohei El Badry, Doaa Abdelhady Ali, Noha Hamdy Eltaweel, Marwa A. Abdel-Wahed. Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00061-9
|
| 175 |
Aleena Haqqi, Rimsha Munir, Muhammad Khalid, Muhammad Khurram, Muhammad Zaid, Muhammad Ali, Zaheer Hussain Shah, Haroon Ahmed, Muhammad Sohail Afzal. Prevalence of Hepatitis C Virus Genotypes in Pakistan: Current Scenario and Review of Literature. Viral Immunology 2019; 32(9): 402 doi: 10.1089/vim.2019.0058
|
| 176 |
Amina Adadi, Safae Adadi, Mohammed Berrada. Gastroenterology Meets Machine Learning: Status Quo and Quo Vadis. Advances in Bioinformatics 2019; 2019: 1 doi: 10.1155/2019/1870975
|
| 177 |
Munazza Mansoor, William A. de Glanville, Ridwa Alam, Khawar Aslam, Mubashir Ahmed, Petros Isaakidis, Aneeta Pasha, Chrispin Chaguza. Prevalence and risk factors for hepatitis C virus infection in an informal settlement in Karachi, Pakistan. PLOS Global Public Health 2023; 3(9): e0002076 doi: 10.1371/journal.pgph.0002076
|
| 178 |
Aisha Noreen, Naik Alam, Zainab Syed, Aroosa Aftab, Farah Shamim, Syed Najeebullah, Dilawar Khan, Salik Javed Kakar, Tahir Ahmed, Fazal Adnan. Prevalence and assessment of associated risk factors of hepatitis B and C infections in low-socioeconomic communities. Future Virology 2022; 17(5): 291 doi: 10.2217/fvl-2021-0060
|
| 179 |
Luigi Elio Adinolfi, Emanuele Durante Mangoni, Aldo Marrone, Rosa Zampino, Luca Rinaldi. Liver Diseases. 2020; : 181 doi: 10.1007/978-3-030-24432-3_17
|
| 180 |
Tasuku Okui. An age-period-cohort analysis of mortality rates for stomach, colorectal, liver, and lung cancer among prefectures in Japan, 1999–2018. Environmental Health and Preventive Medicine 2020; 25(1) doi: 10.1186/s12199-020-00922-0
|
| 181 |
Sharda Patra, Kanika Chopra. Infections and Pregnancy. 2022; : 151 doi: 10.1007/978-981-16-7865-3_12
|
| 182 |
Chun-Yuan Lee, Pei-Hua Wu, Meng-Wei Lu, Tun-Chieh Chen, Po-Liang Lu, Kimberly Page. High prevalence of unawareness of HCV infection status among both HCV-seronegative and seropositive people living with human immunodeficiency virus in Taiwan. PLOS ONE 2021; 16(5): e0251158 doi: 10.1371/journal.pone.0251158
|
| 183 |
Young Eun Chon, Aejeong Jo, Eileen L. Yoon, Jonghyun Lee, Ho Gyun Shin, Min Jung Ko, Dae Won Jun. The Incidence and Care Cascade of the Hepatitis C Virus in Korea. Gut and Liver 2023; 17(6): 926 doi: 10.5009/gnl220322
|
| 184 |
David Greenhalgh, Nader Al‐Rashidi. Modeling the spread of hepatitis C virus amongst people who inject drugs. Engineering Reports 2022; 4(10) doi: 10.1002/eng2.12503
|
| 185 |
Qi Xia, Zheyue Shu, Ting Ye, Min Zhang. Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.595699
|
| 186 |
Lucy Somerville, Karen Doucette. Hepatitis C: Current Controversies and Future Potential in Solid Organ Transplantation. Current Infectious Disease Reports 2018; 20(7) doi: 10.1007/s11908-018-0625-x
|
| 187 |
Ajit Sood, A. Suryaprasad, A. Trickey, S. Kanchi, V. Midha, M. A. Foster, E. Bennett, S. Kamili, F. Alvarez-Bognar, S. Shadaker, V. Surlikar, R. Garg, P. Mittal, S. Sharma, M. T. May, P. Vickerman, F. Averhoff, Sibnarayan Datta. The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey. PLOS ONE 2018; 13(7): e0200461 doi: 10.1371/journal.pone.0200461
|
| 188 |
Michelle G. Brown, John F. Lindo, Ivan E. Vickers, Kereann Nelson, Yakima Phillips, Cameil Wilson-Clarke, Samuel Gavi, Gene D. Morse, Andrew H. Talal. Seroprevalence and Genotype Diversity of Hepatitis C Virus in the Caribbean—A Review. Tropical Medicine and Infectious Disease 2023; 8(7): 370 doi: 10.3390/tropicalmed8070370
|
| 189 |
Massimo Giuseppe Colombo, Erkin Isakovich Musabaev, Umed Yusupovich Ismailov, Igor A Zaytsev, Alexander V Nersesov, Igor Anatoliyevich Anastasiy, Igor Alexandrovich Karpov, Olga A Golubovska, Kulpash S Kaliaskarova, Ravishankar AC, Sanjay Hadigal. Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions. World Journal of Gastroenterology 2019; 25(29): 3897-3919 doi: 10.3748/wjg.v25.i29.3897
|
| 190 |
Lynnette Bhebhe, Motswedi Anderson, Sajini Souda, Wonderful T. Choga, Edward Zumbika, Zachary M. Shaver, Tshepiso Mbangiwa, Bonolo B. Phinius, Chabeni C. Banda, Pinkie Melamu, Rosemary M. Musonda, Max Essex, Jason T. Blackard, Sikhulile Moyo, Simani Gaseitsiwe. Molecular characterization of hepatitis C virus in liver disease patients in Botswana: a retrospective cross-sectional study. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4514-1
|
| 191 |
Yi-Kai Wang, Ying-Wen Wang, Chia-Ling Lu, Yi-Hsiang Huang, Ming-Chih Hou, Yuh-Lih Chang, Wei-Ping Lee, Keng-Hsin Lan. Sofosbuvir-based direct-acting antivirals and changes in cholesterol and low density lipoprotein-cholesterol. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13657-5
|
| 192 |
Qinglong Zhao, Shan Jiang, Meina Li, Laishun Yao, Xiaoyu Ma, Meng Li, Changcong Wang, Yingan Pan, Hantong Zhao, Bo Li. Incidence trend and age-period-cohort analysis of reported hepatitis C among residents aged 30 to 79 in northeastern China, 2008 to 2017. Medicine 2020; 99(36): e22005 doi: 10.1097/MD.0000000000022005
|
| 193 |
Mahdi Mohamadi, Kimia Azarbayjani, Sayed‐Hamidreza Mozhgani, Taravat Bamdad, Ashkan Alamdary, Hadi Razavi Nikoo, Tayebeh Hashempour, Mojtaba Hedayat Yaghoobi, Mehdi Ajorloo. Hepatitis C virus alternative reading frame protein (ARFP): Production, features, and pathogenesis. Journal of Medical Virology 2020; 92(12): 2930 doi: 10.1002/jmv.26091
|
| 194 |
You-Wen Tan, Yan Tao, Long-Gen Liu, Yun Ye, Xin-Bei Zhou, Li Chen, Cong He. Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period survey. World Journal of Gastroenterology 2018; 24(11): 1250-1258 doi: 10.3748/wjg.v24.i11.1250
|
| 195 |
Jan Korbecki, Iwona Szatkowska, Patrycja Kupnicka, Wojciech Żwierełło, Katarzyna Barczak, Iwona Poziomkowska-Gęsicka, Jerzy Wójcik, Dariusz Chlubek, Irena Baranowska-Bosiacka. The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs. International Journal of Molecular Sciences 2022; 23(13): 7151 doi: 10.3390/ijms23137151
|
| 196 |
V. S. Kichatova, K. K. Kyuregyan, N. V. Soboleva, A. A. Karlsen, O. V. Isaeva, M. G. Isaguliants, M. I. Mikhailov. Frequency of Interferon-Resistance Conferring Substitutions in Amino Acid Positions 70 and 91 of Core Protein of the Russian HCV 1b Isolates Analyzed in the T-Cell Epitopic Context. Journal of Immunology Research 2018; 2018: 1 doi: 10.1155/2018/7685371
|
| 197 |
Zana Sidiq Mohammed Saleem, Ibrahim A Naqid, Nawfal R Hussein, Sidra Jalal Mohammad, Jajeen Shaaban Noaman, Rajeen Salih Haji, Vin Ahmed Haji, Zainnab Muhsin Hussein, Piran Hussamaldin Mohammed. The Prevalence of Hepatitis B and C Virus in Patients With End-Stage Kidney Disease on Regular Hemodialysis in Duhok, Iraq: A Brief Report. Avicenna Journal of Clinical Microbiology and Infection 2020; 7(1): 31 doi: 10.34172/ajcmi.2020.06
|
| 198 |
Dalia Y Kadry, Mostafa A Elbahnasawy, Mohamed TM Mansour, Omnia K EL Gebaly, Hala Aziz, Mahmoud M Kamel, Ahmed S Abdel-Moneim, Samah Radwan. The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin’s lymphoma. International Journal of Immunopathology and Pharmacology 2023; 37 doi: 10.1177/03946320231207342
|
| 199 |
Ylenia Pérez Castaño, José Manuel Chouza Pérez, Vanesa Sanz Largo, Edurne Almandoz Cortajarena, Alexandra Gómez García, Francisco Javier Esandi González, Agustín Castiella Eguzkiza, Sandra Arranz Díaz, Itxaso Urtasun Lugea, Maria José Sánchez Iturri, Borja Gil Fernández, Luis Bujanda , Juan Arenas Ruiz-Tapiador. Linkage to care strategy for the micro-elimination of hepatitis C among parenteral drug users on methadone replacement therapy in Gipuzkoa. Revista Española de Enfermedades Digestivas 2020; 112 doi: 10.17235/reed.2020.7194/2020
|
| 200 |
Jose Ramiro Cruz, Rene Berrios Cruz, Jorge Duque Rodríguez, Silvina Kuperman. Blood Safety. 2019; : 225 doi: 10.1007/978-3-319-94436-4_12
|
| 201 |
Muhammad H. Bashir, Javid Fazili, Mohammad F. Madhoun, Rajesh Kanagala, Sixia Chen, Salman Nusrat. Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis. European Journal of Gastroenterology & Hepatology 2018; 30(3): 296 doi: 10.1097/MEG.0000000000001032
|
| 202 |
Matthew J. Akiyama, Abbe Muller, Owen Huang, John Lizcano, Mercy Nyakowa, Lindsey Riback, Jonathan Ross, Henry Bundi, Euphrasia Shitachi Kulabi, Ann Muthoni Mwangi, Helgar Musyoki, Peter Cherutich, Ann Kurth. Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya: A qualitative study. Global Public Health 2022; 17(6): 1016 doi: 10.1080/17441692.2021.1896763
|
| 203 |
Takuya Sho, Goki Suda, Megumi Kimura, Tomoe Shimazaki, Osamu Maehara, Taku Shigesawa, Kazuharu Suzuki, Akihisa Nakamura, Masatsugu Ohara, Machiko Umemura, Takaaki Izumi, Naoki Kawagishi, Masaru Baba, Masato Nakai, Mitsuteru Natsuizaka, Kenichi Morikawa, Koji Ogawa, Naoya Sakamoto. Glecaprevir and Pibrentasvir for Japanese Patients with Human Immunodeficiency Virus and Genotype 3 Hepatitis C Virus Coinfection: A Report of Three Cases. Internal Medicine 2019; 58(6): 797 doi: 10.2169/internalmedicine.1856-18
|
| 204 |
Akari Kaba, Shigeyoshi Yamanaga, Yuji Hidaka, Mariko Toyoda, Masayuki Kashima, Yoshi Takekuma, Akito Inadome, Hiroshi Yokomizo, Akira Miyata. Glecaprevir/Pibrentasvir and Renal Dysfunction in Deceased Donor Renal Transplantation: A Case Report. Transplantation Proceedings 2022; 54(2): 549 doi: 10.1016/j.transproceed.2021.12.028
|
| 205 |
Phearavin Pheng, Laurence Meyer, Olivier Ségéral, Phalla Chea, Siyan Yi, Sovannary Tuot, John M. Kaldor, Vonthanak Saphonn. Hepatitis C seroprevalence among people living with HIV/AIDS and pregnant women in four provinces in Cambodia: an integrated bio-behavioral survey. BMC Infectious Diseases 2022; 22(1) doi: 10.1186/s12879-022-07163-2
|
| 206 |
Dinesh Jothimani, Silas Danielraj, Gomathy Narasimhan, Ilankumaran Kaliamoorthy, Akila Rajakumar, Kumar Palaniappan, Swetha Palanichamy, Ashwin Rammohan, Hemalatha Ramachandran, Rajesh Rajalingam, Mohamed Rela. Nonalcoholic Steatohepatitis: A Rapidly Increasing Indication for Liver Transplantation in India. Journal of Clinical and Experimental Hepatology 2022; 12(3): 908 doi: 10.1016/j.jceh.2021.09.017
|
| 207 |
Kyana Y. Garza, Aashish Pandey, Mark A. Marzinke. Development and validation of a liquid chromatographic-tandem mass spectrometric assay for the quantification of the direct acting antivirals glecaprevir and pibrentasvir in plasma. Journal of Pharmaceutical and Biomedical Analysis 2023; 235: 115629 doi: 10.1016/j.jpba.2023.115629
|
| 208 |
Mirela Pavicic Ivelja, Kresimir Dolic, Leida Tandara, Nikola Perkovic, Antonio Mestrovic, Ivo Ivic. Blood markers of endothelial dysfunction and their correlation to cerebrovascular reactivity in patients with chronic hepatitis C infection. PeerJ 2021; 9: e10723 doi: 10.7717/peerj.10723
|
| 209 |
Wondmagegn Demsiss, Abdurahaman Seid, Temesgen Fiseha, Isabelle Chemin. Hepatitis B and C: Seroprevalence, knowledge, practice and associated factors among medicine and health science students in Northeast Ethiopia. PLOS ONE 2018; 13(5): e0196539 doi: 10.1371/journal.pone.0196539
|
| 210 |
Muhammad Umar Sohail, Asma A Al Thani, Hadi Mohamad Yassine. Comparative Phylogenetic and Residue Analysis of Hepatitis C Virus E1 Protein from the Middle East and North Africa Region. Hepatitis Monthly 2019; 19(8) doi: 10.5812/hepatmon.92437
|
| 211 |
Ahmad Shakeri, Narthaanan Srimurugathasan, Katie J. Suda, Tara Gomes, Mina Tadrous. Spending on Hepatitis C Antivirals in the United States and Canada, 2014 to 2018. Value in Health 2020; 23(9): 1137 doi: 10.1016/j.jval.2020.03.021
|
| 212 |
Claudia Monica Danilescu, Daniela Larisa Sandulescu, Mihail Cristian Pirlog, Costin Teodor Streba, Ion Rogoveanu. Depressive and Anxious Symptoms in Hepatitis C Virus Infected Patients Receiving DAA-Based Therapy. Diagnostics 2021; 11(12): 2237 doi: 10.3390/diagnostics11122237
|
| 213 |
William W.L. Wong, Josephine Wong, Karen E. Bremner, Yasmin Saeed, Kate Mason, Arcturus Phoon, Zeny Feng, Jordan J. Feld, Nicholas Mitsakakis, Jeff Powis, Murray Krahn. Time Costs and Out-of-Pocket Costs in Patients With Chronic Hepatitis C in a Publicly Funded Health System. Value in Health 2022; 25(2): 247 doi: 10.1016/j.jval.2021.08.006
|
| 214 |
Amen Bawazir, Fahad AlGusheri, Hoda Jradi, Mohammed AlBalwi, Abdel-Galil Abdel-Gader. Hepatitis C virus genotypes in Saudi Arabia: a future prediction and laboratory profile. Virology Journal 2017; 14(1) doi: 10.1186/s12985-017-0873-7
|
| 215 |
Giuseppe Luigi Banna, Francesco Passiglia, Francesca Colonese, Stefania Canova, Jessica Menis, Alfredo Addeo, Antonio Russo, Diego Luigi Cortinovis. Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients’ selection. Critical Reviews in Oncology/Hematology 2018; 129: 27 doi: 10.1016/j.critrevonc.2018.06.016
|
| 216 |
Abdool S. Yasseen, Jeffrey C. Kwong, Jordan J. Feld, Naveed Z. Janjua, Christina Greenaway, Lauren Lapointe‐Shaw, Morris Sherman, Tony Mazzulli, Rafal Kustra, Liane MacDonald, Beate Sander, Natasha S. Crowcroft. Viral hepatitis C cascade of care: A population‐level comparison of immigrant and long‐term residents. Liver International 2021; 41(8): 1775 doi: 10.1111/liv.14840
|
| 217 |
Arnolfo Petruzziello, Samantha Marigliano, Giovanna Loquercio, Nicola Coppola, Mauro Piccirillo, Maddalena Leongito, Rosa Azzaro, Francesco Izzo, Gerardo Botti. Hepatitis C Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective study. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0162-5
|
| 218 |
Adam Trickey, Hannah Fraser, Aaron G Lim, Amy Peacock, Samantha Colledge, Josephine G Walker, Janni Leung, Jason Grebely, Sarah Larney, Natasha K Martin, Matthew Hickman, Louisa Degenhardt, Margaret T May, Peter Vickerman. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study. The Lancet Gastroenterology & Hepatology 2019; 4(6): 435 doi: 10.1016/S2468-1253(19)30085-8
|
| 219 |
Corrine I. Voils, Heather A. King, Carolyn T. Thorpe, Dan V. Blalock, Ian M. Kronish, Bryce B. Reeve, Colleen Boatright, Ziad F. Gellad. Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C Treatment. Digestive Diseases and Sciences 2019; 64(10): 2784 doi: 10.1007/s10620-019-05621-7
|
| 220 |
Petra Simicic, Ivana Grgic, Maja Santak, Adriana Vince, Snjezana Zidovec Lepej. Frequency of baseline NS5A resistance-associated substitutions in patients infected with genotype 1 of hepatitis C virus in Croatia. Microbial Pathogenesis 2019; 136: 103694 doi: 10.1016/j.micpath.2019.103694
|
| 221 |
Gaitan Fabrice Njiomegnie, Scott A. Read, Nicole Fewings, Jacob George, Fiona McKay, Golo Ahlenstiel. Immunomodulation of the Natural Killer Cell Phenotype and Response during HCV Infection. Journal of Clinical Medicine 2020; 9(4): 1030 doi: 10.3390/jcm9041030
|
| 222 |
Zuzana Macek Jílková, Arnaud Seigneurin, Celine Coppard, Laurissa Ouaguia, Caroline Aspord, Patrice N. Marche, Vincent Leroy, Thomas Decaens. Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals. Cancers 2020; 12(12): 3820 doi: 10.3390/cancers12123820
|
| 223 |
Paul Henriot, Mathieu Castry, Liem Binh Luong Nguyen, Yusuke Shimakawa, Kévin Jean, Laura Temime. Meta‐analysis: risk of hepatitis C virus infection associated with hospital‐based invasive procedures. Alimentary Pharmacology & Therapeutics 2022; 56(4): 558 doi: 10.1111/apt.17106
|
| 224 |
Alexander Gutwerk, Thomas Wex, Kerstin Stein, Cosima Langner, Ali Canbay, Peter Malfertheiner, Alexander Link. Helicobacter Pylori Serology in Relation to Hepatitis C Virus Infection and IL28B Single Nucleotide Polymorphism. Journal of Clinical Medicine 2018; 7(3): 44 doi: 10.3390/jcm7030044
|
| 225 |
Faisal Abaalkhail, Waleed Al-hamoudi, Ibrahim Altraif, Hazem Mohamed, Hassan Aleid, Dieter Broering, Saleh Alqahtani. Treatment with Grazoprevir/Elbasvir in Post-kidney Transplant Patients with Hepatitis C Virus Genotype 4 Infection. Hepatitis Monthly 2021; 21(4) doi: 10.5812/hepatmon.110260
|
| 226 |
Daniel Candotti, Virginie Sauvage, Pierre Cappy, Mohamed Abdallahi Boullahi, Pascal Bizimana, Guy Olivier Mbensa, Sekou Oumar Coulibaly, Aimée Olivat Rakoto Alson, Hadiza Soumana, Claude Tagny‐Tayou, Edward L. Murphy, Syria Laperche. High rate of hepatitis C virus and human immunodeficiency virus false‐positive results in serologic screening in sub‐Saharan Africa: adverse impact on the blood supply. Transfusion 2020; 60(1): 106 doi: 10.1111/trf.15593
|
| 227 |
Junjie Huang, Don Eliseo Lucero-Prisno, Lin Zhang, Wanghong Xu, Sunny H. Wong, Siew C. Ng, Martin C. S. Wong. Updated epidemiology of gastrointestinal cancers in East Asia. Nature Reviews Gastroenterology & Hepatology 2023; 20(5): 271 doi: 10.1038/s41575-022-00726-3
|
| 228 |
Albert Do, Nancy S. Reau. Chronic Viral Hepatitis: Current Management and Future Directions. Hepatology Communications 2020; 4(3): 329 doi: 10.1002/hep4.1480
|
| 229 |
Francesca Picarazzi, Ilaria Vicenti, Francesco Saladini, Maurizio Zazzi, Mattia Mori. Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge. Molecules 2020; 25(23): 5695 doi: 10.3390/molecules25235695
|
| 230 |
Abdulrahman Alduraywish, Mostafa Ragheb, Ibrahim Taher, Nageh Louis, Khaled Aldossari, Rania Kishk. Prevalence, risk factors and impact of occult HCV infection on liver morbidity among haemodialysis patients: hospital-based cross-sectional study. Scandinavian Journal of Gastroenterology 2020; 55(8): 963 doi: 10.1080/00365521.2020.1790649
|
| 231 |
Lidia Elbieta Sierpińska. Assessment of Health Behaviors of Patients with Hepatitis C. American Journal of Health Behavior 2022; 46(5): 586 doi: 10.5993/AJHB.46.5.9
|
| 232 |
Juliana Reyes‐Urueña, Ana Celly, Sergio Moreno, Xavier Majó, Joan Colom, Jordi Casabona. Hepatitis C virus: Testing rate and attrition at linkage to specialized care, Catalonia, Spain 2011‐2016. Journal of Viral Hepatitis 2021; 28(2): 288 doi: 10.1111/jvh.13427
|
| 233 |
Alice W. Lee, Wura Jacobs, Michelle Tran, Becky Nguyen, Dung N. Hua, John N. Ho, Thai Van Nguyen, Gang Qin. Sociodemographic characteristics associated with hepatitis C virus infection in Vietnamese Americans: A cross-sectional analysis of community screening data. PLOS ONE 2022; 17(9): e0275210 doi: 10.1371/journal.pone.0275210
|
| 234 |
Anna Cambianica, Valentina Marchese, Francesca Pennati, Alessandro Faustinelli, Manuela Migliorati, Fabio Roda, Angiola Spinetti, Serena Zaltron, Simona Fiorentini, Arnaldo Caruso, Eugenia Quiros-Roldan, Francesco Castelli, Emanuele Focà. Chronic Hepatitis C Cascade of Care in Prisoners—Is There Still Some Work to Do? Analysis of Two Large Penitentiaries in Northern Italy. International Journal of Environmental Research and Public Health 2024; 21(1): 104 doi: 10.3390/ijerph21010104
|
| 235 |
Batbold Batsaikhan, Ming-Ying Lu, Ming-Lun Yeh, Ching-I Huang, Chung-Feng Huang, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Ping-Hsin Hsieh, Wan-Long Chuang, Jin-Ching Lee, Ming-Lung Yu, Chia-Yen Dai. Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C. Journal of the Chinese Medical Association 2019; 82(4): 277 doi: 10.1097/JCMA.0000000000000064
|
| 236 |
Maher BM. Boraie, Yasser A. Elnaggar, Mohammed Othman Ahmed, Ahmed M. Mahmoud. Effect of direct acting antiviral therapy of Chronic Hepatitis C virus on insulin resistance and Type2 DM in Egyptian patients (prospective study). Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(4): 2641 doi: 10.1016/j.dsx.2019.07.032
|
| 237 |
Yun Lu, Xiuze Jin, Cheng-a-xin Duan, Feng Chang, Yury E Khudyakov. Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naïve patients in China. PLOS ONE 2018; 13(4): e0195117 doi: 10.1371/journal.pone.0195117
|
| 238 |
Ana Elisa de Figueiredo Miranda Mundim, Fernanda de Oliveira Feitosa de de Castro, Marina Brandão Braz Albuquerque, Cesar Augusto Sam Tiago Vilanova-Costa, Irmtraut Araci Hoffmann Pfrimer, Antonio Márcio Teodoro Cordeiro Silva. Major mutations in the NS3 gene region of hepatitis C virus related to the resistance to direct acting antiviral drugs: a systematic review. VirusDisease 2020; 31(3): 220 doi: 10.1007/s13337-020-00616-9
|
| 239 |
Salman Kazmi, Humaira Farooqi, Umer Sohail, Sohaib Haider Zaidi, Naeem Majeed, Safia Firdus. Sustained virological response (SVR) and safety of two direct acting anti-viral (DAA) combination therapies in Chronic Hepatitis-C infected patients of Lahore, Pakistan. A Randomized Controlled Trial. Pakistan Journal of Health Sciences 2022; : 135 doi: 10.54393/pjhs.v3i06.294
|
| 240 |
Zain Ul Abideen, Shafiqa Siddique, Izza Nasrullah, Jahangir S. Khan, Sidra Rehman, Yigang Tong, Raheel Qamar, Azeem M. Butt. A 2-year retrospective study of viral and host-associated risk factors in Pakistani hepatocellular carcinoma patients. European Journal of Gastroenterology & Hepatology 2019; 31(9): 1103 doi: 10.1097/MEG.0000000000001384
|
| 241 |
V. Estrada, I. Sagastagoitia. Hepatitis C is a risk factor for cardiovascular disease. Revista Clínica Española (English Edition) 2019; 219(6): 322 doi: 10.1016/j.rceng.2019.03.005
|
| 242 |
Stephen M. Davis, Danielle Davidov, Alfgeir L. Kristjansson, Keith Zullig, Adam Baus, Melanie Fisher, Nickolas Zaller. Qualitative case study of needle exchange programs in the Central Appalachian region of the United States. PLOS ONE 2018; 13(10): e0205466 doi: 10.1371/journal.pone.0205466
|
| 243 |
Barrot H. Lambdin, Jennifer Lorvick, Jessie K. Mbwambo, John Rwegasha, Saria Hassan, Paula Lum, Alex H. Kral. Prevalence and predictors of HCV among a cohort of opioid treatment patients in Dar es Salaam, Tanzania. International Journal of Drug Policy 2017; 45: 64 doi: 10.1016/j.drugpo.2017.05.043
|
| 244 |
Zahra Amirsardari, Farzaneh Rahmani, Nima Rezaei. Cognitive impairments in HCV infection: From pathogenesis to neuroimaging. Journal of Clinical and Experimental Neuropsychology 2019; 41(10): 987 doi: 10.1080/13803395.2019.1652728
|
| 245 |
Mandana Namayandeh, Marzieh Jamalidoust, Nahid Heydari Marandi, Nasrin Aliabadi, Atoosa Ziyaeyan, Gholamreza Pouladfar, Mazyar Ziyaeyan. Hepatitis C virus genotypes in patients with chronic hepatitis C infection in southern Iran from 2016 to 2019. Microbiology and Immunology 2020; 64(11): 762 doi: 10.1111/1348-0421.12845
|
| 246 |
Alexander M. Sy, Christopher B. O’Brien. Liver Failure. 2020; : 167 doi: 10.1007/978-3-030-50983-5_9
|
| 247 |
Saranya Chidambaranathan-Reghupaty, Paul B. Fisher, Devanand Sarkar. Mechanisms and Therapy of Liver Cancer. Advances in Cancer Research 2021; 149: 1 doi: 10.1016/bs.acr.2020.10.001
|
| 248 |
Crina Fofiu, Alina Boeriu, Felicia Coman, Alexandru Fofiu, Nikola Panic, Milutin Bulajic, Daniela Dobru. Interferon-Free Regimen: Equally Effective in Treatment Naive and Experienced HCV Patients. Annals of Hepatology 2019; 18(1): 137 doi: 10.5604/01.3001.0012.7905
|
| 249 |
Esther Babady. Molecular Monitoring of Viral Infections. Advances in Molecular Pathology 2018; 1(1): 65 doi: 10.1016/j.yamp.2018.06.006
|
| 250 |
Valentina Pecoraro, Rita Banzi, Elisabetta Cariani, Johanna Chester, Erica Villa, Roberto D'Amico, Vittorio Bertele', Tommaso Trenti. New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials. Journal of Clinical and Experimental Hepatology 2019; 9(4): 522 doi: 10.1016/j.jceh.2018.07.004
|
| 251 |
Shagufta Kamal, Asif Shahzad, Kanwal Rehman, Komal Tariq, Muhammad Sajid Hamid Akash, Muhammad Imran, Mohammed Ali Assiri. Therapeutic Intervention of Serine Protease Inhibitors against
Hepatitis C Virus. Current Medicinal Chemistry 2024; 31(15): 2052 doi: 10.2174/0109298673234823230921090431
|
| 252 |
Sajjad Ahmad, Farah Shahid, Muhammad Tahir ul Qamar, Habib ur Rehman, Sumra Wajid Abbasi, Wasim Sajjad, Saba Ismail, Faris Alrumaihi, Khaled S. Allemailem, Ahmad Almatroudi, Hafiz Fahad Ullah Saeed. Immuno-Informatics Analysis of Pakistan-Based HCV Subtype-3a for Chimeric Polypeptide Vaccine Design. Vaccines 2021; 9(3): 293 doi: 10.3390/vaccines9030293
|
| 253 |
Marek Radkowski, Piotr Grabarczyk, Tomasz Kryczka, Kamila Caraballo Cortès, Dorota Kubicka-Russel, Maciej Janiak, Sylwia Osuch, Karol Perlejewski, Tomasz Laskus. Cytokine profile and viral diversity in the early seronegative stage of community-acquired hepatitis C virus (HCV) infection. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-47335-x
|
| 254 |
Tatsuki Mizuochi, Tomoko Takano, Tadahiro Yanagi, Kosuke Ushijima, Mitsuyoshi Suzuki, Yoko Miyoshi, Yoshinori Ito, Ayano Inui, Hitoshi Tajiri. Epidemiologic features of 348 children with hepatitis C virus infection over a 30-year period: a nationwide survey in Japan. Journal of Gastroenterology 2018; 53(3): 419 doi: 10.1007/s00535-017-1351-0
|
| 255 |
Shu‐Mei Tsai, Jung‐Ta Kao, Yun‐Fang Tsai. Illness trajectory of initial infection for patients with hepatitis C: A qualitative study. Nursing & Health Sciences 2019; 21(1): 112 doi: 10.1111/nhs.12568
|
| 256 |
John O. Link. HCV: The Journey from Discovery to a Cure. Topics in Medicinal Chemistry 2019; 32: 81 doi: 10.1007/7355_2019_67
|
| 257 |
Mohamed Shengir, Mohamed Elgara, Giada Sebastiani. Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond. World Journal of Gastroenterology 2021; 27(17): 1959-1972 doi: 10.3748/wjg.v27.i17.1959
|
| 258 |
Z. M. Younossi, A. Tanaka, Y. Eguchi, L. Henry, R. Beckerman, M. Mizokami. Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan. Journal of Viral Hepatitis 2018; 25(8): 945 doi: 10.1111/jvh.12886
|
| 259 |
Nicola Schiano Moriello, Biagio Pinchera, Ivan Gentile. Personalized care approaches to hepatitis C therapy: recent advances and future directions. Expert Review of Anti-infective Therapy 2024; 22(4): 139 doi: 10.1080/14787210.2024.2328336
|
| 260 |
H. Y. Choi, Y. Kim, H. Cho, B. H. Kim, M. Ki. Risk of diabetes in viral hepatitis B or C patients compared to that in noninfected individuals in Korea, 2002‐2013: A population‐based cohort study. Journal of Viral Hepatitis 2018; 25(3): 272 doi: 10.1111/jvh.12815
|
| 261 |
Kosuke Matsumoto, Hisamitsu Miyaaki, Masanori Fukushima, Ryu Sasaki, Masafumi Haraguchi, Satoshi Miuma, Kazuhiko Nakao. The impact of single‑nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct‑acting antiviral drugs for hepatitis C infection. Biomedical Reports 2021; 16(2) doi: 10.3892/br.2021.1492
|
| 262 |
Aiko Fukui, Naoto Kawabe, Senju Hashimoto, Hiroyuki Kamei, Kentaro Yoshioka. Skeletal muscle mass depletion in patients with hepatitis C virus infection. European Journal of Gastroenterology & Hepatology 2019; 31(1): 59 doi: 10.1097/MEG.0000000000001255
|
| 263 |
James E. Squires, William F. Balistreri. Hepatitis C virus infection in children and adolescents. Hepatology Communications 2017; 1(2): 87 doi: 10.1002/hep4.1028
|
| 264 |
Ariel Bardach, Akram Hernández-Vásquez, Alfredo Palacios, María Calderón, Natalie Soto, Dario Balan, Federico Augustovski. Epidemiology, Use of resources, and Costs of Medical Management of Hepatitis C in Argentina, Colombia, Uruguay, and Venezuela. Value in Health Regional Issues 2019; 20: 180 doi: 10.1016/j.vhri.2019.06.004
|
| 265 |
Jóice Teixeira de Bitencorte, Tássia Flores Rech, Vagner Ricardo Lunge, Deivid Cruz dos Santos, Mário Reis Álvares-da-Silva, Daniel Simon. Association of interferon lambda-4 rs12979860 polymorphism with hepatocellular carcinoma in patients with chronic hepatitis C infection. World Journal of Hepatology 2021; 13(1): 109-119 doi: 10.4254/wjh.v13.i1.109
|
| 266 |
Amanda Abdel-Al, Eman El-Ahwany, Mona Zoheiry, Marwa Hassan, Amged Ouf, Hoda Abu-Taleb, Ali Abdel Rahim, Mohamed Darwish El-Talkawy, Suher Zada. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients. Virus Research 2018; 253: 135 doi: 10.1016/j.virusres.2018.06.007
|
| 267 |
Davit Baliashvili, Henry M Blumberg, David Benkeser, Russell R Kempker, Shaun Shadaker, Francisco Averhoff, Lia Gvinjilia, Natalia Adamashvili, Matthew Magee, George Kamkamidze, Mamuka Zakalashvili, Tengiz Tsertsvadze, Lali Sharvadze, Mamuka Chincharauli, Nestan Tukvadze, Neel R Gandhi. Association of Treated and Untreated Chronic Hepatitis C With the Incidence of Active Tuberculosis Disease: A Population-Based Cohort Study. Clinical Infectious Diseases 2023; 76(2): 245 doi: 10.1093/cid/ciac786
|
| 268 |
Asmaa Abo Elgoud Said, Ahmed H. Afifi, Taha F. S. Ali, Mamdouh Nabil Samy, Usama Ramadan Abdelmohsen, Mostafa A. Fouad, Eman Zekry Attia. NS3/4A helicase inhibitory alkaloids from Aptenia cordifolia as HCV target. RSC Advances 2021; 11(52): 32740 doi: 10.1039/D1RA06139A
|
| 269 |
L H Zain, T Sungkar. Management of hepatitis C infection in the era of direct-acting antiviral therapy. IOP Conference Series: Earth and Environmental Science 2018; 125: 012087 doi: 10.1088/1755-1315/125/1/012087
|
| 270 |
Amina A. Negash, Rebecca M. Olson, Stephen Griffin, Michael Gale, Christopher M. Walker. Modulation of calcium signaling pathway by hepatitis C virus core protein stimulates NLRP3 inflammasome activation. PLOS Pathogens 2019; 15(2): e1007593 doi: 10.1371/journal.ppat.1007593
|
| 271 |
Fei Kong, Xiaoyu Wen, Xiaofeng Wen, Xiaozhong Wang, Guicheng Wu, Shide Lin, Li Wang, Huichun Xing, Xuebing Yan, Sujun Zheng, Qin Ning, Zheng Wang, Liaoyun Zhang, Jianmei Lin, Zhaowei Tong, Chengyu Huang, Minghua Su, Lixin Tong, Jidong Jia, Yongning Xin, Qingjing Zhu, Jing Wang, Li Chen, Xiaowen Li, Xuegang Wu, Duan Niu, Quan Liu, Wei Wei, Yuexin Zhang, Guangming Li, Junqi Niu. Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single‐arm, open‐label, phase 3 trial. Journal of Gastroenterology and Hepatology 2021; 36(9): 2375 doi: 10.1111/jgh.15412
|
| 272 |
Chia-Min Wu, Fu-Hsiung Su, Chih-Hsin Muo, Jou-Chen Huang, Meei-Maan Wu, Chih-Ching Yeh. Analysis of Different Types of Interferon-Associated Retinopathy in Patients with Chronic Hepatitis C Virus Infection Treated with Pegylated Interferon Plus Ribavirin. Viruses 2021; 13(3): 475 doi: 10.3390/v13030475
|
| 273 |
Rabaa Y. Athamneh, Rawan Abudalo, Malik Sallam, Abdelrahim Alqudah, Hasan Alquran, Kawther Faisal Amawi, Hashem A. Abu-Harirah. Sub-genotypes of hepatitis C virus in the Middle East and North Africa: Patterns of distribution and temporal changes. Infection, Genetics and Evolution 2023; 109: 105412 doi: 10.1016/j.meegid.2023.105412
|
| 274 |
Tran Nguyen, Trang Pham, Hong K Tang, Loc Phan, Gary Mize, William M Lee, Robert Gish, Amy Trang, Anh Le, Hai T Phan, Binh T Nguyen, Doan Y Dao. Unmet needs in occupational health: prevention and management of viral hepatitis in healthcare workers in Ho Chi Minh City, Vietnam: a mixed-methods study. BMJ Open 2021; 11(10): e052668 doi: 10.1136/bmjopen-2021-052668
|
| 275 |
Georgina Wood, Katie Wakeham. Manson's Tropical Diseases. 2024; : 886 doi: 10.1016/B978-0-7020-7959-7.00068-3
|
| 276 |
Chayan Bhattacharjee, Maitri Singh, Debisukti Das, Sujit Chaudhuri, Aparna Mukhopadhyay. Current therapeutics against HCV. VirusDisease 2021; 32(2): 228 doi: 10.1007/s13337-021-00697-0
|
| 277 |
Yang Zhou, Botao Zhao, Wen Shi, Xiaobei Ding, Liping Shen, Xin Zhou, Hanqing He. The infection rates of HBV and HCV decreased significantly in Zhejiang Province, China: A comparative study based on the data of two sero‐epidemiological surveys in 1992 and 2020. Journal of Viral Hepatitis 2023; 30(6): 489 doi: 10.1111/jvh.13820
|
| 278 |
Jia Li, Stuart C. Gordon, Loralee B. Rupp, Talan Zhang, Sheri Trudeau, Scott D. Holmberg, Anne C. Moorman, Philip R. Spradling, Eyasu H. Teshale, Joseph A. Boscarino, Mark A. Schmidt, Yihe G. Daida, Mei Lu. Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes. Alimentary Pharmacology & Therapeutics 2019; 49(5): 599 doi: 10.1111/apt.15102
|
| 279 |
Matthew J. Akiyama, Lindsey R. Riback, Mercy Nyakowa, Helgar Musyoki, John A. Lizcano, Abbe Muller, Chenshu Zhang, Josephine G. Walker, Jack Stone, Peter Vickerman, Peter Cherutich, Ann E. Kurth. Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya. International Journal of Drug Policy 2023; 113: 103959 doi: 10.1016/j.drugpo.2023.103959
|
| 280 |
N. G. Danilenko, M. G. Siniauskaya, S. P. Lukashyk, I. A. Karpov, O. G. Davydenko. “Double Punch”: Hepatitis C in Patients with Genetic Defects of Iron Metabolism. Cytology and Genetics 2019; 53(5): 407 doi: 10.3103/S0095452719050062
|
| 281 |
Maria Alejandra Luna-Cuadros, Hao-Wei Chen, Hira Hanif, Mukarram Jamat Ali, Muzammil Muhammad Khan, Daryl Tan-Yeung Lau. Risk of hepatocellular carcinoma after hepatitis C virus cure. World Journal of Gastroenterology 2022; 28(1): 96-107 doi: 10.3748/wjg.v28.i1.96
|
| 282 |
Lia Goncalves Possuelo, Daiane Perin, Patricia Faber Breunig, Daniel Felipe Schroeder, Manuela Filter Allgayer, Camilo Darsie, Marcelo Carneiro, Vanda Hermes, Jane Dagmar Pollo Renner. Hepatitis C: evaluation of outcomes and georeferencing of cases in Santa Cruz do Sul, Brazil, between 2002 and 2015. A cross-sectional study. Sao Paulo Medical Journal 2017; 136(2): 109 doi: 10.1590/1516-3180.2017.0169180917
|
| 283 |
Ahmed A. Ezat, Wael M. Elshemey. A comparative study of the efficiency of HCV NS3/4A protease drugs against different HCV genotypes using in silico approaches. Life Sciences 2019; 217: 176 doi: 10.1016/j.lfs.2018.12.004
|
| 284 |
Babita Agrawal, Shakti Singh, Nancy Gupta, Wen Li, Satish Vedi, Rakesh Kumar. Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension. International Journal of Molecular Sciences 2017; 18(8): 1626 doi: 10.3390/ijms18081626
|
| 285 |
Dariush Naghipour-Khalkhaliani, Daryoush Behzadpour, Seyed Dawood Mousavi Nasab. Distribution of Hepatitis C Virus Genotypes in Rasht, Capital City of Guilan Province, Northern Part of Iran. Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.62030
|
| 286 |
Jacob D. de Boer, Hein Putter, Joris J. Blok, Nouvel A. Cambridge, Simen D. van den Berg, Serge Vogelaar, Gabriela Berlakovich, Markus Guba, Andries E. Braat, ELIAC Eurotransplant Liver and Intestine Advisory Committee. Development of the Eurotransplant Discard Risk Index to Predict Acceptance of Livers for Transplantation: A Retrospective Database Analysis. Experimental and Clinical Transplantation 2021; 19(11): 1163 doi: 10.6002/ect.2021.0228
|
| 287 |
Rui Huang, Huiying Rao, Jia Shang, Hong Chen, Jun Li, Qing Xie, Zhiliang Gao, Lei Wang, Jia Wei, Jianning Jiang, Jian Sun, Jiaji Jiang, Lai Wei. A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5D. Health and Quality of Life Outcomes 2018; 16(1) doi: 10.1186/s12955-018-0941-8
|
| 288 |
Brent C. Lampert, Kevin Kissling. Approaches and strategies to manage the hepatitis C virus-positive heart donor. Current Opinion in Organ Transplantation 2022; 27(3): 229 doi: 10.1097/MOT.0000000000000984
|
| 289 |
Dongxian Ye, Yuqing Tang, Yuanliang Gu, Harris Haleem, Libo Zhang, Youping Zhang, Chunxia Xu, Jinshun Zhao. Evaluation of the effectiveness of a pilot study of hospital-based hepatitis C epidemic surveillance. Medicine 2019; 98(51): e18334 doi: 10.1097/MD.0000000000018334
|
| 290 |
Silvia Nardelli, Oliviero Riggio, Davide Rosati, Stefania Gioia, Alessio Farcomeni, Lorenzo Ridola. Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms. World Journal of Gastroenterology 2019; 25(48): 6928-6938 doi: 10.3748/wjg.v25.i48.6928
|
| 291 |
William B. Coleman, Gregory J. Tsongalis. Essential Concepts in Molecular Pathology. 2020; : 191 doi: 10.1016/B978-0-12-813257-9.00012-7
|
| 292 |
Arwa Kamhawy, Zeinab Nabil Ahmed Said, Salwa Elsayed Abdelhamid, Mohammad El-Sayed, Rasha Eletreby, Hasan El Garem, Mohamed El Kassas, Gamal Esmat. Hepatitis C viral RNA in blood mononuclear cells of patients treated with directly acting antivirals. Arab Journal of Gastroenterology 2021; 22(2): 158 doi: 10.1016/j.ajg.2021.03.001
|
| 293 |
Sarmad Zahoor, Aleena Khan, Sadia Asif, Sair Ahmad Tabraiz, Hossam Mustafa, Sheraz Ansar, Sumera Hanif, Hassan Ali Raza. Past and Future Perspectives for Hepatitis B and C in Pakistan. Cureus 2021; doi: 10.7759/cureus.17521
|
| 294 |
Hailang Li, Ling Hu, Liwen Wang, Yixuan Wang, Meiqi Shao, Yupei Chen, Wenlin Wu, Lei Wang. Iron Activates cGAS-STING Signaling and Promotes Hepatic Inflammation. Journal of Agricultural and Food Chemistry 2022; 70(7): 2211 doi: 10.1021/acs.jafc.1c06681
|
| 295 |
Elizabeth Buganza-Torio, Karen Elizabeth Doucette. Management of Viral Hepatitis in Solid Organ Transplant Recipients. Infectious Disease Clinics of North America 2018; 32(3): 635 doi: 10.1016/j.idc.2018.04.010
|
| 296 |
Sevin Kirdar, Neriman Aydin, Yasin Tiryaki, Bulent Ertugrul, Adil Coskun, Mehmet Bilgen. Dynamics of HCV epidemiology in Aydin province of Turkey and the associated factors. APMIS 2018; 126(2): 109 doi: 10.1111/apm.12790
|
| 297 |
V. S. Kichatova, A. A. Karlsen, O. V. Isaeva, S. A. Solonin, E. Yu. Malinnikova, K. K. Kyuregyan, M. I. Mikhailov. Drug resistant variants of hepatitis C virus genotype 1b in Russia: analysis of aminoacid substitutions in NS5a and core proteins. Journal Infectology 2018; 10(4): 30 doi: 10.22625/2072-6732-2018-10-4-30-36
|
| 298 |
Shahab Mahmoudvand, Somayeh Shokri, Azarakhsh Azaran, Seyed S. Seyedian, Manoochehr Makvandi, Habibollah Mirzaei, Sheida B. Sheikhrobat. Seronegative occult hepatitis C infection among hemodialysis patients: A prevalence study. Therapeutic Apheresis and Dialysis 2021; 25(2): 218 doi: 10.1111/1744-9987.13535
|
| 299 |
Hairui Zhang, Ran Ren, Jinlin Liu, Ying Mao, Guowei Pan, Ke Men, Li Ma. Health-Related Quality of Life among Patients with Hepatitis C Virus Infection: A Cross-Sectional Study in Jianping County of Liaoning Province, China. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/6716103
|
| 300 |
Emily Nguyen, Sam Trinh, Huy Trinh, Huy Nguyen, Khanh Nguyen, Aivien Do, Brian Levitt, Son Do, My Nguyen, Treta Purohit, Eugenie Shieh, Mindie H. Nguyen. Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir. Alimentary Pharmacology & Therapeutics 2019; 49(1): 99 doi: 10.1111/apt.15043
|
| 301 |
Andrey V. Barkhash, Galina V. Kochneva, Elena V. Chub, Aida G. Romaschenko. Single nucleotide polymorphism rs1800872 in the promoter region of the IL10 gene is associated with predisposition to chronic hepatitis C in Russian population. Microbes and Infection 2018; 20(3): 212 doi: 10.1016/j.micinf.2017.11.012
|
| 302 |
Batbold Batsaikhan, Ching-I Huang, Ming-Lun Yeh, Chung-Feng Huang, Nei-Jen Hou, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Ming-Lung Yu, Wan-Long Chuang, Jin-Ching Lee, Chia-Yen Dai. The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C. Oncotarget 2018; 9(30): 21313 doi: 10.18632/oncotarget.25092
|
| 303 |
Livia Melo Villar, Vanessa Salete de Paula, Barbara Vieira do Lago, Juliana Custódio Miguel, Helena Medina Cruz, Moyra Machado Portilho, Vanessa Alves Marques, Roberto Pérez Ravier, Ivana Lo Castro, Héctor Cuello, Carlos Espul. Epidemiology of hepatitis B and C virus infection in Central West Argentina. Archives of Virology 2020; 165(4): 913 doi: 10.1007/s00705-020-04540-7
|
| 304 |
Hang Zhang, Ahmed A. Quadeer, Matthew R. McKay. Evolutionary modeling reveals enhanced mutational flexibility of HCV subtype 1b compared with 1a. iScience 2022; 25(1): 103569 doi: 10.1016/j.isci.2021.103569
|
| 305 |
Jianjian Zhuang, Juxin Yin, Shaowu Lv, Ben Wang, Ying Mu. Advanced “lab-on-a-chip” to detect viruses – Current challenges and future perspectives. Biosensors and Bioelectronics 2020; 163: 112291 doi: 10.1016/j.bios.2020.112291
|
| 306 |
Muhammad Arba, Setyanto Tri Wahyudi, Muhammad Sulaiman Zubair, Dylan Brunt, Mursalin Singh, Chun Wu. Binding of GS-461203 and Its Halogen Derivatives to HCV Genotype 2a RNA Polymerase Drug Resistance Mutants. Scientia Pharmaceutica 2022; 90(2): 26 doi: 10.3390/scipharm90020026
|
| 307 |
Daniela Manuc, Carmen Monica Preda, Irina Sandra, Cristian Baicus, Razvan Cerban, Ileana Constantinescu, Andrei Ovidiu Olteanu, Cosmin Alexandru Ciora, Teodora Manuc, Daniela Elena Chiriac, Andreea Elena Chifulescu, Mircea Diculescu, Cristian Tieranu, Lucian Negreanu, Gabriela Oprea-Calin, Mircea Manuc. Signification of Serum Alpha-Fetoprotein Levels in Cases of Compensated Cirrhosis and Hepatitis C Virus without Hepatocellular Carcinoma. Journal of Medicine and Life 2020; 13(1): 68 doi: 10.25122/jml-2019-0076
|
| 308 |
Sara Lo Menzo, Enrico Biagi, Mariachiara Di Nuzzo, Anastasio Grilli, Carlo Contini. SVR 24 Achievement Two Weeks After a Tripled Dose of Daclatasvir in an HCV Genotype 3 Patient. Annals of Hepatology 2018; 17(4): 661 doi: 10.5604/01.3001.0012.0950
|
| 309 |
JC Jiménez-Mendoza, FE Rivera-López, MF González-Lara, RD Valdez-Echeverría, GE Castro-Narro, A Tore, LF Uscanga-Domínguez, C Moctezuma-Velázquez. Seroprevalence of hepatitis B and C viruses in moderate and severe COVID-19 inpatients: A cross-sectional study at a referral center in Mexico. Annals of Hepatology 2022; 27(3): 100684 doi: 10.1016/j.aohep.2022.100684
|
| 310 |
Noha Mousaad Elemam, Iman M. Talaat, Azzam A. Maghazachi, Maha Saber-Ayad. Liver Injury Associated with COVID-19 Infection: Pathogenesis, Histopathology, Prognosis, and Treatment. Journal of Clinical Medicine 2023; 12(5): 2067 doi: 10.3390/jcm12052067
|
| 311 |
Nur Amalin Zahirah Mohd Amin, Tuan Nur Akmalina Mat Jusoh, Ahmad Adebayo Irekeola, Rafidah Hanim Shueb. Hepatitis C: A Review on Current and Emerging Genotyping Assays. Malaysian Journal of Medicine and Health Sciences 2023; 19(5): 359 doi: 10.47836/mjmhs.19.5.41
|
| 312 |
Ahmed Mohammed Gaballah, Marwa Mohammed Esawy. Comparison of 2 different antibody assay methods, Elecsys Anti-HCVII (Roche) and Vidas Anti-HCV (Biomerieux), for the detection of antibody to hepatitis C virus in Egypt. Diagnostic Microbiology and Infectious Disease 2018; 92(2): 107 doi: 10.1016/j.diagmicrobio.2018.05.013
|
| 313 |
Maria C. Lopez-Osorio, Jose Aldemar Usme-Ciro, Jose Martinez, Dioselina Pelaez-Carvajal, Javier Hernandez, Sergio Hoyos, Juan Carlos Restrepo, Maria-Cristina Navas. Genetic Diversity of Hepatitis C Virus and Resistance Associated Substitutions to Direct-Acting Antiviral Treatment in Colombia. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4115786
|
| 314 |
Gary M. Clifford, Tim Waterboer, Bolormaa Dondog, You Lin Qiao, Dimitri Kordzaia, Doudja Hammouda, Namory Keita, Nahid Khodakarami, Syed Ahsan Raza, Ang Tshering Sherpa, Witold Zatonski, Michael Pawlita, Martyn Plummer, Silvia Franceschi. Hepatitis C virus seroprevalence in the general female population of 9 countries in Europe, Asia and Africa. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0121-1
|
| 315 |
Mohan Krishna Ghanta, Mohammad Faiz Hussain, Asmita Karnalkar, Sirpu Natesh Nagabhishek, Poojith Nuthalapati, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 401 doi: 10.1016/B978-0-323-99283-1.00003-3
|
| 316 |
Petra E de Ruiter, Yashna Gadjradj, Robert J de Knegt, Herold J Metselaar, Jan NM Ijzermans, Luc JW van der Laan. Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid. World Journal of Transplantation 2018; 8(5): 156-166 doi: 10.5500/wjt.v8.i5.156
|
| 317 |
Maléki Assih, Abdoul Karim Ouattara, Birama Diarra, Albert Theophane Yonli, Tegwindé Rebeca Compaore, Dorcas Obiri-Yeboah, Florencia Wendkuuni Djigma, Simplice Karou, Jacques Simpore. Genetic diversity of hepatitis viruses in West-African countries from 1996 to 2018. World Journal of Hepatology 2018; 10(11): 807-821 doi: 10.4254/wjh.v10.i11.807
|
| 318 |
Hepatitis C Virus among Female Sex Workers: A Cross-Sectional Study Conducted along Rivers and Highways in the Amazon Region. Pathogens 2019; 8(4): 236 doi: 10.3390/pathogens8040236
|
| 319 |
Zeina Nehme, Sébastien Pasquereau, Georges Herbein. Histone Modifications in Therapy. 2020; : 255 doi: 10.1016/B978-0-12-816422-8.00011-8
|
| 320 |
Carmen L. Loureiro, Rossana C. Jaspe, Flor H. Pujol. Variation in Hepatitis C Virus Subtype Distribution during 20 Years in Venezuela. Intervirology 2019; 62(5-6): 191 doi: 10.1159/000505065
|
| 321 |
Issam I Raad, Anne-Marie Chaftari, Harrys A Torres, Ehab Mouris Ayoub, Liliane Iskander Narouz, Jalen Bartek, Ray Hachem. Challenge of hepatitis C in Egypt and hepatitis B in Mauritania. World Journal of Hepatology 2018; 10(9): 549-557 doi: 10.4254/wjh.v10.i9.549
|
| 322 |
Ashly Maughan, Onyema Ogbuagu. Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(2): 219 doi: 10.1080/17425255.2018.1421173
|
| 323 |
João Paulo Vilela Rodrigues, Guilherme Rodrigues Fernandes Campos, Cintia Bittar, Ana de Lourdes Candolo Martinelli, Marília Silveira de Almeida Campos, Leonardo Régis Leira Pereira, Paula Rahal, Fernanda Fernandes Souza. Selection dynamics of HCV genotype 3 resistance-associated substitutions under direct-acting antiviral therapy pressure. The Brazilian Journal of Infectious Diseases 2022; 26(6): 102717 doi: 10.1016/j.bjid.2022.102717
|
| 324 |
Xiao-Ning Wu, Feng Xue, Nan Zhang, Wei Zhang, Jing-Jing Hou, Yi Lv, Jun-Xi Xiang, Xu-Feng Zhang. Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019. BMC Public Health 2024; 24(1) doi: 10.1186/s12889-024-17948-6
|
| 325 |
Asrul Akmal Shafie, Muhammad Radzi Abu Hassan, Norazila Abdul Ghani, Beng Hoong Chew, Nor Syahireen Mohammed. Cost analysis of chronic hepatitis C virus management in a Malaysia tertiary hospital. Journal of Pharmaceutical Health Services Research 2018; 9(2): 141 doi: 10.1111/jphs.12210
|
| 326 |
Maria C. Lopez-Osorio, José Aldemar Usme-Ciro, José William Martínez, Dioselina Peláez-Carvajal, Javier Hernández, Sergio Hoyos, Juan Carlos Restrepo, Maria-Cristina Navas. Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia. Virus Research 2022; 318: 198847 doi: 10.1016/j.virusres.2022.198847
|
| 327 |
Mariya A. Derbak, Oksana T. Hanych, Taras M. Ganich, Volodymyr V. Timashev, Vasilina V. Svistak, Valentyna Yu. Koval, Pavlo P. Ganynets. The Effectiveness of the Gastro-esophageal Reflux Disease Treatment in Persons who have Completed Successful Chronic Hepatitis C Antiviral Therapy at the Rehabilitation Stage. Acta Balneologica 2022; 64(4): 333 doi: 10.36740/ABal202204110
|
| 328 |
Itai Yechezkel, Mansun Law, Netanel Tzarum. From Structural Studies to HCV Vaccine Design. Viruses 2021; 13(5): 833 doi: 10.3390/v13050833
|
| 329 |
Lazzat Aibekova, Aizada Bexeitova, Arailym Aldabergenova, Gonzalo Hortelano, Zhangwen Ge, Feng Yi, Yiming Shao, Jack DeHovitz, Sten H. Vermund, Syed Ali. Transmission of HIV and HCV within Former Soviet Union Countries. Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/9701920
|
| 330 |
Antoine Chaillon, Sanjay R. Mehta, Martin Hoenigl, Sunil S. Solomon, Peter Vickerman, Matthew Hickman, Britt Skaathun, Natasha K. Martin, Yury E. Khudyakov. Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection. PLOS ONE 2019; 14(6): e0217964 doi: 10.1371/journal.pone.0217964
|
| 331 |
Petra Simicic, Anamarija Slovic, Leona Radmanic, Adriana Vince, Snjezana Zidovec Lepej. Molecular Epidemiology and Baseline Resistance of Hepatitis C Virus to Direct Acting Antivirals in Croatia. Pathogens 2022; 11(7): 808 doi: 10.3390/pathogens11070808
|
| 332 |
Keerthana Raja, Sembiyaa Arumugam, Sheik S.S.J. Ahmed, Ramakrishnan Veerabathiran. Oncogenic Viruses. 2023; : 197 doi: 10.1016/B978-0-12-824152-3.00006-8
|
| 333 |
Naveen Bhagat, Nipun Verma, Virendra Singh. HCC prediction post SVR: Many tools yet limited generalizability!. Journal of Hepatology 2022; 77(4): 1226 doi: 10.1016/j.jhep.2022.04.028
|
| 334 |
Guilherme Bricks, Jorge Figueiredo Senise, Henrique Pott Junior, Giuliano Grandi, Amanda Passarini, Débora Bellini Caldeira, Dimas Carnaúba Junior, Hamilton Antonio Bonilha de Moraes, Celso Franscisco Hernandes Granato, Adauto Castelo. Seroprevalence of hepatitis E virus in chronic hepatitis C in Brazil. The Brazilian Journal of Infectious Diseases 2018; 22(2): 85 doi: 10.1016/j.bjid.2018.02.001
|
| 335 |
Sara Tarek, Ayman E. Eskander, Safa Meshaal, Eman Badr, Asmaa Abd El-Hakeem. Frequency of hepatitis C virus infection in patients with pediatric inflammatory bowel disease: a cross-sectional study. Egyptian Pediatric Association Gazette 2023; 71(1) doi: 10.1186/s43054-023-00231-5
|
| 336 |
Arzu ALTUNÇEKİÇ YILDIRIM, Celali KURT, Ali Seydi ALPAY, Ahmet DOĞAN. Genotype distribution and risk factors in patients with chronic hepatitis C infection. Journal of Biotechnology and Strategic Health Research 2021; 5(1): 50 doi: 10.34084/bshr.846410
|
| 337 |
Vahideh Takhviji, Ebrahim Azizi, Ali Kordian, Abbas Khosravi, Mostafa Paridar, Mohammad Ali Jalalifar, Omid Kiani Ghalehsardi, Mohammad Abdollahi, Mofid Hosseinzadeh, Zahra Bakshandeh. Hepatitis C virus prevalence among patients with thalassemia and inherited bleeding disorders in Iran: a systematic review and meta-analysis. Hematology & Transfusion International Journal 2018; 6(5) doi: 10.15406/htij.2018.06.00175
|
| 338 |
Flavia F. Fernandes, Hugo Perazzo, Luiz E. Andrade, Alessandra Dellavance, Carlos Terra, Gustavo Pereira, João L. Pereira, Frederico Campos, Maria L. Ferraz, Renata M. Perez. Latent Class Analysis of Noninvasive Methods and Liver Biopsy in Chronic Hepatitis C: An Approach without a Gold Standard. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/8252980
|
| 339 |
Xavier A. Andrade, Luis H. Paz, Mo''ath Nassar, Diana M. Oramas, Harry E. Fuentes, Paula Kovarik, Satya Mishra, Anshu Singh. Primary Liver Diffuse Large B-Cell Lymphoma following Complete Response for Hepatitis C Infection after Direct Antiviral Therapy. Acta Haematologica 2018; 139(2): 77 doi: 10.1159/000484653
|
| 340 |
Safaa S. Abo-Elnour, Amira E. Abdelhamid, Sherine E. Bendary, Ossama A. Ahmed, Heba I. Aly, Dina M. Erfan. Serum Interleukin-35 Level in Correlation with T Regulatory and T helper-17 Cells Frequency in Chronic Viral Hepatitis C Patients. Journal of Pure and Applied Microbiology 2020; 14(4): 2431 doi: 10.22207/JPAM.14.4.21
|
| 341 |
Satish Kumar, P. K. Santra, R. C. Aryan. SYNTHESIS CHARACTERIZATION AND DOCKING STUDY OF HCV NS3/4A PROTEASE INHIBITOR MOLECULES. INDIAN DRUGS 2020; 57(05): 19 doi: 10.53879/id.57.05.12295
|
| 342 |
Larisa Denisa Ursu, Bogdan Calenic, Mircea Diculescu, Alina Dima, Iulia Teodora Stoian, Ileana Constantinescu. Clinical and histopathological changes in different KIR gene profiles in chronic HCV Romanian patients. International Journal of Immunogenetics 2021; 48(1): 16 doi: 10.1111/iji.12515
|
| 343 |
Guy Rostoker, Nosratola D. Vaziri. Impact of iatrogenic iron overload on the course of hepatitis C in the dialysis population: A plea for caution. Hemodialysis International 2017; 21(S1) doi: 10.1111/hdi.12557
|
| 344 |
Tawhida Y. Abdel Ghaffar, Suzan El Naghi, Manal Abdel Gawad, Sarah Helmy, Aisha Abdel Ghaffar, Medhat Yousef, Mohamad Moafy. Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4. Journal of Viral Hepatitis 2019; 26(2): 263 doi: 10.1111/jvh.13032
|
| 345 |
Jia Liu, Wenqian Qi, Song Wang, Yonggui Zhang, Xu Wang, Derong Sun, Yanhui Xu, Jingyi Shi, Honglei Duan, Qian Zhang, Hongguang Wang, Jiangbin Wang. Metabolic disorders induced by PNPLA3 and TM6SF2 gene variants affect chronic kidney disease in patients infected with non-genotype 3 hepatitis C virus. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01858-4
|
| 346 |
|
| 347 |
Lara K Marquez, Javier A Cepeda, Annick Bórquez, Steffanie A Strathdee, Patricia E Gonzalez-Zúñiga, Clara Fleiz, Claudia Rafful, Richard S Garfein, Susan M Kiene, Stephanie Brodine, Natasha K Martin. Is hepatitis C virus (HCV) elimination achievable among people who inject drugs in Tijuana, Mexico? A modeling analysis. International Journal of Drug Policy 2021; 88: 102710 doi: 10.1016/j.drugpo.2020.102710
|
| 348 |
V. Estrada, I. Sagastagoitia. La hepatitis C es un factor de riesgo para enfermedad cardiovascular. Revista Clínica Española 2019; 219(6): 322 doi: 10.1016/j.rce.2019.01.012
|
| 349 |
Zujaja tul Misbah, Lubaba tul Uzma, Kanwal Shaheen, Tehreem Tanveer, Sadia Anjum. Prevalence of Skin diseases among Hepatitis C virus infected patients and their association with HCV infection in Islamabad, Pakistan. 2019 16th International Bhurban Conference on Applied Sciences and Technology (IBCAST) 2019; : 264 doi: 10.1109/IBCAST.2019.8667194
|
| 350 |
Yasuhiro Asahina, Chun‐Jen Liu, Edward Gane, Yoshito Itoh, Norifumi Kawada, Yoshiyuki Ueno, Jin Youn, Chen‐Yu Wang, Joe Llewellyn, Takuma Matsuda, Anuj Gaggar, Hongmei Mo, Hadas Dvory‐Sobol, Gerald Crans, Wan‐Long Chuang, Pei‐Jer Chen, Nobuyuki Enomoto. Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials. Hepatology Research 2020; 50(10): 1109 doi: 10.1111/hepr.13546
|
| 351 |
X. M. LI, R. X. QIU, C. H. SONG, Q. H. HUANG, X. D. WANG, Z. T. HU, X. Z. HE, X. Y. YE, X. G. HUANG, F. F. ZHENG, G. X. LIN. Genotype and genetic variation of HCV infections with low-risk factors in Putian coastal regions, China. Epidemiology and Infection 2017; 145(16): 3385 doi: 10.1017/S0950268817002357
|
| 352 |
H Maqsood, Tamoor Chughtai, Abdul Basit Khan, Shifa Younus, Akifa Abbas, Usman A Akbar, Shaheryar Qazi. Association of Lipid and Body Mass Index Profile With Chronic Hepatitis C Infection Stratified by Age and Gender. Cureus 2021; doi: 10.7759/cureus.20665
|
| 353 |
Joshua D. Duncan, Richard A. Urbanowicz, Alexander W. Tarr, Jonathan K. Ball. Hepatitis C Virus Vaccine: Challenges and Prospects. Vaccines 2020; 8(1): 90 doi: 10.3390/vaccines8010090
|
| 354 |
Ahmed Babiker, Jean Jeudy, Seth Kligerman, Miriam Khambaty, Anoop Shah, Shashwatee Bagchi. Risk of Cardiovascular Disease Due to Chronic Hepatitis C Infection: A Review. Journal of Clinical and Translational Hepatology 2017; 5(4): 1 doi: 10.14218/JCTH.2017.00021
|
| 355 |
Marc Puigvehí, Beatriz De Cuenca, Ana Viu, Moisés Diago, Juan Turnes, Francisco Gea, Juan M. Pascasio, Sabela Lens, Joaquín Cabezas, Ester Badia, Antonio Olveira, Rosa M. Morillas, Xavier Torras, Silvia Montoliu, Patricia Cordero, José L. Castro, Javier Salmerón, Esther Molina, Juan J. Sánchez‐Ruano, Javier Moreno, María D. Antón, José M. Moreno, Juan De la Vega, José L. Calleja, José A. Carrión. Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild‐moderate fibrosis: Results from a real‐world cohort. Liver International 2019; 39(1): 90 doi: 10.1111/liv.13950
|
| 356 |
Malathi Sathiyasekaran, Ganesh Ramaswamy. Diagnosis and Management of Hepatitis B and Hepatitis C Infections in Children
. Pediatric Infectious Disease 2020; 2(1): 12 doi: 10.5005/jp-journals-10081-1238
|
| 357 |
María García-Pola, Lucia Rodríguez-Fonseca, Carlota Suárez-Fernández, Raquel Sanjuán-Pardavila, Juan Seoane-Romero, Samuel Rodríguez-López. Bidirectional Association between Lichen Planus and Hepatitis C—An Update Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2023; 12(18): 5777 doi: 10.3390/jcm12185777
|
| 358 |
Ídila Mont’Alverne Xavier de Oliveira, Rita do Socorro Uchôa da Silva. Rheumatological Manifestations Associated with Viral Hepatitis B or C. Revista da Sociedade Brasileira de Medicina Tropical 2019; 52 doi: 10.1590/0037-8682-0407-2018
|
| 359 |
Xiao Liu, Xiaoqiong Duan, Jacinta A. Holmes, Wenting Li, Sae Hwan Lee, Zeng Tu, Chuanlong Zhu, Shadi Salloum, Anna Lidofsky, Esperance A. Schaefer, Dachuan Cai, Shilin Li, Haoju Wang, Yongfu Huang, Yongju Zhao, Ming‐Lung Yu, Zhiwen Xu, Limin Chen, Jian Hong, Wenyu Lin, Raymond T. Chung. A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha–Inducible Protein 6. Hepatology 2019; 69(3): 1004 doi: 10.1002/hep.30266
|
| 360 |
L Alexa Thompson, Jayne Fenton, Carmen L Charlton. HCV reflex testing: A single-sample, low-contamination method that improves the diagnostic efficiency of HCV testing among patients in Alberta, Canada. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2022; 7(2): 97 doi: 10.3138/jammi-2021-0028
|
| 361 |
Sara Mahmoud Farhan, Rehab Mahmoud Abd El-Baky, Salah aldin Mohammad Abdalla, Ahmed Osama El-Gendy, Ahmed Farag Azmy. Efficacy of Amikacin and Imipenem Against Multi-Drug Resistant Gram-Negative Bacteria Isolated from Wound Infections, Egypt. Iranian Journal of Medical Microbiology 2023; 17(2): 218 doi: 10.30699/ijmm.17.2.218
|
| 362 |
Roy Lothan, Noa Gutman, Dan Yamin. Country versus pharmaceutical company interests for hepatitis C treatment. Health Care Management Science 2022; 25(4): 725 doi: 10.1007/s10729-022-09607-2
|
| 363 |
Mary A Rodgers, Ana Olivo, Barbara J Harris, Chris Lark, Xinxin Luo, Michael G Berg, Todd V Meyer, Aurash Mohaimani, Gregory S Orf, Yitz Goldstein, Amy S Fox, Julie Hirschhorn, William B Glen, Frederick Nolte, Alan Landay, Cheryl Jennings, James Moy, Venice Servellita, Charles Chiu, Rahul Batra, Luke B Snell, Gaia Nebbia, Sam Douthwaite, Amilcar Tanuri, Lavanya Singh, Tulio de Oliveira, Ambroise Ahouidi, Souleymane Mboup, Gavin A Cloherty. Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests. Journal of Clinical Virology 2022; 147: 105080 doi: 10.1016/j.jcv.2022.105080
|
| 364 |
Supiana Dian Nurtjahyani, Retno Handajani. Hepatitis C Virus Genotyping from anti-HCV Negative Sera in Blood Donors. Journal of Pure and Applied Microbiology 2023; 17(3): 1926 doi: 10.22207/JPAM.17.3.58
|
| 365 |
Zurabi Lominadze, Robert S. Brown. Acute HCV Treatment: What Should We Do in the DAA Era?. Current Hepatology Reports 2019; 18(2): 216 doi: 10.1007/s11901-019-00463-3
|
| 366 |
Roseline MINME, Iandra HOLZMANN, Cristiane Valle TOVO, Paulo Roberto Lerias de ALMEIDA. PROFILE OF PATIENTS WITH CHRONIC HEPATITIS C IN A PUBLIC HEALTH PROGRAM IN SOUTHERN BRAZIL. Arquivos de Gastroenterologia 2018; 55(4): 403 doi: 10.1590/s0004-2803.201800000-86
|
| 367 |
Mohammad S. Khuroo, Ahmad A. Sofi. The Discovery of Hepatitis Viruses: Agents and Disease. Journal of Clinical and Experimental Hepatology 2020; 10(4): 391 doi: 10.1016/j.jceh.2020.04.006
|
| 368 |
Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Sunil Kasturi, Amrit Gopan, Sridhar Sundaram, Aditya Kale. Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis. Intestinal Research 2023; 21(3): 392 doi: 10.5217/ir.2022.00094
|
| 369 |
Hsin-I Huang, Chia-Ping Su, Wan-Ting Huang, Wan-Chin Chen. Gender differences in risk exposures for acute hepatitis C infection in Taiwan: a nationwide case–control study. BMC Public Health 2023; 23(1) doi: 10.1186/s12889-023-14995-3
|
| 370 |
Peter A.C. Wing, Meleri Jones, Michelle Cheung, Sampath DaSilva, Connor Bamford, Wing-Yiu Jason Lee, Elihu Aranday-Cortes, Ana Da Silva Filipe, John McLauchlan, David Smith, William Irving, Morven Cunningham, Azim Ansari, Eleanor Barnes, Graham R. Foster. Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir. Gastroenterology 2019; 157(3): 692 doi: 10.1053/j.gastro.2019.05.007
|
| 371 |
María Q. Marín, Kwinten Sliepen, Juan García-Arriaza, Sylvie M. Koekkoek, Patricia Pérez, Carlos Óscar S. Sorzano, Carmen E. Gómez, Rogier W. Sanders, Mariano Esteban. Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV. Vaccines 2020; 8(3): 440 doi: 10.3390/vaccines8030440
|
| 372 |
Sumaiah J. Alarfaj, Abdullah Alzahrani, Anfal Alotaibi, Malak Almutairi, Mashael Hakami, Njood Alhomaid, Noori Alharthi, Ghazwa B. Korayem, Abdullah Alghamdi. The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia. Saudi Pharmaceutical Journal 2022; 30(10): 1448 doi: 10.1016/j.jsps.2022.07.005
|
| 373 |
A. A. Latanova, K. K. Tuchinskaya, E. S. Starodubova, V. L. Karpov. Hepatitis C Virus Nonstructural Protein 3 Increases Secretion of Interleukin-1beta in HEK293T Cells with a Reconstructed NLRP3 Inflammasome. Molecular Biology 2023; 57(5): 876 doi: 10.1134/S0026893323050084
|
| 374 |
Jihene Bettaieb, Anissa Chouikha, Marwa Khedhiri, Ghassen Kharroubi, Malek Badreddine, Nabil Bel Hadj Hmida, Adel Gharbi, Walid Hammemi, Amel Sadraoui, Ahlem Ben Yahia, Zina Meddeb, Afif Ben Salah, Henda Triki. Hepatitis C virus epidemiology in Central-West Tunisia: a population-based cross-sectional study. Archives of Virology 2019; 164(9): 2243 doi: 10.1007/s00705-019-04308-8
|
| 375 |
Reilly Hostager, Manon Ragonnet-Cronin, Ben Murrell, Charlotte Hedskog, Anu Osinusi, Simone Susser, Christoph Sarrazin, Evguenia Svarovskaia, Joel O Wertheim. Hepatitis C virus genotype 1 and 2 recombinant genomes and the phylogeographic history of the 2k/1b lineage. Virus Evolution 2019; 5(2) doi: 10.1093/ve/vez041
|
| 376 |
Nor Asiah Muhamad, Rimah Melati Ab.Ghani, Mohd Hatta Abdul Mutalip, Eida Nurhadzira Muhammad, Hasmah Mohamad Haris, Rozainanee Mohd Zain, Noraidatulakma Abdullah, Nor Azila Muhammad Azami, Nazihah Abd Jalal, Norliza Ismail, Nurul Ain Mhd Yusuf, Raihannah Othman, Azwa Shawani Kamalul Arifin, Mohd Shaharom Abdullah, Mohd Arman Kamaruddin, Muhammad Radzi Abu Hassan, Tahir Aris, Rahman Jamal. Seroprevalence of hepatitis B virus and hepatitis C virus infection among Malaysian population. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77813-5
|
| 377 |
Yazan Abboud, Anna G. Mathew, Mohamad Aghaie Meybodi, Esli Medina-Morales, Saqr Alsakarneh, Catherine Choi, Yi Jiang, Nikolaos T. Pyrsopoulos. Chronic Liver Disease and Cirrhosis Mortality Rates Are Disproportionately Increasing in Younger Women in the United States Between 2000-2020. Clinical Gastroenterology and Hepatology 2024; 22(4): 798 doi: 10.1016/j.cgh.2023.11.013
|
| 378 |
Myrtille Prouté, Sophie Le Coeur, Métrey H. Tiv, Timothée Dub, Parinya Jongpaijitsakul, Anantika Ratnamhin, Chaisiri Angkurawaranon, Apinun Aramrattana, Marc Lallemant. Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs. BMC Public Health 2020; 20(1) doi: 10.1186/s12889-020-09549-w
|
| 379 |
Masoud Behzadifar, Hassan Abolghasem Gorji, Nicola Luigi Bragazzi. The prevalence of hepatitis C virus infection in thalassemia patients in Iran from 2000 to 2017: a systematic review and meta-analysis. Archives of Virology 2018; 163(5): 1131 doi: 10.1007/s00705-018-3767-0
|
| 380 |
Jardel Oliveira Rocha, Elodie Bomfim Hyppolito, Maria Macedo Saraiva Tavares, Érico Antonio Gomes de Arruda, Lara Gurgel Fernandes Távora, Roberto Da Justa Pires Neto, Melissa Soares Medeiros. EFETIVIDADE DE ANTIVIRAIS DE AÇÃO DIRETA NO TRATAMENTO DA COINFECÇÃO VÍRUS DA HEPATITE C E VÍRUS DA IMUNODEFICIÊNCIA HUMANA. Cadernos ESP 2023; 17(1): e1346 doi: 10.54620/cadesp.v17i1.1346
|
| 381 |
Jordi Remon, Francesco Passiglia, Myung-Ju Ahn, Fabrice Barlesi, Patrick M. Forde, Edward B. Garon, Scott Gettinger, Sarah B. Goldberg, Roy S. Herbst, Leora Horn, Kaoru Kubota, Shun Lu, Laura Mezquita, Luis Paz-Ares, Sanjay Popat, Kurt A. Schalper, Ferdinandos Skoulidis, Martin Reck, Alex A. Adjei, Giorgio V. Scagliotti. Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations. Journal of Thoracic Oncology 2020; 15(6): 914 doi: 10.1016/j.jtho.2020.03.006
|
| 382 |
Fardad Ejtehadi, Paymun Farahvashi, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Ladan Aminlari, Nasrin Motazedian, Kourosh Kazemi, Hamed Nikoupour, Saman Nikeghbalian, Hesameddin Eghlimi, Alireza Taghavi, Mohammadreza Fattahi, Kamran Bagheri Lankarani, Seyyed Ali Malek-Hosseini. Clinical Course and Outcome of Liver Transplantation in Patients with Hepatitis C in Iran. Hepatitis Monthly 2021; 21(3) doi: 10.5812/hepatmon.108405
|
| 383 |
Caitlin A. Moran, Lauren F. Collins, Nour Beydoun, Puja K. Mehta, Yetunde Fatade, Ijeoma Isiadinso, Tené T. Lewis, Brittany Weber, Jill Goldstein, Igho Ofotokun, Arshed Quyyumi, May Y. Choi, Kehmia Titanji, Cecile D. Lahiri. Cardiovascular Implications of Immune Disorders in Women. Circulation Research 2022; 130(4): 593 doi: 10.1161/CIRCRESAHA.121.319877
|
| 384 |
Alessandro Soria, Marco Fava, Davide P. Bernasconi, Giuseppe Lapadula, Elisa Colella, Maria G. Valsecchi, Guglielmo M. Migliorino, Roberta D'Ambrosio, Simona Landonio, Monica Schiavini, Angiola Spinetti, Canio Carriero, Elisabetta Degasperi, Giuliana Cologni, Federico Gatti, Paolo Viganò, Hamid Hasson, Caterina Uberti‐Foppa, Luisa Pasulo, Chiara Baiguera, Roberto Rossotti, Maria Vinci, Massimo Puoti, Alessia Giorgini, Barbara Menzaghi, Andrea Lombardi, Angelo Pan, Alessio Aghemo, Paolo A. Grossi, Roberto Boldizzoni, Silvia Colombo, Mauro Viganò, Maria G. Rumi, Paolo Del Poggio, Luca Valenti, Omar Giglio, Anna De Bona, Antonella d'Arminio Monforte, Alberto Colombo, Ombretta Spinelli, Marie G. Pigozzi, Chiara Molteni, Paolo Bonfanti, Natalia Terreni, Paolo Perini, Andrea Capretti, Daniele Bella, Cecilia Liani, Silvia Polo, Gianpiero Aimo, Layla Pagnucco, Sherrie Bhoori, Riccardo Centenaro, Massimo Graffeo, Antonio Ciaccio, Elena Dionigi, Sergio Lazzaroni, Isabella Carderi, Mariella Di Marco, Giuliano Rizzardini, Franco Noventa, Pietro Lampertico, Stefano Fagiuoli. Comparison of three therapeutic regimens for genotype‐3 hepatitis C virus infection in a large real‐life multicentre cohort. Liver International 2020; 40(4): 769 doi: 10.1111/liv.14386
|
| 385 |
Muhammad Sohaib ASGHAR, Uzma RASHEED, Maira HASSAN, Mohammed AKRAM, Rabail YASEEN, Basmah FAYAZ. A CROSS-SECTIONAL SCREENING SURVEY ON THE SEROPREVALENCE OF HEPATITIS B AND HEPATITIS C AMONGST THE GENERAL POPULATION OF RURAL DISTRICTS OF SINDH, PAKISTAN. Arquivos de Gastroenterologia 2021; 58(2): 150 doi: 10.1590/s0004-2803.202100000-26
|
| 386 |
Benli Jia, Dongsheng Yu, Gang Yu, Yunsheng Cheng, Yang Wang, Xiaoqiang Yi, Xiaoping Li, Yong Wang. Naringenin improve hepatitis C virus infection induced insulin resistance by increase PTEN expression via p53-dependent manner. Biomedicine & Pharmacotherapy 2018; 103: 746 doi: 10.1016/j.biopha.2018.04.110
|
| 387 |
Ahmed E. Gaafar, Amr Abd El-Aal, Mohamed Alboraie, Housam M. Hassan, Adel ElTahan, Yasser AbdelRahman, Mohamed-Naguib Wifi, Dalia Omran, Shimaa Afify Mansour, Waleed M. Hassan, Magdy Ismail, Mohamed El Kassas. Prevalence of prolonged QT interval in patients with HCV-related chronic liver disease. The Egyptian Heart Journal 2019; 71(1) doi: 10.1186/s43044-019-0016-0
|
| 388 |
Rafaela S. Fernandes, Marjorie C. L. C. Freire, Renata V. Bueno, Andre S. Godoy, Laura H. V. G. Gil, Glaucius Oliva. Reporter Replicons for Antiviral Drug Discovery against Positive Single-Stranded RNA Viruses. Viruses 2020; 12(6): 598 doi: 10.3390/v12060598
|
| 389 |
Li-Ting Xie, Chun-Hong Yan, Qi-Yu Zhao, Meng-Na He, Tian-An Jiang. Quantitative and noninvasive assessment of chronic liver diseases using two-dimensional shear wave elastography. World Journal of Gastroenterology 2018; 24(9): 957-970 doi: 10.3748/wjg.v24.i9.957
|
| 390 |
Vivianne de Oliveira Landgraf de Castro, Saleem Kamili, Joseph C. Forbi, Andréa Cristina Stabile, Elizeu Ferreira da Silva, Sandra Maria do Valle Leone de Oliveira, Paula Renata Tedesco de Carvalho, Marco Antonio Moreira Puga, Tayana Serpa Ortiz Tanaka, Bárbara Vieira do Lago, Mary Luiza Ibanhes, Aufra Araujo, Alexandra Tejada-Strop, Yulin Lin, Guo-Liang Xia, Amanda Sue, Sheila Araújo Teles, Ana Rita Coimbra Motta-Castro. High prevalence of Hepatitis C Virus infection among people who use crack cocaine in an important international drug trafficking route in Central-West Region Brazil. Infection, Genetics and Evolution 2020; 85: 104488 doi: 10.1016/j.meegid.2020.104488
|
| 391 |
Timothy An, Melinda Dean, Robert Flower, Tayla Tatzenko, Hiu Tat Chan, Philip Kiely, Helen M. Faddy. Understanding occult hepatitis C infection. Transfusion 2020; 60(9): 2144 doi: 10.1111/trf.16006
|
| 392 |
Moosa Tatar, Susana W. Keeshin, Mark Mailliard, Fernando A. Wilson. Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States. JAMA Network Open 2020; 3(9): e2015756 doi: 10.1001/jamanetworkopen.2020.15756
|
| 393 |
Elrashdy M. Redwan, Abdullah A. Aljadawi, Vladimir N. Uversky. Hepatitis C Virus Infection and Intrinsic Disorder in the Signaling Pathways Induced by Toll-Like Receptors. Biology 2022; 11(7): 1091 doi: 10.3390/biology11071091
|
| 394 |
娜娜 李. Related Research Progress in Genotyping of Hepatitis C Virus. Advances in Clinical Medicine 2023; 13(05): 7598 doi: 10.12677/ACM.2023.1351061
|
| 395 |
Tinghua Li, Hongwei Zhang, Zhonggang Fang, Jun Yin, Wei Rao. Clinical performance of the MAGLUMI Anti-HCV (CLIA) Test for detection of hepatitis C virus antibodies. Journal of Virological Methods 2023; 319: 114770 doi: 10.1016/j.jviromet.2023.114770
|
| 396 |
Felix Kleefeld, Gabriele Arendt, Eva Neuen-Jacob, Matthias Maschke, Ingo Husstedt, Mark Obermann, Holger Schmidt, Katrin Hahn. Neurologische Komplikationen der Hepatitis-C-Infektion. Der Nervenarzt 2021; 92(2): 144 doi: 10.1007/s00115-020-00999-6
|
| 397 |
Beatrice N. Vetter, Elena Ivanova Reipold, Stefano Ongarello, Emmanuel Fajardo, Alexander Tyshkovskiy, Iryna Ben, Marta Vasylyev. Prospective evaluation of hepatitis C virus antibody detection in whole blood collected on dried blood spots with the INNOTEST® HCV Ab IV enzyme immunoassay. Journal of Clinical Virology 2021; 137: 104783 doi: 10.1016/j.jcv.2021.104783
|
| 398 |
Daniel Atlaw, Biniyam Sahiledengle, Zerihun Tariku. Hepatitis B and C virus infection among healthcare workers in Africa: a systematic review and meta-analysis. Environmental Health and Preventive Medicine 2021; 26(1) doi: 10.1186/s12199-021-00983-9
|
| 399 |
Benedetto Caroleo, Lidia Colangelo, Maria Perticone, Giovambattista De Sarro, Luca Gallelli. Efficacy and Safety of Elbasvir‐Grazoprevir Fixed Dose in the Management of Polytreated HCV Patients: Evidence From Real‐Life Clinical Practice. The Journal of Clinical Pharmacology 2018; 58(10): 1248 doi: 10.1002/jcph.1135
|
| 400 |
J. Hutton, J. Doyle, R. Zordan, T. Weiland, A. Cocco, J. Howell, S. Iser, J. Snell, S. Fry, K. New, R. Sloane, M. Jarman, D. Phan, S. Tran, A. Pedrana, B. Williams, J. Johnson, S. Glasgow, A. Thompson. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department. International Journal of Drug Policy 2019; 72: 84 doi: 10.1016/j.drugpo.2019.06.021
|
| 401 |
Reza Safdari, Amir Deghatipour, Marsa Gholamzadeh, Keivan Maghooli. Applying data mining techniques to classify patients with suspected hepatitis C virus infection. Intelligent Medicine 2022; 2(4): 193 doi: 10.1016/j.imed.2021.12.003
|
| 402 |
Natalia Echeverría, Victoria Comas, Fabián Aldunate, Paula Perbolianachis, Pilar Moreno, Juan Cristina. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? . World Journal of Hepatology 2021; 13(10): 1234-1268 doi: 10.4254/wjh.v13.i10.1234
|
| 403 |
Reinhard H. Dennin. Current HIV Prevention Policies Are Jeopardizing the “End of AIDS” Project: Realities Counteract Liberal Visions. World Journal of AIDS 2017; 7(02): 138 doi: 10.4236/wja.2017.72012
|
| 404 |
Fahimeh Safarnezhad Tameshkel, Mohammad Hadi Karbalaie Niya, Farhad Zamani, Hossein Ajdarkosh, Mahmoodreza Khoonsari, Amir Hossein Faraji, Nima Motamed, Mehdi Nikkhah, Mitra Ameli, Seyyed Mohammad Miri, Azita Azarkeivan, Masood Reza Sohrabi, Hossein Keyvani. Simultaneous Hepatitis C Virus Genotyping and Variant Detection in Patients with Thalassemia: A Single-Center Phylogenetic Study. Middle East Journal of Digestive Diseases 2022; 14(1): 124 doi: 10.34172/mejdd.2022.265
|
| 405 |
Ming-Shyan Lin, Chang-Min Chung, Ming-Ling Chang, Mei-Yen Chen, Shih-Tai Chang, Pao-Hsien Chu, Tien-Hsing Chen, Wey-Yil Lin, Tung-Jung Huang, Yu-Sheng Lin. The Unraveled Link Between Antiviral Therapy and Heart Failure Hospitalization in Chronic Hepatitis C Virus Infection ― A Nationwide Cohort Study ―. Circulation Journal 2018; 82(6): 1623 doi: 10.1253/circj.CJ-17-1118
|
| 406 |
Xiaoqiong Duan, Xiao Liu, Wenting Li, Jacinta A. Holmes, Annie J. Kruger, Chunhui Yang, Yujia Li, Min Xu, Haiyan Ye, Shuang Li, Xinzhong Liao, Qiuju Sheng, Dong Chen, Tuo Shao, Zhimeng Cheng, Batul Kaj, Esperance A. Schaefer, Shilin Li, Limin Chen, Wenyu Lin, Raymond T. Chung. Microrna-130a Downregulates HCV Replication through an atg5-Dependent Autophagy Pathway. Cells 2019; 8(4): 338 doi: 10.3390/cells8040338
|
| 407 |
Hui Qian, Xiaojuan Chao, Jessica Williams, Sam Fulte, Tiangang Li, Ling Yang, Wen-Xing Ding. Autophagy in liver diseases: A review. Molecular Aspects of Medicine 2021; 82: 100973 doi: 10.1016/j.mam.2021.100973
|
| 408 |
Hafsa Aziz, Shazia Fatima, Mohammad Faheem. Indeterminate Prediction of Hepatitis C Virus Genotype by Commercial Real-Time Polymerase Chain Reaction Assay Resolving by Sequencing to Avoid the Consequence of Inaccurate Typing. Viral Immunology 2020; 33(7): 507 doi: 10.1089/vim.2019.0162
|
| 409 |
Bing Han, Yujia Zheng, Le Wang, Haixu Wang, Jiaxin Du, Fanglei Ye, Tongwen Sun, Lianfeng Zhang. A novel microRNA signature predicts vascular invasion in hepatocellular carcinoma. Journal of Cellular Physiology 2019; 234(11): 20859 doi: 10.1002/jcp.28690
|
| 410 |
Claudinei Mesquita da SILVA, Leyde Daiane de PEDER, Mateus Vailant THOMAZELLA, Jorge Juarez Vieira TEIXEIRA, Dennis Armando BERTOLINI. PROFILE OF HCV GENOTYPES AND HIV-SUBTYPES AMONG HIV-COINFECTED PATIENTS IN SOUTHERN BRAZIL. Arquivos de Gastroenterologia 2019; 56(4): 344 doi: 10.1590/s0004-2803.201900000-68
|
| 411 |
Qunying Han, Xiude Fan, Xiaoyun Wang, Ye Wang, Huan Deng, Xiaoge Zhang, Kun Zhang, Na Li, Zhengwen Liu. High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world setting. Virology Journal 2019; 16(1) doi: 10.1186/s12985-019-1184-y
|
| 412 |
Mona Prasad, George R. Saade, Grecio Sandoval, Brenna L. Hughes, Uma M. Reddy, Lisa Mele, Ashley Salazar, Michael W. Varner, Cynthia Gyamfi-Bannerman, John M. Thorp, Alan T. N. Tita, Geeta K. Swamy, Edward K. Chien, Brian M. Casey, Alan M. Peaceman, Yasser Y. El-Sayed, Jay D. Iams, Ronald S. Gibbs, Baha Sibai, Nicholas Wiese, Saleem Kamili, George A. Macones. Hepatitis C Virus Antibody Screening in a Cohort of Pregnant Women. Obstetrics & Gynecology 2020; 135(4): 778 doi: 10.1097/AOG.0000000000003754
|
| 413 |
Kazem Baesi, Ali Akbar Velayati, Masoumeh Farrokh Ashtiani, Kamal Fakhredini, Mohammad Banifazl, Mona Sadat Larijani, Parya Basimi, Amitis Ramezani. Prevalence of Naturally Occurring Resistance Associated Substitutions in NS3/4AProtease Inhibitors in Iranian HCV/HIV Infected Patients. Current HIV Research 2021; 19(5): 391 doi: 10.2174/1566523221666210707142838
|
| 414 |
Sanja Kiprijanovska, Emilija Sukarova Stefanovska, Predrag Noveski, Viktorija Chaloska Ivanova, Dijana Plaseska-Karanfilska. Influence of OASL gene polymorphisms on host response to interferon therapy in chronic hepatitis C virus patients. The EuroBiotech Journal 2017; 1(2): 117 doi: 10.24190/ISSN2564-615X/2017/02.02
|
| 415 |
K.T. Nachammai, R. Srinithi, P. Sangavi, R. Sangeetha, S. Gowtham Kumar, R. Lakshmi Sundaram, Kulanthaivel Langeswaran. Phospholipases in Physiology and Pathology. 2023; : 219 doi: 10.1016/B978-0-323-95697-0.00008-X
|
| 416 |
Rohan Janardhan Meshram, Gunderao Hanumantrao Kathwate, Rajesh Nivarti Gacche. Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections. Archives of Virology 2022; 167(3): 717 doi: 10.1007/s00705-022-05375-0
|
| 417 |
Matthias Van Haele, Janne Snoeck, Tania Roskams. Human Liver Regeneration: An Etiology Dependent Process. International Journal of Molecular Sciences 2019; 20(9): 2332 doi: 10.3390/ijms20092332
|
| 418 |
Marta Miarons, Azhara Sánchez-Ulayar, Glòria Sempere, Sergio Marín, Josep Maria Castellví. New direct-acting antivirals for hepatitis C treatment and neuropsychiatric symptoms in psychiatric risk groups. European Journal of Hospital Pharmacy 2019; 26(3): 135 doi: 10.1136/ejhpharm-2017-001352
|
| 419 |
Dinesh Jothimani, Radhika Venugopal, Mukul Vij, Mohamed Rela. Post liver transplant recurrent and de novo viral infections. Best Practice & Research Clinical Gastroenterology 2020; : 101689 doi: 10.1016/j.bpg.2020.101689
|
| 420 |
Zobair M. Younossi, Maria Stepanova, Linda Henry, Kwang‐Hyub Han, Sang Hoon Ahn, Young‐Suk Lim, Wan‐Long Chuang, Jia‐Horng Kao, Kinh V. Nguyen, Ching Lung Lai, Henry Lik‐Yuen Chan, Lai Wei. Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health‐related quality of life in East Asian patients with hepatitis C virus infection. Journal of Viral Hepatitis 2018; 25(12): 1429 doi: 10.1111/jvh.12965
|
| 421 |
Karen L. Christopher, Jennifer L. Patnaik, Kylie J. Penland, Mina B. Pantcheva, Anne M. Lynch, Cristos Ifantides. Outcomes and Risk Factors for Complications in Cataract Patients with Hepatitis C Virus Infection. Ophthalmic Epidemiology 2023; 30(5): 492 doi: 10.1080/09286586.2022.2131836
|
| 422 |
Mohsen Gadallah, Sahar Kandil, Amira Mohsen. Association between hepatitis C infection and cerebro‐cardiovascular disease: analysis of a national population‐based survey in Egypt. Tropical Medicine & International Health 2018; 23(7): 738 doi: 10.1111/tmi.13068
|
| 423 |
Yu Xiang, Xiao‐fei Lai, Pu Chen, Yang Yang. The correlation of HCV RNA and HCV core antigen in different genotypes of HCV. Journal of Clinical Laboratory Analysis 2019; 33(1) doi: 10.1002/jcla.22632
|
| 424 |
Kristin Nygaard-Odeh, Hedda Soloy-Nilsen, Magnhild Gangsoy Kristiansen, Ole Lars Brekke, Tom Eirik Mollnes, Michael Berk, Jorgen G. Bramness, Terje Oiesvold. Cytokines in hepatitis C-infected patients with or without opioid maintenance therapy. Acta Neuropsychiatrica 2024; : 1 doi: 10.1017/neu.2023.56
|
| 425 |
Arnolfo Petruzziello, Giovanna Loquercio, Rocco Sabatino, Daniel Vasile Balaban, Najeeb Ullah Khan, Mauro Piccirillo, Luis Rodrigo, Lucia di Capua, Annunziata Guzzo, Francesco Labonia, Gerardo Botti. Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic review. Journal of Clinical Laboratory Analysis 2019; 33(5) doi: 10.1002/jcla.22876
|
| 426 |
Gerald Denk, Christian Lange. Update Hepatitis C. MMW - Fortschritte der Medizin 2022; 164(17): 60 doi: 10.1007/s15006-022-1841-8
|
| 427 |
Linh Tran, Mai Nhu Y, Thai Le Ba Nghia, Abdulrahman Hendam, Nguyen Lam Vuong, Ebrahim Alzalal, Ahmed M. Sayed, Mustafa Mushtaq Hussain, Akash Sharma, Thuan Tieu, Peterson Gitonga Mathenge, Kenji Hirayama, Neal Alexander, Nguyen Tien Huy. Frequent inappropriate use of unweighted summary statistics in systematic reviews of pathogen genotypes or genogroups. Journal of Clinical Epidemiology 2020; 119: 26 doi: 10.1016/j.jclinepi.2019.11.009
|
| 428 |
Stephen Ejeh, Adamu Uzairu, Gideon Adamu Shallangwa, Stephen E. Abechi. Computer-aided identification of a series of novel ligands showing high potency as hepatitis C virus NS3/4A protease inhibitors. Bulletin of the National Research Centre 2021; 45(1) doi: 10.1186/s42269-020-00467-w
|
| 429 |
Elena Chernykh, Olga Leplina, Ekaterina Oleynik, Marina Tikhonova, Tamara Tyrinova, Natalia Starostina, Alexandr Ostanin. Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial). Immunologic Research 2018; 66(1): 31 doi: 10.1007/s12026-017-8967-2
|
| 430 |
Lubomír Skladaný, Marian Oltman, Soňa Fraňková, Sylvia Dražilová, Petr Husa, Jan Šperl, Václav Hejda, Petr Urbánek, Svetlana Adamcová-Selčanová, Martin Janičko, Pavol Kristian, Viera Kupčová, Marek Rác, Ivan Schréter, Ladislav Virág, Adriana Liptáková, Miriam Ondrášová, Peter Jarčuška. Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristics. International Journal of Public Health 2020; 65(9): 1723 doi: 10.1007/s00038-020-01496-y
|
| 431 |
Ifeyinwa M. Okafor, Solomon O. Ugwu, Henshaw U. Okoroiwu. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01504-8
|
| 432 |
Hamzah Z Farooq, Michael James, Jane Abbott, Patrick Oyibo, Pip Divall, Naheed Choudhry, Graham R Foster. Risk factors for hepatocellular carcinoma associated with hepatitis C genotype 3 infection: A systematic review. World Journal of Gastrointestinal Oncology 2024; 16(4): 1596-1612 doi: 10.4251/wjgo.v16.i4.1596
Abstract(36) |
Core Tip(44) |
Full Article(HTML)(230)
|
Full Article with Cover (PDF)-2578K(8)
|
Audio-891K(0)
|
Peer-Review Report-311K(4)
|
Answering Reviewers-179K(3)
|
Supplementary Material-241K(4)
|
Full Article (PDF)-2349K(16)
|
Full Article (XML)-162K(4)
|
Times Cited (0)
|
Total Visits (531)
|
Open
|
| 433 |
Rowan Ahmed, Roaa Kareem, Nanditha Venkatesan, Rinky A Botleroo, Opemipo D Ogeyingbo, Renu Bhandari, Mallika Gyawali, Abeer O Elshaikh. Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection. Cureus 2021; doi: 10.7759/cureus.17237
|
| 434 |
Di Wu, Shiping Hu, Guozi Chen, Longjiao Chen, Jian Liu, Wenlin Chen, Youwen Lv, Xiaoni Chen, Shan Lin, Fenfang Wu. Association of hepatitis C infection and risk of kidney cancer: A systematic review and meta‐analysis of observational studies. Journal of Viral Hepatitis 2021; 28(2): 226 doi: 10.1111/jvh.13434
|
| 435 |
Ling-Xiao Qu, Yang Shi, Kai-Yun Chen, Yi-Han Lu, Hong Ren. The distribution of hepatitis C virus infection in Shanghai, China: a time-spatial study. BMC Infectious Diseases 2021; 21(1) doi: 10.1186/s12879-021-06577-8
|
| 436 |
Hany M. Elsadek, Elsayed S. Abdelbaser, Mohamed H. Emara, Hanan H. Soliman, Alaa A. Farag. Morbidity and mortality during hepatitis C treatment using sofosbuvir and daclatasvir with or without ribavirin, in a cohort of Egyptian patients. European Journal of Gastroenterology & Hepatology 2020; 32(8): 1046 doi: 10.1097/MEG.0000000000001695
|
| 437 |
José A. Gálvez, Rafael Clavería-Gimeno, Juan J. Galano-Frutos, Javier Sancho, Adrian Velázquez-Campoy, Olga Abian, María D. Díaz-de-Villegas. Stereoselective synthesis and biological evaluation as inhibitors of hepatitis C virus RNA polymerase of GSK3082 analogues with structural diversity at the 5-position. European Journal of Medicinal Chemistry 2019; 171: 401 doi: 10.1016/j.ejmech.2019.03.019
|
| 438 |
Lai Wei, Guiqiang Wang, Negar N Alami, Wen Xie, Jeong Heo, Qing Xie, Mingxiang Zhang, Yoon Jun Kim, Seng Gee Lim, Linda M Fredrick, Wenjing Lu, Wei Liu, Hari V Kalluri, Preethi Krishnan, Rakesh Tripathi, Niloufar Mobashery, Margaret Burroughs, Armen Asatryan, Jidong Jia, Jinlin Hou. Glecaprevir–pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies—a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2). The Lancet Gastroenterology & Hepatology 2020; 5(9): 839 doi: 10.1016/S2468-1253(20)30086-8
|
| 439 |
Talaat Zakareya, Mostafa Elhelbawy, Hassan Elzohry, Mohamed Eltabbakh, Mohamed Deif, Mohamed Abbasy, Tatsuo Kanda. Long-Term Impact of Hepatitis C Virus Eradication on Liver Stiffness in Egyptian Patients. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/4961919
|
| 440 |
Trodia Zitha, Chien-Yu Chen, Hatim Mudawi, Waleed Hussein, Maowia Mukhtar, Mazin Shigidi, Mohamed Elamin Awad Yousif, Mohammed Ahmed Ali, Dieter Glebe, Anna Kramvis. Molecular characterization and genotyping of hepatitis C virus from Sudanese end-stage renal disease patients on haemodialysis. BMC Infectious Diseases 2022; 22(1) doi: 10.1186/s12879-022-07833-1
|
| 441 |
Shweta Kumari, Amit Kessel, Divya Singhal, Gurpreet Kaur, David Bern, Claudèle Lemay-St-Denis, Jasdeep Singh, Sahil Jain. Computational identification of a multi-peptide vaccine candidate in E2 glycoprotein against diverse Hepatitis C virus genotypes. Journal of Biomolecular Structure and Dynamics 2023; 41(20): 11044 doi: 10.1080/07391102.2023.2212777
|
| 442 |
Elisabete Andrade, Daniele Rocha, Marcela Fontana-Maurell, Elaine Costa, Marisa Ribeiro, Daniela Tupy de Godoy, Antonio G.P. Ferreira, Amilcar Tanuri, Patrícia Alvarez, Rodrigo Brindeiro. One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in Brazil. The Brazilian Journal of Infectious Diseases 2018; 22(5): 418 doi: 10.1016/j.bjid.2018.08.003
|
| 443 |
Kaho H. Tisthammer, Weiyan Dong, Jeffrey B. Joy, Pleuni S. Pennings. Comparative Analysis of Within-Host Mutation Patterns and Diversity of Hepatitis C Virus Subtypes 1a, 1b, and 3a. Viruses 2021; 13(3): 511 doi: 10.3390/v13030511
|
| 444 |
Christine Chang, Chao‐Hung Hung, Jing‐Houng Wang, Sheng‐Nan Lu. Hepatitis C core antigen highly correlated to HCV RNA. The Kaohsiung Journal of Medical Sciences 2018; 34(12): 684 doi: 10.1016/j.kjms.2018.08.002
|
| 445 |
Petra Surlin, Dorin Nicolae Gheorghe, Liliana Foia, Amelia Surdu, Vasilica Toma, Sorina Mihaela Solomon, Dan Nicolae Florescu, Ion Rogoveanu. Hepatitis C - From Infection to Cure. 2018; doi: 10.5772/intechopen.76135
|
| 446 |
Adel A Alhazmi, Alhanouf Almuflihi, Mohammed M Aly, Abdelgaffar Mohammed, Abdulrahman Alshehri. Hepatitis C-induced Sjögren’s Syndrome With Positive Serology: A Case Report. Cureus 2021; doi: 10.7759/cureus.20091
|
| 447 |
Stephen Ejeh, Adamu Uzairu, Gideon A. Shallangwa, Stephen E. Abechi, Muhammad Tukur Ibrahim. Pharmacoinformatics-based strategy in designing and profiling of some Pyrazole analogues as novel hepatitis C virus inhibitors with pharmacokinetic analysis. Egyptian Journal of Basic and Applied Sciences 2023; 10(1): 240 doi: 10.1080/2314808X.2023.2185994
|
| 448 |
Yu. V. Ostankova, D. E. Valutite, E. B. Zueva, E. N. Serikova, A. N. Shchemelev, S. Boumbaly, T. A.L. Balde, A. V. Semenov. Primary HCV Drug Resistance Mutations in Patients with Newly Diagnosed HIV Infection. Problems of Particularly Dangerous Infections 2020; (3): 97 doi: 10.21055/0370-1069-2020-3-97-105
|
| 449 |
T.L. Hrydina . PECULIARITIES OF TREATMENT AND PREVENTION OF INFECTION CAUSED BY HEPATITIS C VIRUS. Review. Medical Science of Ukraine (MSU) 2022; 18(1): 64 doi: 10.32345/2664-4738.1.2022.09
|
| 450 |
Nicola Coppola, Loredana Alessio, Lorenzo Onorato, Caterina Sagnelli, Margherita Macera, Evangelista Sagnelli, Mariantonietta Pisaturo. Epidemiology and management of hepatitis C virus infections in immigrant populations. Infectious Diseases of Poverty 2019; 8(1) doi: 10.1186/s40249-019-0528-6
|
| 451 |
Dorota Zarębska-Michaluk. Genotype 3-hepatitis C virus’ last line of defense. World Journal of Gastroenterology 2021; 27(11): 1006-1021 doi: 10.3748/wjg.v27.i11.1006
|
| 452 |
Bin Wei, Fanpu Ji, Yee Hui Yeo, Eiichi Ogawa, Christopher D Stave, Shuangsuo Dang, Zongfang Li, Norihiro Furusyo, Ramsey C Cheung, Mindie H Nguyen. Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia. BMJ Open Gastroenterology 2018; 5(1): e000209 doi: 10.1136/bmjgast-2018-000209
|
| 453 |
Bing-Ru Wu, Auda A. Eltahla, Elizabeth Keoshkerian, Melanie R. Walker, Alex Underwood, Nicholas A. Brasher, David Agapiou, Andrew R. Lloyd, Rowena A. Bull. A method for detecting hepatitis C envelope specific memory B cells from multiple genotypes using cocktail E2 tetramers. Journal of Immunological Methods 2019; 472: 65 doi: 10.1016/j.jim.2019.06.016
|
| 454 |
Lin Li, Xian Jiang, Lixin Fu, Liwen Zhang, Yanyan Feng. Reactivation rates of hepatitis B or C or HIV in patients with psoriasis using biological therapies: a systematic review and meta-analysis. Clinical and Experimental Medicine 2022; 23(3): 701 doi: 10.1007/s10238-022-00827-y
|
| 455 |
Letícia Bomfim Campos, Nathália Alves Araújo de Almeida, Catarina Góis de Santana, Evorah Nascimento Pereira Barbosa, Marco Aurelio Pereira Horta, Márcia Amendola Pires, Carlos Eduardo Brandão Mello, Vanessa Salete de Paula, José Júnior França de Barros. Before Direct-Acting Antivirals for Hepatitis C Virus: Evaluation of Core Protein R70Q and L/C91M Substitutions in Chronically Infected Brazilian Patients Unresponsive to IFN and/or RBV. Viruses 2023; 15(1): 187 doi: 10.3390/v15010187
|
| 456 |
Yu Jun Wong, Prem Harichander Thurairajah, Rahul Kumar, Jessica Tan, Kwong Ming Fock, Ngai Moh Law, Weiquan Li, Andrew Kwek, Yu Bin Tan, Jingyun Koh, Zheng Cong Lee, Loshini Senthil Kumar, Eng Kiong Teo, Tiing‐Leong Ang. Efficacy and safety of sofosbuvir/velpatasvir in a real‐world chronic hepatitis C genotype 3 cohort. Journal of Gastroenterology and Hepatology 2021; 36(5): 1300 doi: 10.1111/jgh.15324
|
| 457 |
Kimia Kardani, Parya Basimi, Mehrshad Fekri, Azam Bolhassani. Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine development. Expert Review of Clinical Pharmacology 2020; 13(9): 1001 doi: 10.1080/17512433.2020.1814743
|
| 458 |
Elodie Laugel, Cédric Hartard, Hélène Jeulin, Sibel Berger, Véronique Venard, Jean‐Pierre Bronowicki, Evelyne Schvoerer. Full‐length genome sequencing of RNA viruses—How the approach can enlighten us on hepatitis C and hepatitis E viruses. Reviews in Medical Virology 2021; 31(4) doi: 10.1002/rmv.2197
|
| 459 |
Cole M. Howie, Kyle H. Cichos, Mohamed G. Shoreibah, Eric M. Jordan, Kian R. Niknam, Antonia F. Chen, Erik N. Hansen, Gerald G. McGwin, Elie S. Ghanem. Racial Disparities in Treatment and Outcomes of Patients With Hepatitis C Undergoing Elective Total Joint Arthroplasty. The Journal of Arthroplasty 2024; doi: 10.1016/j.arth.2024.01.054
|
| 460 |
Ignacio Postigo-Hidalgo, N’Faly Magassouba, Barré Soropogui, Elisabeth Fichet-Calvet, Jan Felix Drexler. Association of hepatitis C virus genotype 2 spread with historic slave trade and commerce routes in Western Africa. Virus Evolution 2022; 8(2) doi: 10.1093/ve/veac066
|
| 461 |
Jean Damascene Makuza, Carol Y. Liu, Corneille Killy Ntihabose, Donatha Dushimiyimana, Sabine Umuraza, Marie Paul Nisingizwe, Justine Umutesi, Janvier Serumondo, Soline Dusabeyesu Mugeni, Muhamed Semakula, Neil Gupta, Margaret Hellard, Sabin Nsanzimana. Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4322-7
|
| 462 |
Lyudmila I. Nikolaeva, Alexander N. Belyavtsev, Nadezhda G. Shevchenko, Maya D. Stuchinskaya, Evgeniy I. Samokhvalov, Anna V. Dedova, Georgiy V. Sapronov, Nataliya S. Shastina, Victor V. Kuprianov. The analysis of immunoreactivity of individual B-cell epitopes of hepatitis C virus <i>(Flaviviridae: Hepacivirus: Hepatitis С virus)</i> NS4a antigen. Problems of Virology 2022; 67(3): 237 doi: 10.36233/0507-4088-115
|
| 463 |
Meriem Kacem, Wafa Dhouib, Cyrine Bennasrallah, Imen Zemni, Hela Abroug, Manel Ben Fredj, Arwa Guedich, Leila Safer, Nissaf Ben Alaya, Maha Mastouri, Ines Bouanene, Asma Sriha Belguith, Isabelle Chemin. Occupational exposure to hepatitis C virus infection and associated factors among healthcare workers in Fattouma Bourguiba University Hospital, Tunisia. PLOS ONE 2022; 17(9): e0274609 doi: 10.1371/journal.pone.0274609
|
| 464 |
Shah Jahan Shayan, Rajab Nazari, Frank Kiwanuka. Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis. Harm Reduction Journal 2021; 18(1) doi: 10.1186/s12954-021-00505-4
|
| 465 |
Nicolas Salvadori, Jullapong Achalapong, Chonlatorn Boontan, Choosakun Piriya, Surachet Arunothong, Sawitree Nangola, Chiraphat Kloypan, Eakkapote Prompunt, Woottichai Khamduang, Phornphimon Moolnoi, Sakorn Pornprasert, Sumet Ongwandee, Jean Yves Mary, Gonzague Jourdain, Nicole Ngo‐Giang‐Huong. Uptake, acceptability and interpretability of 3‐in‐1 rapid blood self‐testing for HIV, hepatitis B and hepatitis C. Journal of the International AIDS Society 2022; 25(12) doi: 10.1002/jia2.26053
|
| 466 |
Kuhu Chatterjee, Rohit Gupta, Balram Ji Omar, Pratima Gupta, Deepjyoti Kalita. Genotypic distribution of hepatitis C virus in Uttarakhand. Indian Journal of Medical Microbiology 2021; 39(4): 479 doi: 10.1016/j.ijmmb.2021.06.009
|
| 467 |
Mortada El‐Shabrawi, Sherif Baroudy, Fetouh Hassanin, Ahmed Saed Behairy, Mostafa Yakoot, Ayaat Ahmed. Follow‐up of chronic paediatric hepatitis C virus in a low‐/middle‐income country. Acta Paediatrica 2020; 109(12): 2699 doi: 10.1111/apa.15333
|
| 468 |
Yingjun Ma, Junjiang Zhong. Logistic tensor decomposition with sparse subspace learning for prediction of multiple disease types of human–virus protein–protein interactions. Briefings in Bioinformatics 2023; 24(1) doi: 10.1093/bib/bbac604
|
| 469 |
Detection Of Hepatitis C Virus (Hcv) Infection And Its Genotype In Patients At Hepatology Outpatient Clinic, Dr Soetomo General Hospital, Surabaya.. IOP Conference Series: Earth and Environmental Science 2019; 217: 012051 doi: 10.1088/1755-1315/217/1/012051
|
| 470 |
David Powell, Abby Alpert, Rosalie L. Pacula. A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C. Health Affairs 2019; 38(2): 287 doi: 10.1377/hlthaff.2018.05232
|
| 471 |
Shakir Abdulrahman Jamal, Ibrahim Abdulqader Naqid, Nawfal Rasheed Hussein, Solav Rashed Abdulqader, Avan Ali Nimet, Haider Adil Abdulkhdair, Ramyar Abubakr Qader. The Prevalence of Hepatitis B and C Virus Infections in the Couples Attending a Premarital Screening Program in Zakho City, Kurdistan Region of Iraq. Zahedan Journal of Research in Medical Sciences 2021; (In Press) doi: 10.5812/zjrms.99405
|
| 472 |
Norah A. Terrault, Miriam T. Levy, Ka Wang Cheung, Gonzague Jourdain. Viral hepatitis and pregnancy. Nature Reviews Gastroenterology & Hepatology 2021; 18(2): 117 doi: 10.1038/s41575-020-00361-w
|
| 473 |
Poramate Pitak-Arnnop, Keskanya Subbalekha, Nattapong Sirintawat, Chatpong Tangmanee, Prim Auychai, Chayawee Muangchan, Passanesh Sukphopetch, Jean-Paul Meningaud, Andreas Neff. Are oral lichen planus patients at high risk of hepatitis C? A case-control study. Journal of Stomatology, Oral and Maxillofacial Surgery 2022; 123(3): e37 doi: 10.1016/j.jormas.2021.07.013
|
| 474 |
Tumusime Musafiri, Innocent Kamali, Casmille Kayihura, Jean de la Paix Gakuru, Francoise Nyirahabihirwe, Esdras Nizeyimana, Pilar Kandamage, Placide Habinshuti, Raymond Sekagarura, Jean Damascene Makuza, Nadine Karema, Janvier Serumondo, Theoneste Ntakirutimana, Jean d’Amour Ndahimana, Dale A. Barnhart. Prevalence of hepatitis B and C infection and linkage to care among patients with Non-Communicable Diseases in three rural Rwandan districts: a retrospective cross-sectional study. BMC Infectious Diseases 2024; 24(1) doi: 10.1186/s12879-023-08678-y
|
| 475 |
Mohamed M. Nabeel, Rania K. Darwish, Wafaa Alakel, Rabab Maher, Hossam Mostafa, Ahmed Hashem, Mohamed Elbeshlawy, Amr Abul-Fotouh, Hend I. Shousha, Mohamad Saeed Marie. Changes in Serum Interferon Gamma and Interleukin-10 in Relation to Direct-Acting Antiviral Therapy of Chronic Hepatitis C Genotype 4: A Pilot Study. Journal of Clinical and Experimental Hepatology 2022; 12(2): 428 doi: 10.1016/j.jceh.2021.06.018
|
| 476 |
Melina Santos, Camelia Protopopescu, Elizabeth Delarocque‐Astagneau, Marc Bourlière, Ventizlava Petrov‐Sanchez, Vincent Di Beo, Dominique Larrey, Maël Baudoin, Céline Dorival, Morgane Bureau, Hélène Fontaine, Fabrice Carrat, Fabienne Marcellin, Stanislas Pol, Patrizia Carrieri. Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort). Liver International 2022; 42(1): 38 doi: 10.1111/liv.15056
|
| 477 |
Adam Trickey, Hannah Fraser, Aaron G. Lim, Josephine G. Walker, Amy Peacock, Samantha Colledge, Janni Leung, Jason Grebely, Sarah Larney, Natasha K. Martin, Louisa Degenhardt, Matthew Hickman, Margaret T. May, Peter Vickerman. Modelling the potential prevention benefits of a treat‐all hepatitis C treatment strategy at global, regional and country levels: A modelling study. Journal of Viral Hepatitis 2019; 26(12): 1388 doi: 10.1111/jvh.13187
|
| 478 |
Kumi Ozaki, Takashi Ohtani, Tomokazu Ishida, Kouki Takahashi, Shota Ishida, Kenji Takata, Toyohiko Sakai, Shohei Higuchi, Toshifumi Gabata. Liver fibrosis estimated using extracellular volume fraction obtained from dual-energy CT as a risk factor for hepatocellular carcinoma after sustained virologic response: A preliminary case–control study. European Journal of Radiology 2023; 168: 111112 doi: 10.1016/j.ejrad.2023.111112
|
| 479 |
Po-Jen Hsiao, Chia-Jen Hsiao, Fu-Ru Tsai, Yen-Lin Hou, Chih-Chien Chiu, Wen-Fang Chiang, Kun-Lin Wu, Yuan-Kuei Li, Chen Lin, Jenq-Shyong Chan, Chi-Wen Chang, Chi-Ming Chu. From Bench to Bedside: Clinical and Biomedical Investigations on Hepatitis C Virus (HCV) Genotypes and Risk Factors for Albuminuria. Bioengineering 2022; 9(10): 509 doi: 10.3390/bioengineering9100509
|
| 480 |
Mohamed A. Daw, Lutfi A. Buktir Ali, Amina M. Daw, Nadia E. M. Sifennasr, Aghnyia A. Dau, Mohamed M. Agnan, Abdallah El-Bouzedi. The geographic variation and spatiotemporal distribution of hepatitis C virus infection in Libya: 2007–2016. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3471-4
|
| 481 |
Aysegul Ozakyol. Global Epidemiology of Hepatocellular Carcinoma (HCC Epidemiology). Journal of Gastrointestinal Cancer 2017; 48(3): 238 doi: 10.1007/s12029-017-9959-0
|
| 482 |
Ankit Ganeshpurkar, Gopichand Gutti, Sushil Kumar Singh. Viral Polymerases. 2019; : 1 doi: 10.1016/B978-0-12-815422-9.00001-2
|
| 483 |
Sarah Gander, Angela Morris, Stefanie Materniak. An Evaluation of Hepatitis C Screening in Infants and Children Born to Seropositive Mothers in Saint John, New Brunswick. Cureus 2021; doi: 10.7759/cureus.17377
|
| 484 |
Curtis Mabilangan, Catherine Burton, Sheila O’Brien, Sabrina Plitt, Dean Eurich, Jutta Preiksaitis. Using blood donors and solid organ transplant donors and recipients to estimate the seroprevalence of cytomegalovirus and Epstein–Barr virus in Canada: A cross-sectional study. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2020; 5(3): 158 doi: 10.3138/jammi-2020-0005
|
| 485 |
Dorota Zarębska-Michaluk, Michał Brzdęk, Jerzy Jaroszewicz, Magdalena Tudrujek-Zdunek, Beata Lorenc, Jakub Klapaczyński, Włodzimierz Mazur, Adam Kazek, Marek Sitko, Hanna Berak, Justyna Janocha-Litwin, Dorota Dybowska, Łukasz Supronowicz, Rafał Krygier, Jolanta Citko, Anna Piekarska, Robert Flisiak. Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients. World Journal of Gastroenterology 2022; 28(45): 6380-6396 doi: 10.3748/wjg.v28.i45.6380
|
| 486 |
Amir Atapour, Pooneh Mokarram, Zohreh MostafaviPour, Seyed Younes Hosseini, Younes Ghasemi, Shiva Mohammadi, Navid Nezafat. Designing a Fusion Protein Vaccine Against HCV: An In Silico Approach. International Journal of Peptide Research and Therapeutics 2019; 25(3): 861 doi: 10.1007/s10989-018-9735-4
|
| 487 |
Luis Filipe da Costa Marques Borges, Mariano Gustavo Zalis, Guilherme Santoro‐Lopes, Rafael Brandão Varella. Hepatitis C virus genotypes in hemodialysis patients in Angola. Journal of Medical Virology 2019; 91(3): 518 doi: 10.1002/jmv.25354
|
| 488 |
Yu Jeong Choi, Boyeon Kim, Yoonjung Kim, Kyung-A Lee. Performance Evaluation of Aptima HBV and HCV Quant Assays in the Panther System. Laboratory Medicine Online 2021; 11(3): 177 doi: 10.47429/lmo.2021.11.3.177
|
| 489 |
Qi Wu, Zhubing Li, Qiang Liu. An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTEN. Virology 2018; 520: 94 doi: 10.1016/j.virol.2018.05.011
|
| 490 |
Fiona McPhee, Joseph Ueland, Vincent Vellucci, Scott Bowden, William Sievert, Nannan Zhou. Impact of Preexisting Hepatitis C Virus Genotype 6 NS3, NS5A, and NS5B Polymorphisms on theIn VitroPotency of Direct-Acting Antiviral Agents. Antimicrobial Agents and Chemotherapy 2019; 63(4) doi: 10.1128/AAC.02205-18
|
| 491 |
Tapas Patra, Ratna Ray, Ranjit Ray. Strategies to Circumvent Host Innate Immune Response by Hepatitis C Virus. Cells 2019; 8(3): 274 doi: 10.3390/cells8030274
|
| 492 |
Masako Okada, Hoang Hai, Akihiro Tamori, Sawako Uchida-Kobayashi, Masaru Enomoto, Hiromitsu Kumada, Norifumi Kawada. Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virus. Clinical Journal of Gastroenterology 2019; 12(3): 213 doi: 10.1007/s12328-018-0922-9
|
| 493 |
Panita Mettikanont, Chalermrat Bunchorntavakul, K. Rajender Reddy. Systematic review: epidemiology and response to direct‐acting antiviral therapy in genotype 6 chronic hepatitis C virus infection. Alimentary Pharmacology & Therapeutics 2019; 49(5): 492 doi: 10.1111/apt.15100
|
| 494 |
Mohammad Asrar Izhari. Molecular Mechanisms of Resistance to Direct-Acting Antiviral (DAA) Drugs for the Treatment of Hepatitis C Virus Infections. Diagnostics 2023; 13(19): 3102 doi: 10.3390/diagnostics13193102
|
| 495 |
Nawfal R Hussein, Hashim A Sharaf, Shaveen Mahdi. The Prevalence of Hepatitis C Virus Infection in Pregnant Women in Duhok City, Kurdistan Region of Iraq: A Brief Report. Women’s Health Bulletin 2019; (In Press) doi: 10.5812/whb.91494
|
| 496 |
Nesrin Dilbaz, Murat Kuloğlu, Ekrem Cuneyt Evren, Salih Cihat Paltun, Rabia Bilici, Cemal Onur Noyan, Burak Kulaksizoglu, Vahap Karabulut, Gokhan Umut, Basak Unubol, Enver Ucbilek. HCV Genotype Distribution Among People Who Inject Drug in Turkey: Findings from Multicenter and Cross-Sectional Study. Substance Abuse: Research and Treatment 2023; 17: 117822182311573 doi: 10.1177/11782218231157340
|
| 497 |
Winita Hardikar. Viral hepatitis. Journal of Paediatrics and Child Health 2019; 55(9): 1038 doi: 10.1111/jpc.14562
|
| 498 |
Rachel E. Gicquelais, Betsy Foxman, Joseph Coyle, Marisa C. Eisenberg. Hepatitis C transmission in young people who inject drugs: Insights using a dynamic model informed by state public health surveillance. Epidemics 2019; 27: 86 doi: 10.1016/j.epidem.2019.02.003
|
| 499 |
Joost W. Geenen, Cornelis Boersma, Olaf H. Klungel, Anke M. Hövels. Accuracy of budget impact estimations and impact on patient access: a hepatitis C case study. The European Journal of Health Economics 2019; 20(6): 857 doi: 10.1007/s10198-019-01048-z
|
| 500 |
Ali Hamza, Iftikhar Ahmad, Muhammad Uneeb. Fuzzy logic and Lyapunov‐based non‐linear controllers for HCV infection. IET Systems Biology 2021; 15(2): 53 doi: 10.1049/syb2.12014
|
| 501 |
Hosnieh Fathi, Andrew Clark, Nathan R. Hill, Geoffrey Dusheiko. Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic review. BMC Infectious Diseases 2017; 17(1) doi: 10.1186/s12879-017-2820-z
|
| 502 |
Henrique Pott, Matheus Theodoro, Juliana de Almeida Vespoli, Jorge Figueiredo Senise, Adauto Castelo. Mother-to-child transmission of hepatitis C virus. European Journal of Obstetrics & Gynecology and Reproductive Biology 2018; 224: 125 doi: 10.1016/j.ejogrb.2018.03.034
|
| 503 |
Sayed Muh Reza Mousawee, Maryam Moossavi, Afsane Bahrami, Hamidullah Rasekh, Mohammad Sadegh Naghizadeh, Hassn Abd, Mohammad Fereidouni. The Prevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency Viral Infections Among a Large Population of Afghans. Hepatitis Monthly 2020; 20(7) doi: 10.5812/hepatmon.101012
|
| 504 |
Leona Radmanić, Petra Šimičić, Kristian Bodulić, Adriana Vince, Snjezana Zidovec-Lepej. Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C. Cytokine 2024; 176: 156529 doi: 10.1016/j.cyto.2024.156529
|
| 505 |
Ilya Bendich, Steven Takemoto, Joseph T. Patterson, Alexander Monto, Thomas C. Barber, Alfred C. Kuo. Preoperative Treatment of Hepatitis C Is Associated With Lower Prosthetic Joint Infection Rates in US Veterans. The Journal of Arthroplasty 2019; 34(7): S319 doi: 10.1016/j.arth.2019.02.052
|
| 506 |
Junjie Huang, Veeleah Lok, Chun Ho Ngai, Cedric Chu, Harsh K. Patel, Viveksandeep Thoguluva Chandraseka, Lin Zhang, Ping Chen, Shanjuan Wang, Xiang-Qian Lao, Lap Ah Tse, Wanghong Xu, Zhi-Jie Zheng, Martin C.S. Wong. Disease Burden, Risk Factors, and Recent Trends of Liver Cancer: A Global Country-Level Analysis. Liver Cancer 2021; 10(4): 330 doi: 10.1159/000515304
|
| 507 |
Markus Reiser, Bianka Wiebner, Jürgen Hirsch. Neural-network analysis of socio-medical data to identify predictors of undiagnosed hepatitis C virus infections in Germany (DETECT). Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1832-4
|
| 508 |
Тамара Васильевна Антонова, М. С. Ножкин, Д. А. Лиознов. Хронический гепатит С и онкогематологические заболевания. Clinical Oncohematology 2024; 16(1): 46 doi: 10.21320/2500-2139-2023-16-1-46-53
|
| 509 |
Martin C. S. Wong, Jason L. W. Huang, Jacob George, Junjie Huang, Colette Leung, Mohammed Eslam, Henry L. Y. Chan, Siew C. Ng. The changing epidemiology of liver diseases in the Asia–Pacific region. Nature Reviews Gastroenterology & Hepatology 2019; 16(1): 57 doi: 10.1038/s41575-018-0055-0
|
| 510 |
|
| 511 |
Claudia Palladino, Ifeanyi Jude Ezeonwumelu, Rute Marcelino, Verónica Briz, Inês Moranguinho, Fátima Serejo, José Fernando Velosa, Rui Tato Marinho, Pedro Borrego, Nuno Taveira. Epidemic history of hepatitis C virus genotypes and subtypes in Portugal. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30528-0
|
| 512 |
Joost Boeckmans, Matthias Rombaut, Thomas Demuyser, Baptist Declerck, Denis Piérard, Vera Rogiers, Joery De Kock, Luc Waumans, Koen Magerman, Reinoud Cartuyvels, Jean-Luc Rummens, Robim M. Rodrigues, Tamara Vanhaecke. Infections at the nexus of metabolic-associated fatty liver disease. Archives of Toxicology 2021; 95(7): 2235 doi: 10.1007/s00204-021-03069-1
|
| 513 |
Batbold Batsaikhan, Ching‐I Huang, Ming‐Lun Yeh, Chung‐Feng Huang, Po‐Cheng Liang, Ming‐Yen Hsieh, Jee‐Fu Huang, Ming‐Lung Yu, Wan‐Long Chuang, Jin‐Ching Lee, Pei‐Lun Lee, Chia‐Yen Dai. Association between cryoglobulinemia and liver fibrosis in chronic hepatitis C patients. Journal of Gastroenterology and Hepatology 2018; 33(11): 1897 doi: 10.1111/jgh.14275
|
| 514 |
Wei Wang, Xiaojun Kong, Guangchao Zhao, Xuelian Huang, Jun Yuan, Na Li, Xiaonan Zhang, Kaiyun Luo, Jianfeng Luan, Xuzhou Fan. Seroprevalence of Transfusion Transmissible Infections and Associated Risk Factors in Hospitalized Patients before Transfusion in Jinling Hospital Nanjing University: A Three-Year Retrospective Study. Pathogens 2022; 11(6): 710 doi: 10.3390/pathogens11060710
|
| 515 |
Roya Kahyesh‐Esfandiary, Zohreh‐Azita Sadigh, Maryam Esghaei, Mohammad‐Navid Bastani, Tahereh Donyavi, Alireza Najafi, Atousa Fakhim, Farah Bokharaei‐Salim. Detection of HCV genome in peripheral blood mononuclear cells of Iranian seropositive and HCV RNA negative in plasma of patients with beta‐thalassemia major: Occult HCV infection. Journal of Medical Virology 2019; 91(1): 107 doi: 10.1002/jmv.25279
|
| 516 |
Salvo Danilo Lombardo, Sebastiano Lombardo. Global stability for a mathematical model of hepatitis C: Impact of a possible vaccination with DAAs therapy. RENEWABLE ENERGY SOURCES AND TECHNOLOGIES 2019; 2161: 030020 doi: 10.1063/1.5127485
|
| 517 |
EMILY HAMBURG-SHIELDS, MONA PRASAD. Infectious Hepatitis in Pregnancy. Clinical Obstetrics & Gynecology 2020; 63(1): 175 doi: 10.1097/GRF.0000000000000512
|
| 518 |
Tsung-Lung Tsai, Huei-Min Jhou, Frank S Fan. Conspicuous Response to Direct-Acting Antivirals in Chronic Hepatitis C-related Immune Thrombocytopenia: A Case Report. Cureus 2022; doi: 10.7759/cureus.24193
|
| 519 |
K. G. Young, K. Haq, S. MacLean, R. Dudani, S. M. Elahi, R. Gilbert, R. D. Weeratna, L. Krishnan. Development of a recombinant murine tumour model using hepatoma cells expressing hepatitis C virus nonstructural antigens. Journal of Viral Hepatitis 2018; 25(6): 649 doi: 10.1111/jvh.12856
|
| 520 |
Antonio Travaglino, Silvia Varricchio, Mirella Pace, Adriana Iuliano, Marco Picardi, Fausto Tranfa, Stefania Staibano, Massimo Mascolo. Hepatitis C virus in MALT-lymphoma of the ocular adnexa. Pathology - Research and Practice 2020; 216(4): 152864 doi: 10.1016/j.prp.2020.152864
|
| 521 |
Muhammad Junaid Azhar, Noor Khalid, Shanza Azhar, Umer Irshad, Hassaan Ahmed, Tayyab Mumtaz Khan, Samat Habib , Zuha Ali, Yumnah Anwar, Muhammad Bilal. Study of the Effect of Different Hepatitis C Virus Genotypes on Splenomegaly. Cureus 2020; doi: 10.7759/cureus.10164
|
| 522 |
Ashwin Rammohan. Current management & future directions in post-liver transplant recurrence of viral hepatitis. Journal of Liver Transplantation 2021; 3: 100027 doi: 10.1016/j.liver.2021.100027
|
| 523 |
ChandraLekha Saravanan, Mahalakshmi Baskar, Sheik S.S.J. Ahmed, Ramakrishnan Veerabathiran. Oncogenic Viruses. 2023; : 147 doi: 10.1016/B978-0-12-824156-1.00006-6
|
| 524 |
Alaa Badawi, Giancarlo Di Giuseppe, Paul Arora, Hans Tillmann. Cardiovascular disease risk in patients with hepatitis C infection: Results from two general population health surveys in Canada and the United States (2007-2017). PLOS ONE 2018; 13(12): e0208839 doi: 10.1371/journal.pone.0208839
|
| 525 |
Vivek Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, Pankti Balar, Avinash Khadela, Dixa Vaghela, Shruti Soni, Charles R. Ashby, Amit K. Tiwari. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes. Cancer Reports 2023; 6(S1) doi: 10.1002/cnr2.1821
|
| 526 |
Hossam Gewaid, Haruyo Aoyagi, Minetaro Arita, Koichi Watashi, Ryosuke Suzuki, Shota Sakai, Keigo Kumagai, Toshiyuki Yamaji, Masayoshi Fukasawa, Fumihiro Kato, Takayuki Hishiki, Ayako Mimata, Yuriko Sakamaki, Shizuko Ichinose, Kentaro Hanada, Masamichi Muramatsu, Takaji Wakita, Hideki Aizaki, Mark T. Heise. Sphingomyelin Is Essential for the Structure and Function of the Double-Membrane Vesicles in Hepatitis C Virus RNA Replication Factories. Journal of Virology 2020; 94(23) doi: 10.1128/JVI.01080-20
|
| 527 |
Maria Guido, Alessandra Mangia, Neil D. Theise. MacSween's Pathology of the Liver. 2024; : 402 doi: 10.1016/B978-0-7020-8228-3.00006-5
|
| 528 |
Sonia Samuel, Ahmad Abulawi, Raza Malik. Hepatitis C and Nonalcoholic Steatohepatitis in the 21st Century: Impact on Liver Disease and Liver Transplantation. Gastroenterology Insights 2023; 14(3): 249 doi: 10.3390/gastroent14030018
|
| 529 |
Mei-Yueh Lee, Wei-Chun Chen, Wei-Hao Hsu, Szu-Chia Chen, Jin-Ching Lee. Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism. International Journal of Molecular Sciences 2019; 20(18): 4569 doi: 10.3390/ijms20184569
|
| 530 |
Kazeem Adeboyejo, Victória Riquena Grosche, Diego Pandeló José, Giulia Magalhães Ferreira, Jacqueline Farinha Shimizu, Barnabas J. King, Alexander W. Tarr, Márcia Maria Costa Nunes Soares, Jonathan K. Ball, C. Patrick McClure, Ana Carolina Gomes Jardim. Simultaneous determination of HCV genotype and NS5B resistance associated substitutions using dried serum spots from São Paulo state, Brazil.
Access Microbiology
2022; 4(3) doi: 10.1099/acmi.0.000326
|
| 531 |
Kadir Gişi, Murat İspiroğlu, Ahmet Rıza Şahin, Murat Aral, Bülent Kantarçeken. Hepatitis C Genotype Distribution Changing Through Years in the Kahramanmaraş Region. Viral Hepatitis Journal 2022; 28(2): 67 doi: 10.4274/vhd.galenos.2022.2021-2-3
|
| 532 |
Asma Ahsan, Saira Dar, Fareeha Hassan, Farkhanda Ghafoor, Muhammad Haroon Yousuf, Syed Shahzad-ul-Hussan, Sripathi M Sureban. Characterization of linear epitope specificity of antibodies potentially contributing to spontaneous clearance of hepatitis C virus. PLOS ONE 2021; 16(8): e0256816 doi: 10.1371/journal.pone.0256816
|
| 533 |
Sang Hoon Ahn, Won Hyeok Choe, Yoon Jun Kim, Jeong Heo, Dorota Latarska-Smuga, Jiho Kang, Seung Woon Paik. Impact of Interferon-Based Treatment on Quality of Life and Work-Related Productivity of Korean Patients with Chronic Hepatitis C. Gut and Liver 2020; 14(3): 368 doi: 10.5009/gnl18100
|
| 534 |
Marwa S. Abdel-Tawab, Hanan H. Fouad, Dalia A. Omran, Aml E. Abdou, Shaimaa Mohamed Zaied, Alaa A. Mohamed, Dorota Formanowicz. Evaluation of Serum and Gene Expression of Galectin-4, Interleukin-27, and Complement-7 in Hepatitis C Virus-Infected Egyptian Patients. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8879758
|
| 535 |
Navaneethan Palanisamy, Dario Akaberi, Johan Lennerstrand. Protein backbone flexibility pattern is evolutionarily conserved in the Flaviviridae family: A case of NS3 protease in Flavivirus and Hepacivirus. Molecular Phylogenetics and Evolution 2018; 118: 58 doi: 10.1016/j.ympev.2017.09.015
|
| 536 |
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Immunopathogenesis of Liver Injury During Hepatitis C Virus Infection. Viral Immunology 2019; 32(3): 112 doi: 10.1089/vim.2018.0124
|
| 537 |
Michael Murray. Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents. Clinical Pharmacokinetics 2023; 62(10): 1365 doi: 10.1007/s40262-023-01302-x
|
| 538 |
Abdullah Ely, Prashika Singh, Tiffany S. Smith, Patrick Arbuthnot. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection. Advanced Drug Delivery Reviews 2021; 168: 134 doi: 10.1016/j.addr.2020.05.010
|
| 539 |
H Elalfy, T Besheer, MA El-Maksoud, K Farid, M Elegezy, AM El Nakib, MA El-Aziz, AA El-Khalek, A El-Morsy, A Elmokadem, AZ Elsamanoudy, M El-Bendary. Monocyte/granulocyte to lymphocyte ratio and the MELD score as predictors for early recurrence of hepatocellular carcinoma after trans-arterial chemoembolization. British Journal of Biomedical Science 2018; 75(4): 187 doi: 10.1080/09674845.2018.1494769
|
| 540 |
Bin Wei, Fanpu Ji, Yee Hui Yeo, Eiichi Ogawa, Biyao Zou, Christopher D Stave, Shuangsuo Dang, Zongfang Li, Norihiro Furusyo, Ramsey C Cheung, Mindie H Nguyen. Real-world effectiveness of sofosbuvir plus ribavirin for chronic hepatitis C genotype 2 in Asia: a systematic review and meta-analysis. BMJ Open Gastroenterology 2018; 5(1): e000207 doi: 10.1136/bmjgast-2018-000207
|
| 541 |
Ali A. Rabaan, Shamsah H. Al-Ahmed, Ali M. Bazzi, Wadha A. Alfouzan, Shahab A. Alsuliman, Fatimah A. Aldrazi, Shafiul Haque. Overview of hepatitis C infection, molecular biology, and new treatment. Journal of Infection and Public Health 2020; 13(5): 773 doi: 10.1016/j.jiph.2019.11.015
|